A0_Samples	A17_Age	A18_Sex	A19_Height	A1_OS	A20_Weight	A21_BMI	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A7_Grade	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	age_at_initial_pathologic_diagnosis	age_began_smoking_in_years	assessment_timepoint_category	bcr_patient_barcode	bcr_patient_uuid	birth_control_pill_history_usage_category	cervical_carcinoma_corpus_uteri_involvement_indicator	cervical_carcinoma_pelvic_extension_text	cervical_neoplasm_pathologic_margin_involved_text	cervical_neoplasm_pathologic_margin_involved_type	day_of_form_completion	days_to_birth	days_to_death	days_to_diagnostic_computed_tomography_performed	days_to_diagnostic_mri_performed	days_to_fdg_or_ct_pet_performed	days_to_initial_pathologic_diagnosis	days_to_laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result	days_to_last_followup	days_to_performance_status_assessment	death_cause_text	diagnostic_ct_result_outcomes	diagnostic_ct_result_outcomes.diagnostic_ct_result_outcome	diagnostic_mri_result_outcomes	diagnostic_mri_result_outcomes.diagnostic_mri_result_outcome	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	eastern_cancer_oncology_group	ectopic_pregnancy_count	ethnicity	fdg_or_ct_pet_performed_outcomes	fdg_or_ct_pet_performed_outcomes.fdg_or_ct_pet_performed_outcome	female_breast_feeding_or_pregnancy_status_indicator	follow_ups.follow_up.additional_pharmaceutical_therapy	follow_ups.follow_up.additional_radiation_therapy	follow_ups.follow_up.additional_treatment_completion_success_outcome	follow_ups.follow_up.adjuvant_rad_therapy_prior_admin	follow_ups.follow_up.agent_total_dose_count	follow_ups.follow_up.assessment_timepoint_category	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.brachytherapy_administered_status	follow_ups.follow_up.brachytherapy_first_reference_point_administered_total_dose	follow_ups.follow_up.brachytherapy_method_other_specify_text	follow_ups.follow_up.brachytherapy_method_type	follow_ups.follow_up.chemotherapy_regimen_types.chemotherapy_regimen_type	follow_ups.follow_up.concurrent_chemotherapy_dose	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_additional_surgery_metastatic_procedure	follow_ups.follow_up.days_to_brachytherapy_begin_occurrence	follow_ups.follow_up.days_to_brachytherapy_end_occurrence	follow_ups.follow_up.days_to_chemotherapy_end	follow_ups.follow_up.days_to_chemotherapy_start	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.days_to_performance_status_assessment	follow_ups.follow_up.death_cause_text	follow_ups.follow_up.dose_frequency_text	follow_ups.follow_up.eastern_cancer_oncology_group	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_neoplasm_event_post_initial_therapy_diagnosis_method_text	follow_ups.follow_up.new_neoplasm_event_post_initial_therapy_diagnosis_method_type	follow_ups.follow_up.new_neoplasm_event_type	follow_ups.follow_up.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.other_chemotherapy_agent_administration_specify	follow_ups.follow_up.patient_death_reason	follow_ups.follow_up.performance_status_scale_timing	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.primary_therapy_outcome_success	follow_ups.follow_up.radiation_supplemental.chemotherapy_negation_radiation_therapy_concurrent_administered_text	follow_ups.follow_up.radiation_supplemental.chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason	follow_ups.follow_up.radiation_supplemental.concurrent_chemotherapy_indicator	follow_ups.follow_up.radiation_supplemental.days_to_radiation_therapy_end	follow_ups.follow_up.radiation_supplemental.days_to_radiation_therapy_start	follow_ups.follow_up.radiation_supplemental.external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose	follow_ups.follow_up.radiation_supplemental.external_beam_radiation_therapy_administered_status	follow_ups.follow_up.radiation_supplemental.rt_pelvis_administered_total_dose	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.radiation_therapy_not_administered_reason	follow_ups.follow_up.radiation_therapy_not_administered_specify	follow_ups.follow_up.radiation_type_notes	follow_ups.follow_up.residual_disease_post_new_tumor_event_margin_status	follow_ups.follow_up.rt_administered_type	follow_ups.follow_up.treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_administered_text	follow_ups.follow_up.treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason	follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_chemotherapy_indicator	follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.agent_total_dose_count	follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.chemotherapy_regimen_type	follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.concurrent_chemotherapy_dose	follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.dose_frequency_text	follow_ups.follow_up.treatment.concurrent_rx_tx_info.concurrent_rx_tx.other_chemotherapy_agent_administration_specify	follow_ups.follow_up.treatment.postoperative_rx_tx	follow_ups.follow_up.treatment.radiation_therapy	follow_ups.follow_up.treatment.radiation_therapy_info.brachytherapy_first_reference_point_administered_total_dose	follow_ups.follow_up.treatment.radiation_therapy_info.brachytherapy_method_other_specify_text	follow_ups.follow_up.treatment.radiation_therapy_info.brachytherapy_method_type	follow_ups.follow_up.treatment.radiation_therapy_info.external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose	follow_ups.follow_up.treatment.radiation_therapy_info.radiation_therapy_not_administered_reason	follow_ups.follow_up.treatment.radiation_therapy_info.radiation_therapy_not_administered_specify	follow_ups.follow_up.treatment.radiation_therapy_info.radiation_type_notes	follow_ups.follow_up.treatment.radiation_therapy_info.rt_administered_type	follow_ups.follow_up.treatment.radiation_therapy_info.rt_pelvis_administered_total_dose	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	height	histological_type	history_of_neoadjuvant_treatment	human_papillomavirus_laboratory_procedure_performed_name	human_papillomavirus_laboratory_procedure_performed_text	human_papillomavirus_other_type_text	human_papillomavirus_types.human_papillomavirus_type	hysterectomy_performed_text	hysterectomy_performed_type	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	keratinizing_squamous_cell_carcinoma_present_indicator	laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result_value	lymph_node_examined_count	lymph_node_location_positive_pathology_names.lymph_node_location_positive_pathology_name	lymph_node_location_positive_pathology_text	lymphovascular_invasion_indicator	menopause_status	month_of_form_completion	neoplasm_histologic_grade	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_text	new_tumor_events.new_tumor_event.new_neoplasm_event_post_initial_therapy_diagnosis_method_type	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.residual_disease_post_new_tumor_event_margin_status	new_tumor_events.new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	number_of_successful_pregnancies_which_resulted_in_at_least_1_live_birth	number_pack_years_smoked	oligonucleotide_primer_pair_laboratory_procedure_performed_name	oligonucleotide_primer_pair_laboratory_procedure_performed_text	other_dx	patient_death_reason	patient_history_immune_system_and_related_disorders_names.patient_history_immune_system_and_related_disorders_name	patient_history_immune_system_and_related_disorders_text	patient_id	patient_pregnancy_spontaneous_abortion_count	patient_pregnancy_therapeutic_abortion_count	performance_status_scale_timing	person_neoplasm_cancer_status	pregnancy_stillbirth_count	pregnant_at_diagnosis	primary_lymph_node_presentation_assessment	primary_therapy_outcome_success	race_list.race	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	standardized_uptake_value_cervix_uteri_assessment_measurement	stopped_smoking_year	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tobacco_smoking_history	total_number_of_pregnancies	treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_administered_text	treatment.concurrent_rx_tx_info.chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason	treatment.concurrent_rx_tx_info.concurrent_chemotherapy_indicator	treatment.concurrent_rx_tx_info.concurrent_rx_tx.agent_total_dose_count	treatment.concurrent_rx_tx_info.concurrent_rx_tx.chemotherapy_regimen_type	treatment.concurrent_rx_tx_info.concurrent_rx_tx.concurrent_chemotherapy_dose	treatment.concurrent_rx_tx_info.concurrent_rx_tx.dose_frequency_text	treatment.concurrent_rx_tx_info.concurrent_rx_tx.other_chemotherapy_agent_administration_specify	treatment.postoperative_rx_tx	treatment.radiation_therapy	treatment.radiation_therapy_info.brachytherapy_first_reference_point_administered_total_dose	treatment.radiation_therapy_info.brachytherapy_method_other_specify_text	treatment.radiation_therapy_info.brachytherapy_method_type	treatment.radiation_therapy_info.external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose	treatment.radiation_therapy_info.radiation_therapy_not_administered_reason	treatment.radiation_therapy_info.radiation_therapy_not_administered_specify	treatment.radiation_therapy_info.radiation_type_notes	treatment.radiation_therapy_info.rt_administered_type	treatment.radiation_therapy_info.rt_pelvis_administered_total_dose	tumor_response_cdus_type	tumor_tissue_site	vital_status	weight	year_of_form_completion	year_of_initial_pathologic_diagnosis
TCGA-VS-A959	76	FEMALE	145	1561	47	22.35434007134364	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G3	0	1561			TUMOR FREE		76	Not Available	Not Applicable	TCGA-VS-A959	F2BEA37E-0D19-49E1-91A0-A4DE4DFA2D35	Never Used	Not Available	Not Available	Not Applicable	Not Available	27	-27897	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1197	Not Available	Not Available																												Not Available	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A959-F67680;TCGA-VS-A959-F70914	14773DAD-080D-4D96-954E-915087E5434C;F1DD89AC-B98D-4C9A-80D3-081CB7E5B5F8							9;10						Not Applicable;Not Applicable	1379;1561		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	145	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	11	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A959	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	Unknown	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A959-R62805;TCGA-VS-A959-R62806;TCGA-VS-A959-R62807	A2FE7905-179D-46F5-86EF-50C91BCA091B;7F9008D7-E51E-46D5-95EA-5DCB774A0559;8A39C674-9078-47E5-8EF6-93A5B7EA2E05	Not Available;Not Available;Not Available	24;24;24	161;147;175	154;112;152	Complete Response;Complete Response;Complete Response	7;7;7	5;25;4	900;4500;2700	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	11	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2700	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	47	2014	2010
TCGA-VS-A957	64	FEMALE	156	1688	91	37.39316239316239	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	NX	MX	Stage IB1	G3	0	1688			TUMOR FREE		64	Not Available	Not Applicable	TCGA-VS-A957	CB31B3CE-8595-4D75-9436-BB59E95C3A19	Never Used	Not Available	Not Available	Not Applicable	Not Available	27	-23585	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1280	118	Not Available					TCGA-VS-A957-D62800	FE43C9DF-DCCC-4A9A-B4E6-05BD6260167D	Not Available	24	140	119	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A957-F67668;TCGA-VS-A957-F72066	7631DBF2-214A-4B2C-A78A-06AB51516919;79448B6A-ED3E-4C33-9A11-31A00A661151							9;9						Not Applicable;Not Applicable	1462;1688		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;4							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A957	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Regional site	TCGA-VS-A957-R62798;TCGA-VS-A957-R62799	D57AC135-AF2C-4BE8-B846-A30F9C9D0B2C;E9C6559D-35B0-4A9D-AE68-C8000AE06F3B	Not Available;Not Available	24;24	147;160	108;154	Complete Response;Complete Response	7;7	25;5	4500;900	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1b1	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Adverse event/ complications	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	91	2014	2010
TCGA-R2-A69V	42	FEMALE	157	596	116	47.06073268692442	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G3	0	596			TUMOR FREE		42	Not Available	Not Applicable	TCGA-R2-A69V	0E137272-A21C-4C5E-BFD1-A774B339A753	Unknown	ABSENT	Not Available	Not Applicable	Not Available	15	-15479	Not Applicable	Not Available	Not Available	15	0	Not Available	596	Not Available	Not Available					TCGA-R2-A69V-D58931	20E60A9F-1F04-4860-9614-D90A6622C0AC	Not Available	15	118	83	Cisplatin-xrt	Unknown	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available																																																																																										FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	18	Not Available	Not Available	PRESENT	Peri (6-12 months since last menstrual period)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A69V	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-R2-A69V-R58932;TCGA-R2-A69V-R58933	4496D2C3-D5F4-41A7-ACDD-AA986353770B;30E84F8F-CC64-41E6-BC65-C943F5A8062C	Not Available;Not Available	28;16	852;121	114;114	Unknown;Unknown	4;5	3;3	4500;1800	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Gy	2014;2014	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	R2	1	Not Available	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	4500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	116	2013	2011
TCGA-ZJ-AAXA	64	FEMALE	155	43	78	32.46618106139438	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB1	G2	0	43			Unknown		64	18	Not Applicable	TCGA-ZJ-AAXA	E8DE2228-3AAA-48AD-A2E4-2940280AF6FD	Unknown	Unknown	Not Available	Not Applicable	Unknown	30	-23603	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	43	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Unknown	Not Available	Unknown	Unknown	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	4	26	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXA	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	1989	NO	YES	ZJ	3	4	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	78	2014	2009
TCGA-C5-A1MF	49	FEMALE	163	1617	70	26.346494034400994	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	MX	Stage IB2	G2	0	1617			TUMOR FREE		49	20	Not Applicable	TCGA-C5-A1MF	4f514ed4-3be6-44bc-a531-210027846459	Former User	ABSENT	Not Available	margins free of tumor	Other Location, specify	25	-17911	Not Applicable	31	Not Available	Not Available	0	Not Available	1617	34	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1MF-F20976;TCGA-C5-A1MF-F55178	BAA0B122-260B-4EB3-93A9-FD52D70CFE96;6FE65EF9-BD23-4C71-9048-D26F5C83EA2C	Completed as planned;None	Not Available;None	Not Applicable;None	HDR;None	Not Available;None	Not Available;None	25;28	Not Applicable;None	72;None	119;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	1617;Not Available	Not Applicable;None	168;Not Available	Not Applicable;Not Available	Not Available;None	1;Not Available	Scheduled Follow-up Submission;None	None;YES	1;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not done per treating physicians discretion;None	NO;None	119;None	72;None	0;None	Completed as Planned;None	5040;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	45	Other HPV type(s)	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	40	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G2												Not Available	0	0	2	10	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A1MF	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1MF-R21309	86805415-A64D-4D0B-A114-39CEFAA2AE0C	1	8	119	72	Not Available	2	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b2	Not Available	1995	NO	YES	C5	4	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	70	2012	2004
TCGA-C5-A1M6	55	FEMALE	165	955	77	28.282828282828284	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIB	G3	1	316.0	Lung	Distant Metastasis	WITH TUMOR		55	Not Available	Not Applicable	TCGA-C5-A1M6	825a6fbb-aede-436f-800b-c7f096da0a77	Former User	Not Available	Not Available	Not Applicable	Not Available	21	-20090	955	316	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-C5-A1M6-D29218;TCGA-C5-A1M6-D33208;TCGA-C5-A1M6-D33209;TCGA-C5-A1M6-D33210;TCGA-C5-A1M6-D33211	90E18313-1409-40E4-AF66-1ED55A60D35B;C82C2709-144B-4A16-A2AB-5A74C1C6427D;8437E363-F915-4549-9B5A-B5E612653094;1D46A633-9DAF-4335-BD53-C5D30B1E79B0;37FC5233-BCCA-45AA-BCC1-7312562622AC	Not Available;Not Available;Not Available;Not Available;Not Available	12;22;22;22;22	489;489;489;489;489	341;341;341;341;341	Cisplatinum;Bleomycin;Vincristine;Mitomycin C;Hydrocortisone	Not Available;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	3;6;6;6;6	6;Not Available;Not Available;Not Available;Not Available	10;Not Available;Not Available;Not Available;Not Available	mg/m2/day;Not Available;Not Available;Not Available;Not Available	RECURRENCE;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	0	Not Available			NO	YES	NO	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A1M6-F29215	325B5E5D-07BB-4334-9AB0-0BAE75F21CE9	Completed as planned	Not Available	Not Applicable	Not Available	Not Available	Not Available	12	Not Available	20	75	Not Available	Not Available	955	Not Available	316	204	Not Applicable	Not Available	0	Scheduled Follow-up Submission		3	Lung	CT	Other, specify	Distant Metastasis	Not Applicable	YES													Not Available	Cervical Cancer	Post-Adjuvant Therapy	WITH TUMOR	NO	Complete Remission/Response	Not Applicable	Not done per treating physicians discretion	NO	75	20	4500	Completed as Planned	5840	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	HPV 18	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G3												Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1M6	0	0	Not Available	WITH TUMOR	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1M6-R29221	5372C829-641C-41EE-B038-A44B7323AC65	1	12	75	20	Not Available	3	Not Available	4500	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	1	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	77	2011	1998
TCGA-VS-A950	42	FEMALE	165	1221	57	20.9366391184573	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3a	NX	MX	Stage IIIA	G3	1				WITH TUMOR		42	Not Available	Not Applicable	TCGA-VS-A950	3D190F07-2F79-4EE6-9F63-0B563DC05C74	Never Used	Not Available	Not Available	Not Applicable	Not Available	1	-15365	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	967	0	Not Available																												0	Not Available	Not Evaluated			Not Available			Partial Response;Partial Response			Not Applicable;Not Applicable	TCGA-VS-A950-F67689;TCGA-VS-A950-F72073	27384DFA-92BE-4EB5-8CD7-E1A19B558CB3;E1E10220-9345-4289-B7F7-2CF51BFF5C29							9;9						Not Applicable;Not Applicable	1210;1221		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;4							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Partial Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A950	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Partial Remission/Response	Unknown	Primary Tumor Field;Regional site;Regional site	TCGA-VS-A950-R65889;TCGA-VS-A950-R65890;TCGA-VS-A950-R65891	ACE2847F-F224-4239-B61B-B29AC8CB6E06;9308D006-C156-46F2-AAF0-4805F7E22F5A;E1C2B852-A584-4BAC-BAC4-C10525F42C25	Not Available;Not Available;Not Available	1;1;1	119;104;79	91;97;42	Partial Response;Partial Response;Partial Response	10;10;10	4;5;25	2600;900;4500	NO;NO;NO	Internal;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2600	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	57	2014	2011
TCGA-VS-A9UY	29	FEMALE	163	555	46	17.31341036546351	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b2	NX	MX	Stage IVB	G2	1	412.0	Head & Neck	Distant Metastasis	WITH TUMOR		29	Not Available	Not Applicable	TCGA-VS-A9UY	A1B99260-8643-4CEF-95A0-3853D64762B7	Unknown	Not Available	Not Available	Not Applicable	Not Available	5	-10707	555	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available					TCGA-VS-A9UY-D64585	47D7D03D-BCC9-4123-AE5B-71157465604C	Not Available	5	34	6	Cisplatin	Clinical Progressive Disease	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	9	G2	NO	YES	Not Available	412	Head & Neck	Brain MRI	Other, specify	Distant Metastasis	Not Available	NO	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A9UY	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	Unknown	Primary Tumor Field;Regional site;Regional site	TCGA-VS-A9UY-R64582;TCGA-VS-A9UY-R64583;TCGA-VS-A9UY-R64584	5CCD2C7C-8CF2-43AD-8F06-956C5563043D;3ACF373D-DD02-4177-8E02-295F9577762D;A2A7E4AC-5B37-40E8-842F-105806517BA8	Not Available;Not Available;Not Available	5;5;5	74;69;42	56;61;6	Radiographic Progressive Disease;Radiographic Progressive Disease;Radiographic Progressive Disease	9;9;9	4;5;25	2800;900;4500	NO;NO;NO	Internal;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1b2	Not Available	Not Available	NO	YES	VS	1	Not Available	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Dead	46	2014	2012
TCGA-EA-A5ZF	56	FEMALE	151	828	51	22.367440024560327	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	NX	M0	Stage IB1	G2	1	440.0	Cervix	Locoregional Recurrence	TUMOR FREE		56	Not Available	Not Applicable	TCGA-EA-A5ZF	0C6BB7DC-45A6-4190-A7C9-B080D49FD58A	Former User	ABSENT	Not Available	Not Applicable	Unknown	24	-20506	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	26	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A5ZF-F57094;TCGA-EA-A5ZF-F70910	8396F0DA-CBB2-4F1E-9119-A536E9003E95;9B580ED5-35E3-4FB2-8A16-AF9AAC22A06B							3;10						Not Applicable;Not Applicable	455;828		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	3;3							Unknown;Not Available	Unknown;Not Available	440;Not Available	440;Not Available	Cervix;Not Available	Not Applicable;Not Applicable	Tumor Resection;Not Available	Locoregional Recurrence;Not Available	Not Available;Not Available	YES;Not Available	R0;Not Available	YES;NO		Not Available;Not Available	Not Available;Not Available	WITH TUMOR;WITH TUMOR	NO;NO	Complete Remission/Response;Complete Remission/Response									Unknown;Unknown						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	Unknown;Unknown	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	151	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Peri (6-12 months since last menstrual period)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5ZF	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1b1	Not Available	Not Available	YES	NO	EA	1	3	Not Applicable	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	51	2013	2012
TCGA-PN-A8MA	43	FEMALE	167	90	71	25.458065904119906	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIB	G3	1				WITH TUMOR		43	Not Available	during adjuvant therapy	TCGA-PN-A8MA	55ADD854-E63F-4335-BEA9-23C3EB1E766A	Former User	Unknown	Not Available	Not Applicable	Not Available	25	-15918	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	90	90	Not Available					TCGA-PN-A8MA-D57802	0BA1607D-3682-49B1-A7AB-F5CF48525262	Not Available	13	48	13	Cisplatin	Unknown	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	NOT HISPANIC OR LATINO			Not Available			Stable Disease			Not Applicable	TCGA-PN-A8MA-F64853	CA0DB769-E918-43C2-8318-352C13AC26EE							17						Not Applicable	90		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	WITH TUMOR	YES	Stable Disease									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Unknown	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	8	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8MA	1	Not Available	Other	WITH TUMOR	Not Available	NO	NO	Stable Disease	BLACK OR AFRICAN AMERICAN	Regional site	TCGA-PN-A8MA-R57803	CA6BD07F-2B17-4D19-9C70-DEEAE4442A9B	Not Available	13	48	13	Unknown	5	27	54	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	Not Available	YES	NO	PN	Unknown	9	Not Applicable	Not Available	YES	3	Cisplatin	50mg	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Adverse event/complications	Not Applicable	Not Applicable	External beam radiation	Not Available	Not Available	Cervical	Alive	71	2014	2013
TCGA-EK-A2PG	88	FEMALE	155	46	55	22.892819979188346	Cervical Squamous Cell Carcinoma	Cervical	Alive					G3	0	46			Not Available		88	Not Available	Not Applicable	TCGA-EK-A2PG	5194A247-CFEE-4C11-9475-CF5521A8C6E3	Not Available	Not Available	Not Available	Not Applicable	Not Available	12	-32500	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	16	0	Not Available																												4	Not Available	Not Available			Not Available			Unknown			Not Applicable	TCGA-EK-A2PG-F58223	C06D1BDE-AEAB-40CB-A6B3-E6CD12D22DF6							2						Not Applicable	46		Not Available	Not Available		Not Available		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G3												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2PG	Not Available	Not Available	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	55	2011	2005
TCGA-MA-AA43	48	FEMALE	152	346	72	31.16343490304709	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	NX	MX	Stage IIIB	G3	0	346			TUMOR FREE		48	16	Not Applicable	TCGA-MA-AA43	ED74703A-6838-4F4E-9524-D6FB7B208687	Never Used	Not Available	Not Available	Not Applicable	Not Available	22	-17658	Not Applicable	Not Available	70	66	0	Not Available	227	39	Not Available				Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent																								1	Not Available	HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-MA-AA43-F65483	E9D6C13D-CE66-451C-9838-BF61821F5F14							23						Not Applicable	346		346	Not Available		0		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	6	11.6	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA43	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	Not Available	2013	YES	NO	MA	4	6	Not Applicable	Not Available	YES	2	Cisplatin	68	Once weekly	Not Applicable	YES	YES	8239	pulse dose rate	Other	4500	Not Available	Not Applicable	Not Applicable	3D conformal	11400	Not Available	Cervical	Alive	72	2014	2013
TCGA-VS-A9UC	32	FEMALE	153	825	76	32.46614549959418	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G2	1				WITH TUMOR		32	Not Available	Not Applicable	TCGA-VS-A9UC	CCA23650-1B06-4977-91E8-F35E73E70C48	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-11790	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	511	-2	Not Available					TCGA-VS-A9UC-D63478	C0D9120A-6CA4-4746-997B-0B828C421848	Not Available	11	203	146	Cisplatin	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Stable Disease;Unknown			Not Applicable;Not Applicable	TCGA-VS-A9UC-F68147;TCGA-VS-A9UC-F72065	30AE72CB-4D04-42ED-B21A-1FFE6EBC7C09;E57A7E4C-C0F7-411D-8E0C-67E1D83F153F							13;9						Not Applicable;Not Applicable	691;825		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;4							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown		Not Available;Not Available	Not Available;Not Available	WITH TUMOR;Unknown	YES;YES	Stable Disease;Stable Disease									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	153	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UC	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Stable Disease	Unknown	Regional site	TCGA-VS-A9UC-R63472	F632EE3A-AF6E-442C-9E1A-4A780707202F	Not Available	11	173	146	Stable Disease	8	18	3240	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	3240	Not Available	Cervical	Alive	76	2014	2012
TCGA-EK-A2PL	36	FEMALE	167	13	113	40.517766861486606	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIIB	Not Available	0	13			WITH TUMOR		36	Not Available	Not Applicable	TCGA-EK-A2PL	45CADCF3-EA98-4063-9255-5C18D6A5CBAB	Not Available	Not Available	Not Available	Not Applicable	Not Available	2	-13384	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	0	Not Available																												0	Not Available	Not Available			Not Available			Unknown			Not Applicable	TCGA-EK-A2PL-F58252	929E0F41-6CB6-4AB8-856E-541C2FD52601							3						Not Applicable	13		13	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Not Available	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available												Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2PL	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	113	2011	2008
TCGA-EX-A69M	62	FEMALE	158	253	58	23.233456176894727	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b2	N0	M0	Stage IB2	G3	1	77.0	Lung	New Primary Tumor	TUMOR FREE		62	Not Available	Not Applicable	TCGA-EX-A69M	1E4D7755-B971-4C6E-A2B9-DD83D92BC4C9	Never Used	Not Available	Not Available	Not Applicable	Not Available	19	-22917	Not Applicable	Not Available	Not Available	18	0	Not Available	186	Not Available	Not Available																												1	1	Not Evaluated		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-EX-A69M-F59393	3E98B27E-ED50-4CB9-B639-FDBE296C901A							12						253	Not Available		Not Available	Lung Cancer		Not Available		NO	5							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	YES		Other, specify	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2014	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Other, specify	Immunostain	HPV 63	HPV 16;Other HPV type(s)	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	11	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	6	G3	NO	NO	Not Available	77	Lung	Not Applicable	Cytology	New Primary Tumor	Not Available	NO	Not Available	YES	0	Not Available	3	Not Available	Not Available	Not Applicable	Yes	Not Available	Not Available	Not Available	A69M	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	2012	YES	NO	EX	4	4	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	58	2013	2012
TCGA-VS-A9U5	57	FEMALE	162	1535	74	28.196921201036428	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G3	0	1535			TUMOR FREE		57	Not Available	Not Applicable	TCGA-VS-A9U5	939ABCA1-8BD0-4271-9A9B-666764EEB3B6	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-21149	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1185	-3	Not Available					TCGA-VS-A9U5-D63439	EF658883-3A46-4E6C-8256-6A45287BD55E	Not Available	11	71	36	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A9U5-F67679;TCGA-VS-A9U5-F70880	C77D4FAC-452C-4ECB-BCC9-C6CF2EB23444;7CD8ECFE-6FA6-43F2-B2AF-825BADD7C5D3							9;10						Not Applicable;Not Applicable	1367;1535		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9U5	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field;Regional site	TCGA-VS-A9U5-R63436;TCGA-VS-A9U5-R63437;TCGA-VS-A9U5-R63438	3205BDED-AD93-42B2-833E-DE286E657AC6;33C219CA-7D2D-4F53-8B02-F15DEF82BFE2;04155CD0-4945-45DB-A599-F56BA91340DF	Not Available;Not Available;Not Available	11;11;11	91;87;71	80;77;36	Complete Response;Complete Response;Complete Response	8;8;8	5;4;25	900;2800;4500	NO;NO;NO	External;Internal;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	74	2014	2010
TCGA-JX-A3Q8	40	FEMALE	158	1357	68	27.23922448325589	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G3	0	1357			TUMOR FREE		40	Not Available	Post operative visit	TCGA-JX-A3Q8	34629EB8-0C5E-4910-8E13-BF7D6A1E337F	Former User	ABSENT	Not Available	Not Applicable	Unknown	17	-14839	Not Applicable	Not Available	Not Available	32	0	Not Available	922	6	Not Available																												0	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response;Complete Response			Post-operative follow-up;Follow-up visit	TCGA-JX-A3Q8-F60569;TCGA-JX-A3Q8-F71653	8B97CEC3-3A1C-48CD-B059-764085D513B8;449DBD89-864C-4D2F-8067-97A93137F2FD							11;27						Not Applicable;Not Applicable	922;1357		922;1357	Not Available;Not Available		0;0		NO;NO	6;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Other	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not done per treating physicians discretion;Not Available	NO;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not done per treating physician discretion;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	158	Endocervical Type of Adenocarcinoma	No	PCR	Not Applicable	31.33, 35.39, 45.51, 52.56.58.59.68	HPV 16;HPV 18;Other HPV type(s)	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	14	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3Q8	1	1	Other	TUMOR FREE	0	NO	YES	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	7.1	Not Available	NO	YES	JX	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	68	2014	2011
TCGA-ZJ-AAXN	34	FEMALE	173	0	59	19.713321527615356	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N1	M0	Stage IB2	Not Available	0	0			Unknown		34	21	Not Applicable	TCGA-ZJ-AAXN	5F22E050-C172-4F2D-A1F9-6CB749B6EF98	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-12701	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	173	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	1	2.1	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXN	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b2	Not Available	Not Available	NO	YES	ZJ	2	1	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	59	2014	2010
TCGA-ZJ-A8QO	73	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive					Not Available	0	0			Unknown		73	Not Available	Not Applicable	TCGA-ZJ-A8QO	EB3BA1FB-8254-4C02-A982-507F075CBAC1	Unknown	Not Available	Not Available	Not Applicable	Not Available	19	-26723	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8QO	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	Unknown																			Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	ZJ	Unknown	Not Available	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2007
TCGA-C5-A1MQ	35	FEMALE	175	1031	116	37.87755102040816	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIA	G2	0	1031			TUMOR FREE		35	Not Available	Not Applicable	TCGA-C5-A1MQ	eb59cf69-1997-41b9-bf69-69ad7da292a1	Not Available	ABSENT	Not Available	Not Applicable	Microscopic parametrial involvement	21	-12836	Not Applicable	Not Available	Not Available	23	0	Not Available	17	Not Available	Not Available					TCGA-C5-A1MQ-D31341	AA6B4B82-7328-43D8-809B-164E794CE799	Not Available	30	151	99	Cisplatin	Not Available	4	6	40	mg/m2	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	70	mg	Not Available	2012	Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable	Not Applicable	Complete Response	YES	6	Not Applicable	TCGA-C5-A1MQ-F31340	8747457F-34C4-471D-8AEF-A966CC0FB408	Completed as planned	2400	Not Applicable	HDR	Cisplatin	70mg	30	Not Applicable	99	151	151	99	Not Applicable	1031	Not Applicable	1031	Not Applicable	Once weekly	0	Scheduled Follow-up Submission		4	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Applicable	Not Available	YES	151	99	Not Available	Completed as Planned	5120	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Alive	2012	FEMALE	175	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	33	Not Available	Not Available	PRESENT	Not Available	10	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1MQ	2	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1MQ-R31342	766A0747-65D4-4C44-8595-6B477F47C520	1	30	151	99	Not Available	4	32	5120	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	Not Available	NO	YES	C5	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	116	2011	2009
TCGA-C5-A1MH	71	FEMALE	Not Available	1186	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G3	1	178.0	Lung	Distant Metastasis	WITH TUMOR		71	Not Available	Not Applicable	TCGA-C5-A1MH	3143822c-66c4-4b58-8d29-e92d065ff049	Not Available	Not Available	Not Available	Not Applicable	Not Available	19	-26234	1186	-2	Not Available	1	0	Not Available	Not Available	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-C5-A1MH-D29284;TCGA-C5-A1MH-D29287	DEB8FE59-1B43-48EE-AD48-8F8D46FC5F71;35858E07-7A94-4FB6-AB9E-C355907B7DF2	Not Available;Not Available	13;13	65;Not Available	8;1036	Cisplatin;Cisplatin	Not Available;Not Available	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Metastatic	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	0	NOT HISPANIC OR LATINO		Extra-Pelvic Metastatic Disease Absent	NO	YES	NO	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A1MH-F29283	D94180C5-06D9-49C6-AA86-3CB531275AD3	Completed as planned	Not Available	Not Applicable	HDR	Cisplatin	Not Available	13	Not Available	38	71	65	8	1186	Not Available	178	155	Not Applicable	Once weekly	1	Scheduled Follow-up Submission		3	Lung	PET, needle biopsy	Other, specify	Distant Metastasis	Not Applicable	YES													Not Available	Cervical Cancer	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Not Applicable	Not Available	YES	71	38	Not Available	Completed as Planned	Not Available	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G3												Not Available	Not Available	Not Available	2	15	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1MH	0	0	Not Available	WITH TUMOR	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1MH-R29286	C22870A8-BB88-472A-87BE-7E4F4A0328D2	1	13	71	38	Not Available	3	6	Not Available	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	9.95	2003	NO	YES	C5	3	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Progression	Cervical	Dead	Not Available	2011	2004
TCGA-IR-A3LF	64	FEMALE	155	2949	86	35.79604578563996	Endocervical Adenocarcinoma of the Usual Type	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	2949			TUMOR FREE		64	Not Available	Not Applicable	TCGA-IR-A3LF	785DDEA1-399D-47D8-B2B0-39E95EAA24B5	Never Used	ABSENT	Not Available	Not Applicable	Not Available	24	-23721	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2949	Not Available	Not Available																												Not Available	0	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-IR-A3LF-F60818	70AB0558-49A0-4C31-95A3-CC3E9A040099							17						Not Applicable	2949		Not Available	Not Available		Not Available		YES	6							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	Not Available	NO	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	155	Endocervical Adenocarcinoma of the Usual Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Simple Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	16	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LF	1	0	Not Available	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-IR-A3LF-R39512;TCGA-IR-A3LF-R39513	3828E7A7-0FB6-484C-A794-E3A615FC1A4F;1CEBBFDD-8367-437F-92E4-6FF11EDEAFF1	Not Available;Not Available	24;24	121;162	82;127	Complete Response;Complete Response	1;1	25;5	4500;2500	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	IR	1	3	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2500	Not Applicable	HDR	0	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Alive	86	2013	2004
TCGA-VS-A8EI	38	FEMALE	158	729	58	23.233456176894727	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	NX	M0	Stage IIB	GX	0	729			TUMOR FREE		38	Not Available	Not Applicable	TCGA-VS-A8EI	7B228C3B-E604-41A1-9B76-8DD3D5A59FFE	Never Used	Not Available	Not Available	Not Applicable	Not Available	22	-14129	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	428	-1	Not Available					TCGA-VS-A8EI-D64588	9081E806-69F2-43F6-8E10-E6D99C3BACD3	Not Available	5	47	16	Cisplatin	Complete Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Follow up;Not Applicable	TCGA-VS-A8EI-F67687;TCGA-VS-A8EI-F70922	433EC1C0-4DAA-4770-8F22-49B2530B6B52;7976B932-2FF2-4246-9CCD-4F57B94887A3							9;10						Not Applicable;Not Applicable	549;729		549;Not Available	Not Available;Not Available		0;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A8EI	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field	TCGA-VS-A8EI-R61983;TCGA-VS-A8EI-R61984	C760397C-788E-48CA-83EB-04D4E14B9662;5A554AAC-3801-46FD-8943-B3AECC7C7CFF	Not Available;Not Available	10;10	48;76	8;64	Complete Response;Complete Response	7;7	25;4	4500;2800	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3b	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	58	2014	2012
TCGA-EK-A2RB	48	FEMALE	175	9	105	34.285714285714285	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IVB	G3	0	9			TUMOR FREE		48	Not Available	post-op	TCGA-EK-A2RB	F92A994D-B080-42C9-966F-34C1000865E3	Not Available	Not Available	Not Available	Not Applicable	Not Available	7	-17752	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	9	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			post-op	TCGA-EK-A2RB-F58259	96BC3B25-A51B-42C3-A6F8-1B9970506198							3						Not Applicable	9		2	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Other	Not Available	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	175	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Cervical biopsies and cystoscopy	Other method, specify:	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	G3												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RB	Not Available	Not Available	Other	TUMOR FREE	Not Available	Not Available	NO	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	2	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	105	2011	2011
TCGA-EA-A43B	43	FEMALE	164	791	72	26.76977989292088	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	791			TUMOR FREE		43	Not Available	Not Applicable	TCGA-EA-A43B	3265F9C1-7242-4C7D-B4AD-B6519EE94F84	Never Used	Not Available	Not Available	Not Applicable	Not Available	20	-15871	Not Applicable	36	Not Available	Not Available	0	Not Available	55	53	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-EA-A43B-D58725;TCGA-EA-A43B-D58726	43CFF346-D800-4B3C-A1D3-FCF8590970A9;BD1405B3-FE04-4F41-8E66-1F933D432F75	Not Available;Not Available	22;22	70;70	70;70	Cisplatin;5-Fluorouracil	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-EA-A43B-F58719	9506CB3E-973A-42E9-B6C8-3BCA30395F4C							22						Not Applicable	791		Not Available	Not Available		Not Available		NO	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available;Not Available	Cisplatin;Other	Not Available;Not Available	Not Available;Not Available	Not Applicable;5-Fluorouracil	YES	YES	3500	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	8200	Alive	2014	FEMALE	164	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	24	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A43B	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field	TCGA-EA-A43B-R58723;TCGA-EA-A43B-R59524	F86C037E-C3CB-4778-9F00-D133DE88D2FA;8BA40F86-9F00-456E-B2A0-F809372B6201	Not Available;Not Available	14;14	131;131	70;70	Complete Response;Complete Response	5;5	Not Available;Not Available	82;35	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	1	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	72	2012	2012
TCGA-VS-A9UU	42	FEMALE	162	442	67	25.529644871208657	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G1	0	442			TUMOR FREE		42	23	Not Applicable	TCGA-VS-A9UU	4770EC81-9174-4D2A-AF54-70C00696FB0B	Current User	Not Available	Not Available	Not Applicable	Not Available	1	-15534	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	442	26	Not Available					TCGA-VS-A9UU-D65893	96F43D49-0111-4847-BC76-553F3DD390C3	Not Available	1	57	43	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-VS-A9UU-F67691	9685B0F5-A99F-45B8-9A14-93EC32C1AFBE							9						Not Applicable	442		Not Available	Not Available		Not Available		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	7	2	Not Available	Not Applicable	No	Not Available	HIV	Not Available	A9UU	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	Unknown	Primary Tumor Field;Regional site	TCGA-VS-A9UU-R65894;TCGA-VS-A9UU-R65895	EA54EC3F-AFAA-4E5E-A003-70DBF35C2227;474577FA-95A7-4F7F-A9D5-8038B5F40AFB	Not Available;Not Available	1;1	95;77	78;40	Complete Response;Complete Response	10;10	4;25	2800;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	2	7	Not Applicable	Not Available	YES	3	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	67	2014	2013
TCGA-EK-A2H0	24	FEMALE	156	1847	88	36.16042077580539	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G3	0	1847			TUMOR FREE		24	Not Available	Not Applicable	TCGA-EK-A2H0	C83C52F4-3815-4F49-8218-CF80AAA62E2F	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-8918	Not Applicable	Not Available	Not Available	21	0	Not Available	1398	28	Not Available					TCGA-EK-A2H0-D31970	3CF33478-3029-494E-AE79-DF669875863C	Not Available	14	90	54	Cisplatin	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2012	0	Not Available	Not Available			Not Available	Not Applicable;None	Not Applicable;None	Complete Response;Complete Response	YES;None	6;None	Not Applicable;Not Applicable	TCGA-EK-A2H0-F31965;TCGA-EK-A2H0-F65241	695F359E-7C62-4EC8-BB17-F4F7DEFA1822;1341E0D8-957A-4E21-A840-14682D4DE2C9	Completed as planned;None	60;None	Not Applicable;None	HDR;None	Cisplatin;None	385 mg/m2;None	14;19	Not Applicable;None	79;None	100;None	90;None	54;None	Not Applicable;Not Applicable	1398;1847	Not Applicable;None	28;Not Available	Not Applicable;Not Available	Once weekly;None	0;Not Available	Scheduled Follow-up Submission;None	None;NO	5;9	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;None	Not Available;Not Available	Preoperative;Not Available	TUMOR FREE;Unknown	YES;YES	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	YES;None	112;None	54;None	0;None	Treatment not completed;None	4500;None	YES;YES	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;YES	None;YES	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Alive	2012;2014	FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	G3												Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2H0	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-EK-A2H0-R31973	49E947F8-C3A4-4F86-A74D-3CCA3E73DFC6	1	14	112	54	Not Available	5	26	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	0	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	88	2011	2007
TCGA-C5-A7CJ	42	FEMALE	163	3097	60	22.58270917234371	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2a	N1	MX	Stage IIA	G2	0	3097			TUMOR FREE		42	22	Not Applicable	TCGA-C5-A7CJ	F8F470D2-924F-41DD-92C5-516B0BF68E44	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	3	-15652	3097	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A7CJ-D56515	1AACD955-9EB2-4DFA-BA7A-89FD85626A3E	Not Available	11	Not Available	62	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	30	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	2	30	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A7CJ	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Regional site	TCGA-C5-A7CJ-R56979	9A87C89B-FCF1-4B29-9E79-60476DABF22B	Not Available	27	Not Available	61	Not Available	2	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	Not Available	Not Available	NO	YES	C5	2	2	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Not Available	Cervical	Dead	60	2014	2002
TCGA-EA-A3HR	57	FEMALE	146	940	86	40.345280540439106	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a	N0	M0	Stage II	G2	0	940			TUMOR FREE		57	Not Available	Not Applicable	TCGA-EA-A3HR	638035F6-2909-4A44-980F-468AC5D74E18	Never Used	ABSENT	Not Available	Not Applicable	Not Available	20	-20980	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	40	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			NO			Complete Response			At last contact	TCGA-EA-A3HR-F66108	428B7DEF-957B-4563-B463-3721D9EFAA3E							2						Not Applicable	940		940	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	146	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	11	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HR	0	13	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	Not Available	YES	NO	EA	1	15	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	86	2011	2011
TCGA-EA-A5O9	39	FEMALE	160	788	99	38.671875	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G2	0	788			TUMOR FREE		39	Not Available	Not Applicable	TCGA-EA-A5O9	1636242C-12DA-412E-A362-914A20ADD708	Never Used	ABSENT	Not Available	Not Applicable	Not Available	22	-14472	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	27	26	Not Available																												1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A5O9-F56059;TCGA-EA-A5O9-F68730	B65064F9-7541-43D5-8F63-D1FF7DE466F1;07C23351-F1BE-4C08-9A4F-C11C0058F0B9							24;12						Not Applicable;Not Applicable	423;788		423;Not Available	Not Available;Not Available		0;Not Available		NO;NO	1;12							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Unknown;Unknown	NO;NO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.1	8070/3	C53.1	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	10	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5O9	0	7	Preoperative	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-EA-A5O9-R56060	B8E32CDA-72B6-4792-8A67-AD9EE06DAAEB	Not Available	24	81	56	Complete Response	1	Not Available	37	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	YES	NO	EA	1	11	Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	99	2013	2012
TCGA-MA-AA3Y	48	FEMALE	156	542	65	26.70940170940171	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	542			TUMOR FREE		48	Not Available	Not Applicable	TCGA-MA-AA3Y	2F261704-D600-4226-90D5-D51BA416B55C	Never Used	ABSENT	negative	Not Applicable	Not Available	16	-17795	Not Applicable	20	Not Available	Not Available	0	Not Available	542	22	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	Not Available	HISPANIC OR LATINO			Not Available			Complete Response			Post operative	TCGA-MA-AA3Y-F65479	65856116-9078-4757-947F-702B972C56BF							23						Not Applicable	542		542	Not Available		0		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	29	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA3Y	1	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	MA	1	1	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	65	2014	2012
TCGA-UC-A7PG	44	FEMALE	Not Available	370	82		Cervical Squamous Cell Carcinoma	Cervical	Dead	T3b	N1	MX	Stage IIIB	G1	0	370			WITH TUMOR		44	18	Not Applicable	TCGA-UC-A7PG	53D99A89-6EBD-4637-91DB-7CE43EBC6B8B	Unknown	Unknown	Not Available	Not Applicable	Not Available	17	-16231	370	-54	Not Available	Not Available	0	Not Available	Not Available	-10	Not Available		Unknown;Unknown;Unknown;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-UC-A7PG-D61868	DB97B514-17D5-4D9A-9C22-0896A63486ED	Not Available	17	90	58	cisplatin	Clinical Progressive Disease	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	0	Not Evaluated			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	9	Pelvic (external iliac, internal iliac, obturator);Common iliac	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	8	0	3	52	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A7PG	0	2	Preoperative	WITH TUMOR	0	NO	YES	Progressive Disease	WHITE	Primary Tumor Field;Primary Tumor Field;Primary Tumor Field	TCGA-UC-A7PG-R61864;TCGA-UC-A7PG-R61865;TCGA-UC-A7PG-R61867	55D33DE1-8933-464D-AD7A-F8CBD393343B;FFFA2557-E8F4-4B02-9AE1-A2868CE0CADE;5A3DA945-65A2-49B5-9E24-6B5381DF8E60	Not Available;Not Available;Not Available	17;17;17	90;90;110	58;58;73	Radiographic Progressive Disease;Radiographic Progressive Disease;Radiographic Progressive Disease	7;7;7	6;6;5	4400;900;4400	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T3b	Not Available	Not Available	NO	YES	UC	2	5	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	4400	Not Applicable	HDR	Not Available	Not Available	Not Applicable	external beam and bilateral parametrial boost	Other	5400	Not Available	Cervical	Dead	82	2014	2003
TCGA-VS-A9UO	43	FEMALE	159	1456	40	15.822158933586488	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T2b	N0	MX	Stage IIB	G2	0	1456			TUMOR FREE		43	Not Available	Not Applicable	TCGA-VS-A9UO	4DA121DA-9193-4AC5-8206-03CB1F7C2C14	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-15813	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1080	0	Not Available					TCGA-VS-A9UO-D63484	7DF378B9-E2A9-41C7-BCF8-FFE5A356565D	Not Available	11	69	52	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A9UO-F67681;TCGA-VS-A9UO-F70918	3ACFCC88-56F5-482E-B16D-1833ADF3A887;3DB9D479-A2AA-416C-AC1C-0AC3BED90647							9;10						Not Applicable;Not Applicable	1260;1456		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	159	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	45	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UO	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Regional site	TCGA-VS-A9UO-R63485;TCGA-VS-A9UO-R63486	33D580A0-D636-487D-9F03-B6F95BFCB812;1F6C4990-36E0-43DE-8633-17BF1FB3FC48	Not Available;Not Available	11;11	108;97	92;52	Complete Response;Complete Response	8;8	4;25	2800;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	Not Available	Not Available	NO	YES	VS	1	1	Not Applicable	Not Available	YES	3	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	40	2014	2011
TCGA-VS-A9UT	72	FEMALE	144	482	42	20.25462962962963	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b1	N1	MX	Stage IB	G3	0	482			TUMOR FREE		72	Not Available	Not Applicable	TCGA-VS-A9UT	A945FD96-FFB3-4787-BACD-60DA4560C8A5	Never Used	Not Available	Not Available	Uninvolved margins	Other Location, specify	1	-26603	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	104	-1	Not Available																												1	Not Available	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-VS-A9UT-F68155	95A662B8-1508-4BA1-B0D0-F9FDBBA4DCC4							13						Not Applicable	482		Not Available	Not Available		Not Available		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	144	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	14	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UT	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b1	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	42	2014	2013
TCGA-C5-A1BJ	34	FEMALE	169	4385	49	17.15626203564301	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G2	0	4385			TUMOR FREE		34	24	Not Applicable	TCGA-C5-A1BJ	7941d1c7-5319-4e8d-a15f-60b61cb68a9b	Not Available	Not Available	Not Available	Not Applicable	Not Available	13	-12611	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	4385	Not Available	Not Available																												Not Available	0	Not Available			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1BJ-F30721;TCGA-C5-A1BJ-F57082	BE89C288-53FC-4C20-90EE-E10246554CCD;A33C4AD5-1F9B-4701-8EA4-5982B3D33751	Completed as planned;None	Not Available;None	Not Applicable;None	HDR;None	Not Available;None	Not Available;None	16;3	Not Applicable;None	21;None	35;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	4385;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;YES	4;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not done per treating physicians discretion;None	NO;None	57;None	2;None	4500;None	Completed as Planned;None	5040;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	169	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G2												Not Available	Not Available	Not Available	0	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BJ	0	0	Not Available	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1BJ-R30723	BBFBA676-87B6-41E6-8133-DD7607402605	1	16	57	2	Not Available	4	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	1997	NO	YES	C5	4	0	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	49	2011	1997
TCGA-Q1-A6DT	55	FEMALE	Not Available	275	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Dead	TX	NX	MX	Stage I	GX	1				WITH TUMOR		55	Not Available	Not Applicable	TCGA-Q1-A6DT	46ADFBBE-3ADD-41CD-A388-B1EE0790BF62	Unknown	Not Available	Not Available	Not Applicable	Not Available	20	-20286	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	103	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Progressive Disease			Not Applicable	TCGA-Q1-A6DT-F62826	8368B9C4-A20D-4CD3-820E-3E0147E2AED9							25						275	Not Available		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Cervical Cancer	Not Available	WITH TUMOR	NO	Not Available									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A6DT	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	NO	NO	Not Available	WHITE																			Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	YES	NO	Q1	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2013	2013
TCGA-VS-A94X	40	FEMALE	158	506	42	16.824226886716872	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	NX	MX	Stage IIB	G2	0	506			WITH TUMOR		40	Not Available	Not Applicable	TCGA-VS-A94X	240EF385-DECC-48F7-A798-A81B4AB0410E	Not Available	Not Available	Not Available	Not Applicable	Not Available	21	-14955	506	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available					TCGA-VS-A94X-D62787	85118345-207B-43EC-A69C-E16BD65A1EA5	Not Available	24	92	64	Cisplatin	Partial Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Unknown	Not Available	A94X	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	NO	Partial Remission/Response	BLACK OR AFRICAN AMERICAN	Primary Tumor Field;Regional site;Regional site	TCGA-VS-A94X-R62784;TCGA-VS-A94X-R62785;TCGA-VS-A94X-R62786	2C410AFD-5E18-4F82-A8B0-7566770655F9;6434B557-529A-443B-BB52-0389C645DBBE;93DD4C94-7109-41A8-9BE6-634168B46DD1	Not Available;Not Available;Not Available	24;24;24	129;114;114	107;59;108	Partial Response;Partial Response;Partial Response	7;7;7	4;25;5	2800;4500;900	NO;NO;NO	Internal;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Dead	42	2014	2010
TCGA-HM-A3JJ	40	FEMALE	173	659	72	24.056934745564504	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N1	MX	Stage IB1	G3	1	385.0		Distant Metastasis	WITH TUMOR		40	Not Available	Not Applicable	TCGA-HM-A3JJ	F150D999-CDEC-427E-B8B2-00731C648989	Former User	Not Available	Not Available	Not Applicable	Not Available	12	-14736	659	13	Not Available	Not Available	0	Not Available	Not Available	26	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-HM-A3JJ-D29258	801FEF42-121B-46DF-ABD7-6CCECA54F4D8	Not Available	13	138	110	Cisplatin	Not Available	3	5	70	mg	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	350	mg	Not Available	2012	0	Not Available	NOT HISPANIC OR LATINO			NO	NO	YES	Progressive Disease	YES	5	Not Applicable	TCGA-HM-A3JJ-F29259	FB92D8C0-4D24-43F4-948D-7982266BBBAA	Not Available	Not Available	Not Applicable	Not Available	Cisplatin	70 mg	13	Not Available	Not Available	Not Available	138	110	659	Not Available	385	Not Available	Not Applicable	Once weekly	Not Available	Scheduled Follow-up Submission		3	Not Available	FINE NEEDLE ASPIRATION BIOPSY	Other, specify	Distant Metastasis	Not Applicable	YES													Not Available	Cervical Cancer	Not Available	WITH TUMOR	YES	Complete Remission/Response	Not Applicable	Not Available	YES	150	110	Not Available	Completed as Planned	5040	YES	Not Available	Not Applicable	Not Applicable	Not Available	Not Available																				Dead	2012	FEMALE	173	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	18,31,33,35,39,45,51,52,56,58,59,68	Other HPV type(s)	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	41	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G3												Not Available	4	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3JJ	Not Available	1	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Local Recurrence;Primary Tumor Field	TCGA-HM-A3JJ-R29328;TCGA-HM-A3JJ-R29327	33060CAC-6528-4489-BD38-417AC6BAF6C5;6E60DD71-D115-4A48-8432-9726F4C74A4C	2;1	14;14	532;150	530;110	Not Available;Not Available	3;3	3;28	2250;5040	NO;NO	OTHER;EXTERNAL BEAM	Cyberknife;Not Applicable	PALLIATIVE;ADJUVANT	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b1	Not Available	Not Available	YES	NO	HM	Not Available	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Dead	72	2013	2010
TCGA-RA-A741	34	FEMALE	165	444	86	31.588613406795226	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	GX	0	444			Unknown		34	21	Not Applicable	TCGA-RA-A741	BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2	Unknown	Not Available	Not Available	Not Applicable	Not Available	13	-12607	Not Applicable	-15	14	Not Available	0	Not Available	118	0	Not Available		Unknown;Unknown;Unknown;Unknown;Pelvic Nodes Absent;Unknown		Bladder Absent;Unknown;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Unknown	TCGA-RA-A741-D51218;TCGA-RA-A741-D51219;TCGA-RA-A741-D56699;TCGA-RA-A741-D66182	CA996310-983C-4D64-A2A3-1AD4558A97F2;27032B2D-9885-4398-B8E1-82EF7C0D1194;B52F8D6F-C07A-453C-A246-B713967195E8;E0AD8182-60F5-46E5-8B7E-C8623125249C	Not Available;Not Available;Not Available;Not Available	13;13;19;3	254;254;76;254	118;118;9;233	carboplatin;paclitaxel;cisplatin;avastin	Complete Response;Complete Response;Unknown;Complete Response	11;11;2;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2014;2014	0	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-RA-A741-F66178	F1336B1B-5842-41DE-BC42-3ECD4B484E01							3						Not Applicable	444		444	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	5	Cisplatin	75	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Alive	2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	4	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	0	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A741	0	0	Preoperative	Unknown	0	NO	YES	Unknown	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-RA-A741-R51263;TCGA-RA-A741-R51264	D9BFAB19-4E70-4099-82CF-B2BFBC11BB07;856076F7-5BD3-48E5-9A08-F0E18E0553B6	Not Available;Not Available	14;14	57;76	37;9	Unknown;Unknown	11;11	5;25	55;45	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2013	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	2013	YES	NO	RA	4	0	Not Applicable	Not Available	YES	6	Cisplatin	40 MG/M2	Once weekly	Not Applicable	YES	YES	5500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Not Available	Cervical	Alive	86	2013	2013
TCGA-C5-A0TN	21	FEMALE	Not Available	348	55		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N1	MX	Stage IB2	G3	1	62.0	Other, specify	Distant Metastasis	WITH TUMOR		21	Not Available	Not Applicable	TCGA-C5-A0TN	14c65927-b9dd-4ef6-9917-db7bc431ff2f	Not Available	ABSENT	Not Available	Not Applicable	Microscopic parametrial involvement	23	-7760	348	Not Available	-2	Not Available	0	Not Available	Not Available	Not Available	Not Available				Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	TCGA-C5-A0TN-D30749	1E4E1C91-1CF4-4AE9-A35F-599B3586D121	Not Available	16	Not Available	67	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	PROGRESSION	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available	YES	YES	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A0TN-F30748	580778C0-44D2-4307-B52C-EF7DAEFF20A4	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Available	Not Available	Not Available	348	Not Available	62	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		4	Other, specify	CT	Other, specify	Distant Metastasis	Pelvis/Liver	YES													Not Available	Cervical Cancer	Not Available	WITH TUMOR	NO	Progressive Disease	Not Applicable	Not Available	NO	57	47	Not Available	Treatment not completed	1440	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	surgery	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	10	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	G3												Not Available	2	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0TN	Not Available	3	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Local Recurrence;Primary Tumor Field	TCGA-C5-A0TN-R30751;TCGA-C5-A0TN-R30750	1FD559E6-464D-4A77-81D6-3F572F0C29F2;A6534FAD-4FCB-482A-A830-654FAB429416	2;1	16;16	111;57	98;47	Not Available;Not Available	4;4	2;4	360;1440	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	PROGRESSION;ADJUVANT	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	Not Available	Not Available	NO	YES	C5	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Progression	Cervical	Dead	55	2011	1997
TCGA-MY-A5BD	62	FEMALE	157	1667	91	36.91833340094933	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIB	G1	0	1667			TUMOR FREE		62	Not Available	Not Applicable	TCGA-MY-A5BD	CEF2EFB2-93CC-4BDF-A343-9965E7E0432C	Not Available	PRESENT	Not Available	Not Applicable	Not Available	20	-22901	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	904	Not Available	Not Available					TCGA-MY-A5BD-D67175	6E4581C1-EB5C-493C-8EEC-E6B8ECE74BB5	Not Available	31	119	70	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-MY-A5BD-F67085	E8AC2DF3-EC67-44C8-BD56-D7B26ECA878B							30						Not Applicable	1667		Not Available	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease									YES						Not Applicable	Not Available	YES	6	Cisplatin	40mg	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	15	Not Available	Not Applicable	Not Applicable	External beam radiation	45	Alive	2014	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	26	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5BD	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-MY-A5BD-R67176	0EA875DA-9A41-4E7C-8DFA-A146245D620B	Not Available	31	126	60	Complete Response	10	28	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	Not Available	NO	YES	MY	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	91	2013	2010
TCGA-ZJ-AAXF	62	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIB	G3	0	0			Unknown		62	Not Available	Not Applicable	TCGA-ZJ-AAXF	0ACD1E47-1099-469B-A6D4-E00DB47F57A9	Unknown	Unknown	Not Available	Not Applicable	Not Available	28	-22709	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXF	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	Not Available	NO	YES	ZJ	Unknown	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2015	2010
TCGA-LP-A5U3	40	FEMALE	160	25	50	19.53125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	25			TUMOR FREE		40	Not Available	Not Applicable	TCGA-LP-A5U3	1399D31D-9D5E-441A-B400-8B8A92A6FF8B	Never Used	ABSENT	Not Available	Not Applicable	Not Available	3	-14698	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	25	Not Available	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A5U3	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	LP	1	3	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	50	2014	2012
TCGA-EK-A2RA	74	FEMALE	160	1246	72	28.125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	MX	Stage IIA2	G3	1				WITH TUMOR		74	41	Not Applicable	TCGA-EK-A2RA	ADA77320-FD05-4E43-BE72-864391044B35	Not Available	PRESENT	Not Available	Not Applicable	Not Available	4	-27209	Not Applicable	30	Not Available	Not Available	0	Not Available	302	0	Not Available																												0	Not Available	HISPANIC OR LATINO			Not Available			Stable Disease;Complete Response			Not Applicable;Not Applicable	TCGA-EK-A2RA-F58256;TCGA-EK-A2RA-F62993	63BA1DDB-BC51-49A6-B0E7-2E73A933A114;079ECFF7-7A11-4789-97F3-2E013929E7C6							3;29						Not Applicable;Not Applicable	489;1246		5;Not Available	Not Available;Not Available		0;Not Available		YES;NO	4;7							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Preoperative;Not Available	WITH TUMOR;Not Available	NO;NO	Not Available;Not Available									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Total Abdominal Hysterectomy	Other	C53.9	8072/3	C53.9	YES	aortic and pelvic lymphadenectomy, total abdominal hysterectomy and BSO.	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	32	Not Available	Not Available	ABSENT	Not Available	1	G3												Not Available	0	0	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RA	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	Not Available																			Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a2	Not Available	2010	NO	YES	EK	4	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	72	2012	2011
TCGA-VS-A9V0	58	FEMALE	158	573	76	30.443839128344816	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b	NX	MX	Stage IB	G3	1	475.0	Other, specify	Distant Metastasis	WITH TUMOR		58	27	Not Applicable	TCGA-VS-A9V0	A5885835-9473-455A-BAC0-6FA43FA8A866	Never Used	Not Available	Not Available	Not Applicable	Not Available	1	-21215	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	529	Not Available	Not Available					TCGA-VS-A9V0-D65886	F3AA1D6F-478C-4EAB-A251-42884E286649	Not Available	1	166	144	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	Not Evaluated			Not Available			Complete Response			Follow up	TCGA-VS-A9V0-F67690	3F9C4FC7-3654-4899-8283-9F5A367023BB							9						Not Applicable	573		551	Not Available		1		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	WITH TUMOR	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	158	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G3	Not Available	Not Available	Not Available	475	Other, specify	Pelvic MRI	Other, specify	Distant Metastasis	Retroperitoneal lymph node and pelvic lymph node and lung	NO	Not Available	YES	Not Available	Not Available	7	4.5	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9V0	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	NO	Not Available	Complete Remission/Response	Unknown	Regional site;Primary Tumor Field	TCGA-VS-A9V0-R65884;TCGA-VS-A9V0-R65885	11C10893-DDA5-4FD2-84A2-76371809E434;AF0526C4-B6DB-45F1-939D-3A98C142F75B	Not Available;Not Available	1;1	169;186	132;168	Complete Response;Complete Response	10;10	25;4	4500;2800	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1b	Not Available	2012	NO	YES	VS	4	7	Not Applicable	Not Available	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	76	2014	2013
TCGA-VS-A8EJ	60	FEMALE	167	607	113	40.517766861486606	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	NX	M1	Stage IIB	G3	0	607			WITH TUMOR		60	Not Available	Not Applicable	TCGA-VS-A8EJ	2E08A89E-4035-4782-B54F-F98EEF5DB80D	Unknown	Not Available	Not Available	Not Applicable	Not Available	22	-22000	607	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available					TCGA-VS-A8EJ-D62775;TCGA-VS-A8EJ-D62776;TCGA-VS-A8EJ-D62777	D2AD658E-3F2A-48BD-82EE-431A683B66BE;908D2796-3195-4448-8BD1-72E85523306F;D2D50CB6-E465-45B9-A255-2178CEC9FE12	Not Available;Not Available;Not Available	24;24;24	155;322;322	136;169;169	Cisplatin;Cisplatin;Fluoruracil	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	7;7;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Unknown	Not Available	A8EJ	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Regional site	TCGA-VS-A8EJ-R61944	0CDBB9A8-E1AD-44FB-B68B-5E39F7F417BE	Not Available	10	463	423	Radiographic Progressive Disease	7	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	NX	T2b	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2700	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	113	2014	2008
TCGA-FU-A3HY	47	FEMALE	170	954	74	25.60553633217993	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N1	MX	Stage IB2	G2	0	954			TUMOR FREE		47	16	Not Applicable	TCGA-FU-A3HY	674E010C-7AD4-4DC2-86B0-284CD4560633	Former User	Not Available	Not Available	Not Applicable	Not Available	16	-17228	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	20	Not Available	Not Available					TCGA-FU-A3HY-D64211	6B9972B5-AE6C-4658-BA1B-30CDE0D8C214	Not Available	27	91	60	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			Not Applicable	TCGA-FU-A3HY-F64205	90A241D4-404D-4072-8DAE-45A7F75BFE56							27						Not Applicable	954		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	2400	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	39	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2												Not Available	1	Not Available	6	5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HY	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-FU-A3HY-R64208;TCGA-FU-A3HY-R64210	F463D0BF-6C78-4B0A-A0FF-8A10494BEFCB;7E548335-4144-439D-B0D6-CD48A926B744	Not Available;Not Available	27;27	95;125	61;113	Complete Response;Complete Response	8;8	25;3	4500;2400	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b2	Not Available	Not Available	YES	NO	FU	2	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	74	2012	2011
TCGA-LP-A4AW	52	FEMALE	158	27	52	20.829995193078034	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IA	G1	0	27			TUMOR FREE		52	Not Available	Not Applicable	TCGA-LP-A4AW	74E47DED-2C00-4455-AAA6-CD662DFBF05E	Unknown	Not Available	Not Available	Not Applicable	Not Available	12	-19079	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	27	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	3	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	3	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A4AW	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	ASIAN																			Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	LP	1	2	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	52	2013	2011
TCGA-FU-A23L	60	FEMALE	163	725	56	21.077195227520797	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a1	N0	MX	Stage IIA1	G3	0	725			Not Available		60	Not Available	Not Applicable	TCGA-FU-A23L	86731af9-2d33-4521-9cf9-5f6152ca15d7	Not Available	PRESENT	Not Available	Not Applicable	Not Available	18	-21962	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	37	Not Available	Not Available					TCGA-FU-A23L-D56155	74452C14-7355-4AD6-958B-BCB5BF4E44E9	Not Available	29	106	80	Cisplatin	Complete Response	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	Not Available			NO			Complete Response			Not Applicable	TCGA-FU-A23L-F56151	80146D90-A1A8-4BD2-99A7-EF5F8FF73CAE							29						Not Applicable	725		725	Not Available		0		NO	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	1500	Unknown	Other	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Alive	2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	11	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	7	G3												Not Available	0	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A23L	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-FU-A23L-R56153;TCGA-FU-A23L-R56154	96E9A3D8-5057-49A6-959B-A2CFFCE01EF3;ADD8CB4B-F58C-441D-90AD-E37F0F85104F	Not Available;Not Available	29;29	113;134	75;120	Complete Response;Complete Response	1;1	25;3	4500;1500	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIA1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a1	Not Available	Not Available	NO	YES	FU	1	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	56	2011	2010
TCGA-JW-AAVH	46	FEMALE	155	552	165	68.67845993756504	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	552			TUMOR FREE		46	16	Not Applicable	TCGA-JW-AAVH	1C0B5C18-8760-4483-A88C-1D1D89F61998	Unknown	Not Available	Not Available	Not Applicable	Not Available	3	-16894	Not Applicable	21	Not Available	Not Available	0	Not Available	204	170	Not Available		Bladder Present;Extra-Pelvic Metastatic Disease Absent;Pelvic Nodes Present																										2	Not Available	HISPANIC OR LATINO			Not Available			Complete Response			Postoperative follow up	TCGA-JW-AAVH-F70299	66142FA6-FB51-4DA0-981D-74148E3C1E2A							3						Not Applicable	552		552	Not Available		0		NO	2							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2015	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	15	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	4	20	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AAVH	6	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	YES	Not Applicable	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	JW	2	10	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Adverse event/complications	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	165	2014	2013
TCGA-DG-A2KL	53	FEMALE	155	1367	75	31.21748178980229	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a	N0	M0	Stage IIA	G1	0	1367			TUMOR FREE		53	Not Available	Not Applicable	TCGA-DG-A2KL	2DA977FC-8B46-4C40-9636-B12FD36A98E4	Unknown	ABSENT	Not Available	Not Applicable	Positive vaginal margin	20	-19539	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1367	Not Available	Not Available		Bladder Absent;Unknown;Parametrium Absent;Unknown;Pelvic Nodes Absent;Unknown			TCGA-DG-A2KL-D61036	DE7C7E8A-DFA5-4D71-9D40-1A65B07AA599	Not Available	20	169	141	Cisplatin	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	0	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-DG-A2KL-F61032	FC03DED3-A59E-4CB3-B908-C7D3666867A7							20						Not Applicable	1367		Not Available	Not Available		Not Available		YES	6							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Preoperative	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	2100	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Dilation and curettage	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	8	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	6	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	5	25	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2KL	0	0	Pre-Adjuvant Therapy	TUMOR FREE	0	NO	YES	Complete Remission/Response	Not Evaluated	Regional site;Primary Tumor Field	TCGA-DG-A2KL-R61034;TCGA-DG-A2KL-R61035	DF3402EA-6D5C-4315-92EB-FFEFD702A50F;678174BF-5E6F-43BF-A97A-37E5CB184838	Not Available;Not Available	20;20	177;193	141;179	Not Available;Not Available	6;6	25;3	4500;2100	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	Not Available	NO	YES	DG	2	5	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	75	2014	Not Available
TCGA-C5-A7UC	48	FEMALE	Not Available	523	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N0	M0	Stage IB	G3	0	523			TUMOR FREE		48	Not Available	Not Applicable	TCGA-C5-A7UC	5C326E9B-85E2-4673-9033-C11827467E1A	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	3	-17765	523	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Not Available	Non-keratinizing squamous cell carcinoma	Not Available	27	Not Available	Not Available	Not Available	Not Available	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A7UC	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	C5	Not Available	Not Available	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	Not Available	2014	2002
TCGA-C5-A2M1	37	FEMALE	168	1169	76	26.927437641723355	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G2	0	1169			TUMOR FREE		37	Not Available	Not Applicable	TCGA-C5-A2M1	8911C80C-C903-48E4-AF5B-FFEDEF9ABC47	Former User	ABSENT	Not Available	margins free of tumor	Other Location, specify	8	-13835	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1169	13	Not Available																												1	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	NO;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A2M1-F21312;TCGA-C5-A2M1-F63928	056DEC61-EEAC-4E8F-A5A9-5164D1007DFC;DA3BA7B8-18F0-49AA-BB2E-AD4EA476B3A3	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	8;21	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	1169;Not Available	Not Applicable;None	86;Not Available	Not Applicable;Not Available	Not Available;None	1;Not Available	Scheduled Follow-up Submission;None	None;YES	2;8	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not done per treating physicians discretion;None	NO;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;Not Available	Not done per treating physician discretion;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	168	Endocervical Type of Adenocarcinoma	No	PCR	Not Applicable	Not Available	HPV 16	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	31	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2												Not Available	0	0	2	Not Available	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A2M1	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	C5	1	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	76	2012	2005
TCGA-DS-A7WI	43	FEMALE	165	252	57	20.9366391184573	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2a2	N1	MX	Stage IIA2	G2	1	206.0	Other, specify	Locoregional Recurrence	WITH TUMOR		43	Not Available	Not Applicable	TCGA-DS-A7WI	C14468EB-E725-4029-96CC-75BB9EBD9DEF	Never Used	Not Available	Not Available	Not Applicable	Not Available	23	-15970	252	4	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent			TCGA-DS-A7WI-D54772	7D8F75F1-23CB-44C0-B948-3494D6D754CE	Not Available	23	108	80	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-DS-A7WI-F54771	52E1E93F-25AB-4B77-A402-01A0FF532F19							23						252	Not Available		Not Available	Not Available		Not Available		NO	12							NO	NO	Not Available	206	Other, specify	Not Applicable	Not Available	Locoregional Recurrence	Retroperitoneum	NO	Not Available	YES		Cervical Cancer	Not Available	WITH TUMOR	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Dead	2013	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	15	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G2	NO	NO	Not Available	206	Not Applicable	Core biopsy	Other, specify	Locoregional Recurrence	Retroperitoneum	NO	Not Available	YES	1	0	7	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A7WI	1	0	Preoperative	WITH TUMOR	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-DS-A7WI-R54773	48E93AD6-5B6C-405C-8889-BDBDA79CDE58	Not Available	23	123	81	Complete Response	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a2	Not Available	Not Available	YES	NO	DS	1	8	Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Dead	57	2013	2013
TCGA-EA-A50E	45	FEMALE	152	227	45	19.47714681440443	Cervical Squamous Cell Carcinoma	Cervical	Dead	T4	N1	M0	Stage IVA	G2	1	208.0	Vulva	Locoregional Recurrence	WITH TUMOR		45	Not Available	Not Applicable	TCGA-EA-A50E	6A18D184-D3A2-49C2-BD4B-9C18F91B98C7	Former User	PRESENT	Pelvic spread	Not Applicable	Positive bladder margin	27	-16609	Not Applicable	-1	Not Available	Not Available	0	Not Available	8	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Progressive Disease			Not Applicable	TCGA-EA-A50E-F45973	CBA7D148-F0A5-473A-9EF4-D93261D05FF6							26						227	Not Available		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	208	Vulva	Not Applicable	Not Available	Locoregional Recurrence	Not Available	NO	Not Available	YES		Cervical Cancer	Not Available	WITH TUMOR	NO	Progressive Disease									NO						Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2013	FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	6	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	6	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A50E	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	NO	YES	Not Available	ASIAN																			Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T4	Not Available	Not Available	YES	NO	EA	1	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	45	2013	2012
TCGA-C5-A1M5	53	FEMALE	Not Available	2052	70		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N0	M0	Stage IB	G2	1	693.0	Other, specify	Distant Metastasis	WITH TUMOR		53	Not Available	Not Applicable	TCGA-C5-A1M5	0fec73a1-8d3a-495b-8008-c52f190f4270	Not Available	ABSENT	Not Available	margins free of tumor	Other Location, specify	19	-19672	2052	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	NO;NO;NO	YES;NO;NO	Progressive Disease;Not Available;Not Available	NO;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	TCGA-C5-A1M5-F29079;TCGA-C5-A1M5-F29081;TCGA-C5-A1M5-F29080	64E03343-E813-4C07-896B-38A94FFF00B0;6F67FC15-C790-4F6E-9CE3-AD3DB29927D1;F3E33A52-90DA-4FFB-A199-4082716E66C7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	7;7;7	Not Available;Not Available;1152	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2052;2052;2052	Not Available;Not Available;Not Available	693;1804;1124	14;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	1;Not Available;Not Available	Scheduled Follow-up Submission;Additional New Tumor Event;Additional New Tumor Event		3;3;3	Other, specify;Other, specify;Other, specify	Not Applicable;Not Applicable;Not Applicable	Tumor Resection;Tumor Resection;Tumor Resection	Distant Metastasis;Distant Metastasis;Distant Metastasis	Regional recurrence NOS;vagina;vagina	YES;YES;YES													Not Available;Not Available;Not Available	Cervical Cancer;Not Available;Not Available	Preoperative;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	NO;Not Available;Not Available	Complete Remission/Response;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not done per treating physicians discretion;Not Available;Not Available	NO;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;Not Available;Not Available	Not done per treating physician discretion;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;RX	Not Available;Not Available;Not Available																				Dead;Dead;Dead	2012;2012;2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	59	Not Available	Not Available	PRESENT	Indeterminate (neither Pre or Postmenopausal)	9	G2												Not Available	0	0	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1M5	0	0	Not Available	WITH TUMOR	0	Not Available	YES	Not Available	WHITE	Local Recurrence	TCGA-C5-A1M5-R29078	5B7F18C9-326F-486E-A153-D91C4709038E	1	7	1124	698	Not Available	3	Not Available	Not Available	NO	COMBINATION	Not Applicable	RECURRENCE	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	C5	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	70	2011	1996
TCGA-LP-A4AV	63	FEMALE	153	0	42	17.941817249775728	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G2	0	0			TUMOR FREE		63	Not Available	Not Applicable	TCGA-LP-A4AV	F241D6B1-2C32-4478-8F8D-8C746464F7D1	Unknown	Not Available	Not Available	Not Applicable	Not Available	12	Not Available	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	153	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Evaluated	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A4AV	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	ASIAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	LP	1	4	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	42	2013	2011
TCGA-DS-A1OC	47	FEMALE	140	376	78	39.795918367346935	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IB	G2	0	376			TUMOR FREE		47	Not Available	Not Applicable	TCGA-DS-A1OC	e711b88e-fa0e-4781-8549-7a53ed3a13a1	Not Available	ABSENT	Not Available	None	Other Location, specify	12	-17357	Not Applicable	34	Not Available	Not Available	0	Not Available	376	0	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DS-A1OC-D15191;TCGA-DS-A1OC-D15190	98AB3883-AF06-4239-BC79-D7D1BC76FBD7;0B4D1E76-9AEA-4129-8E9B-AD0843B068D4	Not Available;Not Available	12;12	332;332	252;252	Gemzar;Cisplatin	Not Available;Not Available	8;8	4;4	1000;50	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	7080;360	mg;mg	Not Available;Not Available	2011;2011	1	0	HISPANIC OR LATINO			NO	Not Applicable;None;None	Not Applicable;None;None	Not Available;Complete Response;Complete Response	YES;None;None	4;None;None	Not Applicable;Not Applicable;Not Applicable	TCGA-DS-A1OC-F15188;TCGA-DS-A1OC-F53356;TCGA-DS-A1OC-F64299	DFC8B6C2-1077-4131-B99C-1BFB21836B09;66DF1C14-85B0-4881-BDAE-8156355036AE;7248771C-277E-4AAD-B8AA-4D65115849ED	Not Available;None;None	Not Available;None;None	Not Applicable;None;None	Not Available;None;None	Cisplatin;Other;None;None	Cisplatin: 90 mg; Gemzar: 1770 mg;None;None	12;11;28	Not Applicable;None;None	Not Available;None;None	Not Available;None;None	332;None;None	252;None;None	Not Applicable;Not Applicable;Not Applicable	376;376;376	Not Applicable;None;None	Not Available;Not Available;Not Available	Not Applicable;Not Available;Not Available	Not Available;None;None	Not Available;Not Available;Not Available	Scheduled Follow-up Submission;None;None	None;YES;YES	8;12;8	Not Applicable;None;None	Not Available;None;None	Not Applicable;None;None	Not Applicable;None;None	Not Available;None;None	NO;None;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Applicable;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Unknown;Not Available	Gemzar;None;None	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;YES;YES	Not Available;Not Available;Complete Remission/Response	Not Applicable;None;None	Not Available;None;None	YES;None;None	155;None;None	117;None;None	Not Available;None;None	Completed as Planned;None;None	5040;None;None	YES;YES;YES	Not Available;None;None	Not Applicable;None;None	Not Applicable;None;None	Not Applicable;None;None	External beam radiation;None;None	None;Not Applicable;Not Applicable	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;Not Applicable;None	None;YES;YES	None;YES;YES	None;Not Available;Not Available	None;Not Applicable;Not Applicable	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Applicable;Not Applicable	None;Not Applicable;Not Applicable	None;Not Available;Not Available	None;Not Available;Not Available	Alive;Alive;Alive	2011;2013;2014	FEMALE	140	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	19	Other Location, specify	Left External Iliac/Obturator	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	G2												Not Available	2	0	3	Not Available	Not Available	Not Applicable	Yes	Not Available	Not Available	Not Available	A1OC	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-DS-A1OC-R15189	A95697FD-5421-4DE3-84A2-3571920993EE	1	12	155	117	Not Available	8	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	DS	4	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	78	2011	2010
TCGA-Q1-A73S	33	FEMALE	160	688	68	26.5625	Adenosquamous	Cervical	Alive	T1b1	N1	MX	Stage IB1	G2	0	688			Unknown		33	19	Not Applicable	TCGA-Q1-A73S	B0F63819-FC86-4981-9D92-0115C6DE3BCE	Former User	PRESENT	Not Available	Not Applicable	Not Available	31	-12229	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	316	316	Not Available					TCGA-Q1-A73S-D50813	5017EAAD-0177-496C-A6DB-E916EE13386D	Not Available	31	76	42	Cisplatin	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-Q1-A73S-F62725	398788E9-83BE-41CB-A3BA-1B6FDEB5500A							23						Not Applicable	688		589	Not Available		0		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	40 mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Adenosquamous	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8560/3	C53.9	YES	Hysterectomy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	18	Other Location, specify	Obturator	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	2	7.5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A73S	Not Available	Not Available	Post-Adjuvant Therapy	Unknown	Not Available	NO	YES	Unknown	WHITE	Primary Tumor Field	TCGA-Q1-A73S-R50812	A0B54EF3-0D50-4835-A7B2-B6A2FB11725D	Not Available	31	93	29	Not Available	10	25	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b1	Not Available	2012	YES	NO	Q1	4	4	Not Applicable	Not Available	YES	6	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	68	2013	2012
TCGA-Q1-A5R1	32	FEMALE	183	474	92	27.47170712771358	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b1	N0	MX	Stage IB1	G2	0	474			TUMOR FREE		32	Not Available	Post-op	TCGA-Q1-A5R1	F93CCD2D-3C77-4BD3-8CAC-5203BD57735F	Current User	ABSENT	Not Available	Not Applicable	Unknown	26	-11705	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	113	6	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Post-operative	TCGA-Q1-A5R1-F56897	5E9D3F51-24D0-414E-945A-4720DCC569F5							25						Not Applicable	474		474	Not Available		0		NO	2							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	183	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8482/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	4	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A5R1	Not Available	Not Available	Other	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	YES	NO	Q1	1	2	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	92	2013	2012
TCGA-JX-A5QV	37	FEMALE	165	636	61	22.405876951331496	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	636			TUMOR FREE		37	Not Available	Not Applicable	TCGA-JX-A5QV	ACF5CBF3-09CA-4F4D-A44E-1792613190FC	Never Used	ABSENT	Not Available	Not Applicable	Unknown	11	-13667	Not Applicable	Not Available	Not Available	8	0	Not Available	243	7	Not Available																												0	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response;Complete Response			Not Applicable;Follow-up	TCGA-JX-A5QV-F60568;TCGA-JX-A5QV-F71657	284DE7B7-5359-476C-BF85-5DDF8BC67DC9;E43ED47D-9FCF-4089-9098-1FB49E4D48FD							11;27						Not Applicable;Not Applicable	243;636		243;636	Not Available;Not Available		0;0		NO;NO	6;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Post-Adjuvant Therapy;Other	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;Discrepancy						Not Applicable;Not Applicable	Unknown;Not Available	NO;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;Discrepancy	2400;Not Available	Not Applicable;Not Applicable	LDR;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	IMRT;Not Available	5120;Not Available	Alive;Alive	2014;2015	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	13	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	4	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A5QV	1	0	Preoperative	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-JX-A5QV-R63623;TCGA-JX-A5QV-R63622	6F46A440-07E9-474B-AF81-CE435012F81D;E4DF9E09-F015-4F83-96EF-401C36BA33F1	Not Available;Not Available	14;14	124;124	68;68	Complete Response;Complete Response	8;8	6;32	2400;5120	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	JX	1	5	Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2400	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	5120	Not Available	Cervical	Alive	61	2014	2012
TCGA-JW-A5VJ	56	FEMALE	155	652	57	23.72528616024974	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G3	1	267.0	Head & Neck	Distant Metastasis	WITH TUMOR		56	Not Available	Not Applicable	TCGA-JW-A5VJ	F0BB0D18-1190-463D-A0BA-839C2C776794	Never Used	Not Available	Not Available	Not Applicable	Not Available	3	-20714	Not Applicable	0	Not Available	Not Available	0	Not Available	401	7	Not Available		Paraaortic Nodes Present;Pelvic Nodes Present																										2	1	HISPANIC OR LATINO			Not Available			Progressive Disease;Progressive Disease			Not Applicable;at hospiace	TCGA-JW-A5VJ-F58231;TCGA-JW-A5VJ-F61351	89AF6DF0-4A55-492B-AD18-D8957D7A9421;0CE5195B-6229-47E9-9F64-E30CA9DC6826							3;27						Not Applicable;Not Applicable	588;652		258;652	Not Available;Not Available		3;3		NO;NO	4;6							YES;Not Available	YES;Not Available	Not Available;Not Available	267;Not Available	Head & Neck;Not Available	FNA of supraclavicular LN positive for malignancy;Not Applicable	Other, specify;Not Available	Distant Metastasis;Not Available	Not Available;Not Available	NO;Not Available	Not Available;Not Available	YES;NO		Not Available;Not Available	Post-Adjuvant Therapy;Other	WITH TUMOR;WITH TUMOR	NO;NO	Partial Remission/Response;Progressive Disease									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	5;Not Available	Carboplatin;Not Available	40mg/m2;Not Available	Once weekly;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	4200;Not Available	Not Applicable;Not Applicable	LDR;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;Not Available	5040;Not Available	Alive;Alive	2014;2014	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	6	G3	YES	YES	Not Available	267	Head & Neck	FNA of supraclavicular LN positive for malignancy	Other, specify	Distant Metastasis	pelvis	NO	Not Available	YES	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5VJ	0	0	Not Available	WITH TUMOR	0	NO	NO	Progressive Disease	AMERICAN INDIAN OR ALASKA NATIVE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	YES	NO	JW	1	3	Not Applicable	Not Available	YES	5	Cisplatin	40mg/m2	Once weekly	Not Applicable	NO	NO	4200	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Alive	57	2013	2012
TCGA-VS-A9U6	52	FEMALE	156	1320	66	27.120315581854044	Cervical Squamous Cell Carcinoma	Cervical	Alive	T4	NX	M1	Stage IVB	GX	1	711.0		Distant Metastasis	WITH TUMOR		52	Not Available	Not Applicable	TCGA-VS-A9U6	98784BBE-E286-48DF-838D-1A88040658BF	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-19109	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1213	0	Not Available					TCGA-VS-A9U6-D63446	BDE69B17-53CF-4220-96CA-A9006A4A466E	Not Available	11	105	74	Cisplatin	Stable Disease	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Progressive Disease			Not Applicable	TCGA-VS-A9U6-F68123	A1A6B1CC-0926-4AE2-89FE-9C299D671B4F							13						Not Applicable	1320		Not Available	Not Available		Not Available		NO	11							YES;YES	NO;NO	Not Available;Not Available	1311;1311	Other, specify;Other, specify	Not Applicable;Not Applicable	Not Available;Not Available	Distant Metastasis;Distant Metastasis	Ovary;Liver	NO;NO	Not Available;Not Available	YES		Not Available	Not Available	WITH TUMOR	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	GX	NO	NO	770	711	Not Applicable	Not Applicable	Tumor Resection	Distant Metastasis	Diaphragm	YES	R2	YES	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9U6	1	Not Available	Preoperative	WITH TUMOR	Not Available	NO	Not Available	Stable Disease	WHITE	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A9U6-R63443;TCGA-VS-A9U6-R63444;TCGA-VS-A9U6-R63445	7CFBCD8F-1211-4E0C-9D0B-C25BE5A84F70;3E559AED-BD7B-45B0-BBA6-9B9947483817;2F8A2FD6-726B-444C-A4C8-BC9C1153E998	Not Available;Not Available;Not Available	11;11;11	129;115;129	120;74;116	Stable Disease;Stable Disease;Stable Disease	8;8;8	5;25;4	900;4500;2600	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	NX	T4	Not Available	Not Available	NO	YES	VS	1	2	Not Applicable	Not Available	Not Available	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2600	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	66	2014	2011
TCGA-EX-A69L	41	FEMALE	163	602	73	27.47562949301818	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	602			TUMOR FREE		41	Not Available	Not Applicable	TCGA-EX-A69L	6DCA2A6F-7F2C-4524-B528-396A889B2A3F	Never Used	Not Available	Not Available	Not Applicable	Not Available	19	-15121	Not Applicable	11	Not Available	Not Available	0	Not Available	136	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Unknown																										Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-EX-A69L-F63787	E77C3FA8-D5CA-49E7-BC64-D26186144BE2							18						Not Applicable	602		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Not Available									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	26	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A69L	1	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EX	1	2	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	73	2013	2012
TCGA-C5-A1ML	49	FEMALE	Not Available	636	120		Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IB2	G3	1				WITH TUMOR		49	Not Available	Not Applicable	TCGA-C5-A1ML	374f614a-bcd1-4283-ac6f-fc27ddc79987	Not Available	Not Available	Not Available	Not Applicable	Not Available	21	-18067	636	37	Not Available	37	0	Not Available	Not Available	Not Available	Not Available		Extra-Pelvic Metastatic Disease Present		Extra-Pelvic Metastatic Disease Present																								Not Available	0	Not Available			NO	Not Applicable	Not Applicable	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A1ML-F30188	5576A62C-C406-4C50-B11A-CAAA1901F2D3	Completed as planned	Not Available	Not Applicable	HDR	Not Available	Not Available	4	Not Applicable	68	111	Not Available	Not Available	636	Not Available	Not Applicable	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		4	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Cervical Cancer	Not Available	WITH TUMOR	NO	Progressive Disease	Unknown	Other	NO	111	68	Not Available	Completed as Planned	5040	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Dead	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	HPV 16	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	G3												Not Available	Not Available	Not Available	2	37	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1ML	0	0	Not Available	WITH TUMOR	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1ML-R30189	0E9242BD-B2DB-48D7-859B-7058DA6EB4D8	1	4	111	68	Not Available	4	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	14.46	Not Available	NO	YES	C5	2	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	120	2011	2005
TCGA-EA-A3QE	45	FEMALE	154	761	73	30.78090740428403	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G2	0	761			TUMOR FREE		45	Not Available	Not Applicable	TCGA-EA-A3QE	A4E444B5-BBCA-4EF0-B92F-908D608CBB91	Never Used	ABSENT	Not Available	Not Applicable	Not Available	9	-16460	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	47	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			At last contact	TCGA-EA-A3QE-F66113	002DABBC-A0DA-47B4-8D50-08241D99D769							2						Not Applicable	761		761	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	154	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	14	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2												Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3QE	0	4	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	EA	1	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	73	2012	2011
TCGA-FU-A40J	38	FEMALE	160	426	78	30.46875	Endocervical Type of Adenocarcinoma	Cervical	Alive	T2a1	N1	MX	Stage IIIB	G3	0	426			TUMOR FREE		38	Not Available	Not Applicable	TCGA-FU-A40J	63DCFA32-C69E-45AD-BEA3-AE672ACB11C6	Unknown	ABSENT	Not Available	Not Applicable	Not Available	4	-14182	Not Applicable	Not Available	10	Not Available	0	Not Available	41	Not Available	Not Available				Extra-Pelvic Metastatic Disease Absent;Parametrium Absent	TCGA-FU-A40J-D64220;TCGA-FU-A40J-D64221	7ADAFA1B-FAE9-4369-A13A-0D7734550AC0;CB60C6D5-AFC3-4B83-9DBF-D649951043AF	Not Available;Not Available	27;27	306;306	104;104	Carboplatin;Taxol	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-FU-A40J-F64213	4FB13BD1-679C-46B1-8321-622608B86191							27						Not Applicable	426		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available;Not Available	Carboplatin;Other	Not Available;Not Available	Not Available;Not Available	Not Applicable;Taxol	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Other	pt only received external beam tx - she moved during tx & brachytherapy was not scheduled due to travel constraints	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	160	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	28	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A40J	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	WHITE	Primary Tumor Field	TCGA-FU-A40J-R64214	CDDE50F8-D9A0-4028-BDF7-DDD202A2F2DF	Not Available	27	196	89	Complete Response	8	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a1	Not Available	Not Available	YES	NO	FU	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	78	2012	2012
TCGA-C5-A901	44	FEMALE	166	518	54	19.5964581216432	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	N1	MX		G2	0	518			TUMOR FREE		44	Not Available	Not Applicable	TCGA-C5-A901	E8F07D20-D043-4C69-8898-87D0F0FC5A9A	Not Available	Not Available	Not Available	Not Applicable	Positive vaginal margin	1	-16186	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	518	Not Available	Not Available																												Not Available	Not Available	Not Evaluated			Not Available			Not Available			Not Applicable	TCGA-C5-A901-F66739	8135C852-8BB5-4B95-9180-607DBD4C7745							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	Not Available	NO	Not Available									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	166	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Keratinizing squamous cell carcinoma	Not Available	19	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Not Available	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	Not Available	2	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A901	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Applicable	MX	N1	TX	Not Available	Not Available	NO	YES	C5	5	0	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	54	2014	2000
TCGA-C5-A2LV	36	FEMALE	165	2234	84	30.853994490358126	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N1	MX	Stage IB	G3	0	2234			TUMOR FREE		36	20	Not Applicable	TCGA-C5-A2LV	00BCA18C-B3D4-45A3-8F19-034CC40449A4	Never Used	ABSENT	Not Available	margins free of tumor	Other Location, specify	8	-13447	Not Applicable	8	Not Available	Not Available	0	Not Available	2234	-1	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	NO;None	Not Available;None	post-operative;Not Applicable	TCGA-C5-A2LV-F21292;TCGA-C5-A2LV-F57088	41BD0FF3-C9C1-42F4-8ACF-C7B33A6B05A1;4D0B1FD4-34D1-4EA4-B203-50106BF6D4EA	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	8;3	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	2234;Not Available	Not Applicable;None	69;Not Available	Not Applicable;Not Available	Not Available;None	0;Not Available	Scheduled Follow-up Submission;None	None;YES	2;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Other;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not done per treating physicians discretion;None	NO;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;Not Available	Not done per treating physician discretion;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	Not Available	HPV 16	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	49	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G3												Not Available	1	0	3	16	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A2LV	1	2	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	Not Available	Not Available	NO	YES	C5	2	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	84	2012	2003
TCGA-HG-A9SC	49	FEMALE	173	504	68	22.720438370810918	Adenosquamous	Cervical	Alive	T2b	N0	MX	Stage IIB	G3	0	504			TUMOR FREE		49	Not Available	Not Applicable	TCGA-HG-A9SC	CF87812F-6DB6-4592-9842-C62B3E4FF03F	Former User	Unknown	Not Available	Not Applicable	Not Available	19	-17963	Not Applicable	3	Not Available	Not Available	0	Not Available	217	21	Not Available					TCGA-HG-A9SC-D60991	64D96D07-DE09-491B-8668-3102380DA868	Not Available	19	106	69	cisplatin	Complete Response	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-HG-A9SC-F67183;TCGA-HG-A9SC-F70995	CC64109E-CC66-473C-8FBD-E4B9266B1C77;A6C90463-1F71-479D-A17B-9FD433ED772A							31;18						Not Applicable;Not Applicable	329;504		318;504	Not Available;Not Available		0;0		NO;NO	10;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;YES	5;5	Cisplatin;Cisplatin	40 mg/m2;40 mg/m2	Once weekly;Once weekly	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	173	Adenosquamous	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8560/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	21	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A9SC	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-HG-A9SC-R60992	BA9FB3DB-3734-497E-B6B6-7347009B50BE	Not Available	19	108	69	Complete Response	6	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	Not Available	Not Available	NO	YES	HG	1	0	Not Applicable	Not Available	YES	5	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	68	2014	2013
TCGA-VS-A8EH	56	FEMALE	157	986	44	17.85062274331616	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	NX	M0	Stage IIIB	G2	0	986			TUMOR FREE		56	39	Not Applicable	TCGA-VS-A8EH	05026179-B1DA-411E-A286-89727B1AE380	Never Used	Not Available	Not Available	Not Applicable	Not Available	22	-20728	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	615	41	Not Available					TCGA-VS-A8EH-D62772	6AA03F28-F6A9-444D-86FF-1E86AA069F1A	Not Available	24	88	67	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Follow up;Not Applicable	TCGA-VS-A8EH-F67675;TCGA-VS-A8EH-F70875	AA6EFE09-6544-4806-87D5-23DC2F0563F5;1235FFEA-8406-44B1-9E05-6A7CDED4816D							9;10						Not Applicable;Not Applicable	804;986		804;Not Available	Not Available;Not Available		1;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	3	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8EH	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	Unknown	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A8EH-R61979;TCGA-VS-A8EH-R61980;TCGA-VS-A8EH-R61981	00E0700B-2300-4E0D-83FA-453ED5BB3550;D467909F-CCFB-4181-A323-FB1240171606;41A8DF8C-71AB-42B9-81F9-346A4FB5E24E	Not Available;Not Available;Not Available	10;10;10	108;124;138	68;116;115	Complete Response;Complete Response;Complete Response	7;7;7	25;5;4	4500;900;2400	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3b	Not Available	Not Available	NO	YES	VS	2	4	Not Applicable	Adverse event/ complications	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2400	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	44	2014	2012
TCGA-JW-A5VG	35	FEMALE	158	834	110	44.06345136997276	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a	NX	MX	Stage IIA	G3	0	834			TUMOR FREE		35	Not Available	Not Applicable	TCGA-JW-A5VG	0BD52D75-5113-4EF1-BC75-509F59EAEF2B	Never Used	Not Available	Not Available	Not Applicable	Not Available	3	-13109	Not Applicable	-8	Not Available	Not Available	0	Not Available	439	439	Not Available		Pelvic Nodes Present			TCGA-JW-A5VG-D58206	907266E1-5423-4E3C-9C72-00B915F1BE87	Not Available	2	53	26	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	0	HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-JW-A5VG-F58243	5C399796-349F-4BA8-AF35-2C6823C498CE							3						Not Applicable	834		834	Not Available		0		NO	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	YES	5	Cisplatin	40mg/m2	Once weekly	Not Applicable	NO	NO	4500	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5VG	0	0	Post-Adjuvant Therapy	TUMOR FREE	0	NO	Not Available	Complete Remission/Response	AMERICAN INDIAN OR ALASKA NATIVE	Regional site;Primary Tumor Field	TCGA-JW-A5VG-R58207;TCGA-JW-A5VG-R58211	2ED5375A-A1E7-4EFB-BC65-BF7C67608DF3;CFCCCA45-538F-44C5-BC85-40F00F243EA3	Not Available;Not Available	3;3	55;57	27;57	Complete Response;Complete Response	4;4	25;Not Available	6150;4745	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2a	Not Available	Not Available	NO	YES	JW	1	5	Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4500	Not Applicable	LDR	0	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Alive	110	2013	2012
TCGA-Q1-A73Q	46	FEMALE	158	284	87	34.850184265342094	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX	Stage I	GX	1				Unknown		46	13	Not Applicable	TCGA-Q1-A73Q	5C72BDA2-2EC0-455F-AB27-7247FD5FFFF9	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-16851	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	179	179	Not Available					TCGA-Q1-A73Q-D50823	9AAD51FE-13BD-4BFC-BE91-D2006570638D	Not Available	31	45	24	Cisplatin	Unknown	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	1	NOT HISPANIC OR LATINO			Not Available			Partial Response			Not Applicable	TCGA-Q1-A73Q-F62730	CB7257C3-4DC4-4278-9424-03E780517625							23						Not Applicable	284		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	WITH TUMOR	YES	Not Available									YES						Not Applicable	Not Available	YES	5	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	1740	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Alive	2014	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	3.3	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A73Q	Not Available	Not Available	Post-Adjuvant Therapy	Unknown	Not Available	NO	NO	Unknown	WHITE	Primary Tumor Field	TCGA-Q1-A73Q-R50824	2FCE251E-CEFF-4560-9EFB-22742B60BDB8	Not Available	31	173	26	Unknown	10	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	YES	NO	Q1	2	2	Not Applicable	Not Available	YES	5	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	2900	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	87	2013	2013
TCGA-DG-A2KJ	50	FEMALE	Not Available	2893	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N1	M0	Stage IIIB	G3	0	2893			TUMOR FREE		50	Not Available	Not Applicable	TCGA-DG-A2KJ	7C93642D-7E05-40F8-B1EF-A014EDCFBA42	Unknown	ABSENT	Not Available	Not Applicable	Not Available	10	-18453	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1791	Not Available	Not Available		Bladder Absent;Unknown;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	TCGA-DG-A2KJ-D58846	FDC804FE-9CBF-44F9-BAD5-F9056C21DD23	Not Available	25	175	145	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2014	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Follow-up visit	TCGA-DG-A2KJ-F49764;TCGA-DG-A2KJ-F65461	C6E947C3-2468-4FC3-ADD2-117BED8E75DA;F2346D33-68B9-46C6-97EC-67BE1FDC175C							10;23						Not Applicable;Not Applicable	1791;2893		Not Available;Not Available	Not Available;Not Available		0;0		NO;NO	10;9							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Pre-Adjuvant Therapy;Other	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;YES	5;5	Cisplatin;Cisplatin	Not Available;Not Available	Once weekly;Once weekly	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;External beam radiation	4500;4500	Alive;Alive	2013;2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	endometrial biopsy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	23	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Unknown	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2KJ	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	YES	Not Available	Not Evaluated	Regional site	TCGA-DG-A2KJ-R58847	14667F7F-D488-4C55-8BDE-A25444E95973	Not Available	25	180	145	Not Available	4	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	Not Available	Not Available	NO	YES	DG	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2013	2006
TCGA-VS-A8QF	42	FEMALE	159	1800	68	26.89767018709703	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX	Stage IIB	G2	0	1800			TUMOR FREE		42	12	Not Applicable	TCGA-VS-A8QF	21254CB0-68F3-4ECC-8D9A-73FB0E994C5B	Unknown	Not Available	Not Available	Not Applicable	Not Available	30	-15374	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1507	92	Not Available					TCGA-VS-A8QF-D62000	E09A597F-8072-47C3-BAA2-520E63D22AAA	Not Available	10	118	92	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response;Complete Response			Not Applicable;Not Applicable;Not Applicable	TCGA-VS-A8QF-F67683;TCGA-VS-A8QF-F68175;TCGA-VS-A8QF-F70917	73AADEE8-B506-409E-9E5B-57ADF921BFEB;23533688-E704-46C6-88F9-D8788DC206BA;E805D1F7-0135-49E3-8BC5-596C11F7F450							9;13;10						Not Applicable;Not Applicable;Not Applicable	1617;1762;1800		Not Available;Not Available;Not Available	Not Available;Not Available;Not Available		Not Available;Not Available;Not Available		NO;NO;NO	11;11;3							Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO		Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;YES;YES	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response									YES;YES;YES						Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	YES;YES;YES	YES;YES;YES	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Alive;Alive;Alive	2014;2014;2015	FEMALE	159	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A8QF	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A8QF-R61997;TCGA-VS-A8QF-R61998;TCGA-VS-A8QF-R61999	6E859F03-4394-4ECD-9BA8-E2B414A4B46D;2517B5CF-3445-4581-A08E-CCA8D5AF7F01;F8ED23BF-1872-4F1E-983A-90B4A92C5362	Not Available;Not Available;Not Available	10;10;10	133;152;154	99;140;139	Complete Response;Complete Response;Complete Response	7;7;7	25;9;4	4500;900;2800	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	2010	NO	YES	VS	4	5	Not Applicable	Adverse event/ complications	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	68	2014	2010
TCGA-EX-A449	42	FEMALE	168	447	107	37.9109977324263	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b1	NX	M1	Stage IVB	G1	0	447			WITH TUMOR		42	Not Available	Not Applicable	TCGA-EX-A449	EB0EB159-732E-43FF-A402-7F2D9F67DAA8	Not Available	ABSENT	Not Available	Not Applicable	Macroscopic parametrial involvement	1	-15559	Not Applicable	-12	Not Available	Not Available	0	Not Available	34	Not Available	Not Available		Extra-Pelvic Metastatic Disease Absent;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Absent			TCGA-EX-A449-D47410;TCGA-EX-A449-D47412;TCGA-EX-A449-D47413	F031D1DD-20A0-4CFE-93B8-51E09B7099EC;1CA76EBB-F1FB-4769-BE88-45DF8439B867;6D6F9C3B-74AC-4E3B-8DEF-41396B7471D1	Not Available;Not Available;Not Available	27;27;27	109;200;200	47;109;109	Cisplatin;Carboplatin;Taxol	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-EX-A449-F47567	76415BCE-E8CC-42FB-86F7-0ABC2604D44E							27						Not Applicable	447		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Alive	2013	FEMALE	168	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Total Abdominal	Other	C53.9	8384/3	C53.9	YES	Total Abdominal Hysterectomy	Other method, specify:	Not Available	Not Available	Not Available	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	Yes	Not Available	Not Available	Not Available	A449	Not Available	1	Not Available	WITH TUMOR	1	NO	NO	Not Applicable	WHITE	Primary Tumor Field	TCGA-EX-A449-R47569	40D9C014-C00C-4A9B-8FFE-09DAD4CCE249	Not Available	27	86	49	Complete Response	8	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M1	NX	T1b1	Not Available	Not Available	YES	NO	EX	Unknown	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	107	2012	2012
TCGA-DS-A1OA	77	FEMALE	160	879	51	19.921875	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N1	M0	Stage IB	G3	1	379.0		Locoregional Recurrence	WITH TUMOR		77	Not Available	Not Applicable	TCGA-DS-A1OA	46c67dd6-8e66-411d-ad05-95daa9005eb2	Never Used	ABSENT	Not Available	None	Other Location, specify	12	-28160	879	24	Not Available	Not Available	0	Not Available	Not Available	29	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent			TCGA-DS-A1OA-D15180;TCGA-DS-A1OA-D15318;TCGA-DS-A1OA-D15182;TCGA-DS-A1OA-D15181;TCGA-DS-A1OA-D15179	72D1CA7A-6404-463A-B036-A3AB953DAE03;1C316E84-6CA7-434F-BE32-6A8AEE5B89A9;EE9F6CF1-BC40-4073-A3AD-390DACD90E15;7798FE45-492F-423C-B95A-100F4A4BE5A8;F3F96461-3EEB-4FE9-9B1A-7B6C71D1D4CB	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	596;786;702;682;91	423;758;702;607;63	Gemzar;Gemzar;Xeloda;Vinorelbine;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	14;3;1;8;5	1000;1200;14000;35;150	mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;ADJUVANT	Not Applicable;Not Applicable;Stable/Persistent;Stable/Persistent;Not Applicable	2;5;4;3;1	IV;IV;PO;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	14600;3600;14000;275;750	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	0	0	NOT HISPANIC OR LATINO			NO	YES	NO	Not Available	YES	5	Not Applicable	TCGA-DS-A1OA-F15176	66FCAD69-679F-4F12-ACD1-2DA70AB8CF8E	Completed as planned	1000	Not Applicable	LDR	Carboplatin	150 mg	12	Not Available	113	120	91	63	879	879	379	Not Available	Not Applicable	Once weekly	Not Available	Scheduled Follow-up Submission		8	Not Available	Not Applicable	Not Available	Locoregional Recurrence	Not Applicable	YES													Not Available	Cervical Cancer	Not Available	WITH TUMOR	YES	Not Available	Not Applicable	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	Not Applicable	Not Applicable	Not Available	Not Available																				Dead	2003	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	8	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G3												Not Available	8	0	7	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1OA	0	0	Preoperative	WITH TUMOR	0	Not Available	YES	Not Available	ASIAN	Primary Tumor Field	TCGA-DS-A1OA-R15178	A6EFD717-21AE-419E-8884-8B19320B406F	1	12	120	113	Not Available	8	2	1000	NO	IMPLANTS	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	DS	1	7	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Partial response	Cervical	Dead	51	2011	2001
TCGA-FU-A770	33	FEMALE	175	34	67	21.877551020408163	Endocervical Adenocarcinoma of the Usual Type	Cervical	Alive	T2a2	N1	MX	Stage IIIB	G2	0	34			TUMOR FREE		33	16	Not Applicable	TCGA-FU-A770	128FD280-9A04-4038-9269-9A945B9A4DC9	Former User	ABSENT	Tumor extends 1.0cm into 1.3 cm thick cervical/lower uterine segment wall	Not Applicable	Not Available	26	-12248	Not Applicable	Not Available	Not Available	0	0	Not Available	34	30	Not Available																												1	0	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	175	Endocervical Adenocarcinoma of the Usual Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	D&C	Other method, specify:	Not Available	Not Available	10	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	1	7	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A770	1	0	Preoperative	TUMOR FREE	0	NO	YES	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a2	Not Available	Not Available	YES	NO	FU	2	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	67	2014	2013
TCGA-JW-A69B	44	FEMALE	155	863	69	28.720083246618106	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b2	NX	MX	Stage IB2	GX	0	863			TUMOR FREE		44	Not Available	Not Applicable	TCGA-JW-A69B	FB4AF6B2-4BED-4DBE-9309-29F59ED30FB2	Never Used	Not Available	Not Available	Not Applicable	Not Available	10	-16080	Not Applicable	34	Not Available	Not Available	0	Not Available	306	34	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	0	HISPANIC OR LATINO			Not Available			Complete Response			Follow up Visit	TCGA-JW-A69B-F69345	526F1C65-18FB-46AD-8B93-B28C465C8633							20						Not Applicable	863		863	Not Available		0		NO	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Other	Not Available	Not Available	External Radiation Therapy	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2015	FEMALE	155	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A69B	1	0	Preoperative	TUMOR FREE	0	NO	NO	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1b2	Not Available	Not Available	YES	NO	JW	1	4	Not Applicable	Scheduling problems	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4631	Not Applicable	LDR	0	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Alive	69	2014	2012
TCGA-IR-A3LK	69	FEMALE	165	908	96	35.26170798898072	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b2	N0	M0	Stage IB2	G3	1	574.0	Other, specify	Distant Metastasis	WITH TUMOR		69	Not Available	Not Applicable	TCGA-IR-A3LK	B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E	Never Used	ABSENT	Not Available	Not Applicable	Microscopic parametrial involvement	13	-25440	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	808	Not Available	Not Available					TCGA-IR-A3LK-D38335;TCGA-IR-A3LK-D38336;TCGA-IR-A3LK-D38337	E502C966-183F-4170-A354-B67DE0DE5D91;BAB25380-1F3B-440A-95A3-4698D5A3EC9C;8ADC65C5-06CD-4C1A-8D30-394CAA5648CB	Not Available;Not Available;Not Available	14;14;14	101;707;707	73;598;598	Cisplatin;Carboplatin;Paclitaxel	Complete Response;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	0	Not Available			NO			Progressive Disease			Not Applicable	TCGA-IR-A3LK-F38333	3A108750-52F1-4F7D-8792-26882DD1D8FC							14						908	Not Available		Not Available	Not Available		Not Available		NO	12							YES;YES	NO;NO	Not Available;Not Available	574;574	Other, specify;Other, specify	Needle biopsy;Not Applicable	Other, specify;Not Available	Distant Metastasis;Locoregional Recurrence	thoracic lymph nodes, liver, abdominal wall;peritoneum, pelvis	NO;NO	Not Available;Not Available	YES		Cervical Cancer	Not Available	WITH TUMOR	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	5	Cisplatin	30mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	0	Not Available	Not Applicable	Not Applicable	IMRT	5040	Dead	2012	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	17	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3												Not Available	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LK	0	0	Not Available	WITH TUMOR	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-IR-A3LK-R38334	F0EBAD73-8386-4A60-841C-7B2090ED13C2	Not Available	14	108	71	Complete Response	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	IR	1	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	96	2012	2009
TCGA-2W-A8YY	51	FEMALE	160	533	42	16.40625	Adenosquamous	Cervical	Alive	T2a2	N0	M0	Stage IB2	G3	0	533			TUMOR FREE		51	Not Available	Not Applicable	TCGA-2W-A8YY	5AEAC31A-176A-4F93-A376-A93A670821BB	Former User	PRESENT	Not Available	Not Applicable	Macroscopic parametrial involvement	15	-18886	Not Applicable	Not Available	Not Available	145	0	Not Available	148	148	Not Available					TCGA-2W-A8YY-D58309	14ACEFE0-DDC0-4A31-B354-D0A304A6C773	Not Available	15	99	57	Cisplatin	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-2W-A8YY-F66376	B00C7A3F-75A6-4B30-B06E-E56DD131B750							23						Not Applicable	533		357	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	56mg/56mL	Once weekly	Not Applicable	YES	YES	1500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Alive	2014	FEMALE	160	Adenosquamous	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8560/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	18	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A8YY	0	0	Post-Adjuvant Therapy	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-2W-A8YY-R58310;TCGA-2W-A8YY-R58311	92D36651-ADD4-4EDD-BF5E-F78C04A8349B;315C6764-B58E-474B-B3F6-CDA440AC8169	Not Available;Not Available	15;15	79;100	47;93	Complete Response;Complete Response	5;5	25;3	45;15	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a2	Not Available	2000	YES	NO	2W	4	1	Not Applicable	Not Available	YES	6	Cisplatin	56mg/56mL	Once weekly	Not Applicable	YES	YES	1500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Not Available	Cervical	Alive	42	2014	2013
TCGA-4J-AA1J	31	FEMALE	165	542	48	17.63085399449036	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G3	0	542			TUMOR FREE		31	Not Available	Not Applicable	TCGA-4J-AA1J	53EAC147-7EB8-4C54-A982-5E058D6749F8	Never Used	ABSENT	no extension	Not Applicable	Not Available	13	-11611	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	226	226	Not Available																												0	0	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-4J-AA1J-F67415;TCGA-4J-AA1J-F72061	FEDDE494-6ACC-4A28-8626-56B94DB2CA42;DDAC54CD-8079-4AC8-BCA5-16E5814BABBF							13;7						Not Applicable;Not Applicable	406;542		406;406	Not Available;Not Available		0;0		NO;NO	11;4							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not done per treating physicians discretion	NO;NO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	40;40	Not Applicable;Not Applicable	HDR;HDR	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Unknown;Unknown	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	15	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA1J	0	0	Post-Adjuvant Therapy	TUMOR FREE	0	YES	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-4J-AA1J-R68104	8B8EAD60-859F-4817-B3FE-E7DF78875C73	Not Available	13	71	50	Complete Response	11	20	40	NO	Internal	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	YES	NO	4J	1	4	Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	40	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Unknown	Not Available	Not Available	Cervical	Alive	48	2014	2013
TCGA-EX-A8YF	44	FEMALE	168	473	57	20.19557823129252	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a1	N0	M0	Stage IB1	G3	1	396.0	Other, specify	Locoregional Recurrence	TUMOR FREE		44	Not Available	Not Applicable	TCGA-EX-A8YF	1DFB4565-81E1-4A1B-BB59-9B5629D6C447	Not Available	Not Available	Not Available	Not Applicable	Not Available	13	-16258	Not Applicable	21	Not Available	Not Available	0	Not Available	144	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										Not Available	Not Available	Not Evaluated			Not Available			Progressive Disease			Not Applicable	TCGA-EX-A8YF-F68767	8A3DEA2B-F772-4AC8-898E-2729ADE517C9							15						Not Applicable	473		Not Available	Not Available		Not Available		NO	12							YES;YES	Not Available;Not Available	Not Available;Not Available	396;396	Other, specify;Other, specify	Dx biopsy;Not Applicable	Other, specify;Not Available	Locoregional Recurrence;Distant Metastasis	Vagina;Abdominopelvis	NO;NO	Not Available;Not Available	YES		Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	168	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	37	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8YF	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Not Available	TCGA-EX-A8YF-R57521	5F422E11-2128-49FA-907E-653C39B645E1	Not Available	13	Not Available	Not Available	Complete Response	3	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a1	Not Available	Not Available	YES	NO	EX	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	57	2014	2013
TCGA-EA-A4BA	49	FEMALE	162	755	96	36.57978966620942	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G2	0	755			TUMOR FREE		49	Not Available	Not Applicable	TCGA-EA-A4BA	9E79059F-3453-4AA6-9849-55A267C711A4	Never Used	ABSENT	Not Available	Not Applicable	Not Available	5	-17995	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	10	7	Not Available					TCGA-EA-A4BA-D49909;TCGA-EA-A4BA-D49910;TCGA-EA-A4BA-D49911	18657CF1-F5AA-48A1-BAB8-1B511F341EA4;1780B434-014B-456D-9F14-298A819FC3EB;B4F30A70-2AB7-4FA1-888B-AC1E7096ACAC	Not Available;Not Available;Not Available	14;14;14	134;134;134	38;38;38	Carboplatin;Cyclophosphamide;Doxorubicin	Complete Response;Complete Response;Complete Response	10;10;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	1	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A4BA-F49908;TCGA-EA-A4BA-F63128	F967F126-EB6A-4D79-AF63-7F77756DB164;28870754-AD37-4A56-B200-F5DF764FF9CA							14;31						Not Applicable;Not Applicable	390;755		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	10;7							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;YES	Not Available;Not Available;Not Available;3	Carboplatin;Other;Other;Carboplatin	Not Available;Not Available;Not Available;570	Unknown;Unknown;Unknown;Once weekly	Not Applicable;Cyclophosphamide;Doxorubicin;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;External beam radiation	3770;3770	Alive;Alive	2013;2014	FEMALE	162	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	10	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A4BA	Not Available	2	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-EA-A4BA-R50169	D79220A4-F0AA-4434-B04C-C5030F3A80EB	Not Available	16	79	58	Complete Response	10	Not Available	37.7	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	YES	NO	EA	1	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	96	2013	2012
TCGA-DG-A2KM	46	FEMALE	169	1946	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IB1	G2	0	1946			TUMOR FREE		46	Not Available	Not Applicable	TCGA-DG-A2KM	E87FADBE-C58C-41D1-B413-8CF6CE70CE94	Former User	ABSENT	Not Available	Not Applicable	Not Available	10	-16808	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1218	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DG-A2KM-D49780	EA657419-8880-44EF-9936-5476962614BA	Not Available	10	155	118	Cisplatin	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2013	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Available	TCGA-DG-A2KM-F49776;TCGA-DG-A2KM-F68502	2BC5317B-7D88-4CF2-AF95-73FB5DE12207;6E50CF35-4A25-4C31-B0E3-EB264A9D288C							10;20						Not Applicable;Not Applicable	1218;1946		Not Available;Not Available	Not Available;Not Available		0;0		NO;NO	10;11							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Pre-Adjuvant Therapy;Other	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;YES	2;Not Available	Cisplatin;Cisplatin	Not Available;Not Available	Once weekly;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	4500;4500	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;External beam radiation	5500;5500	Alive;Alive	2013;2014	FEMALE	169	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	9	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Unknown	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2KM	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	YES	Complete Remission/Response	Not Evaluated	Regional site	TCGA-DG-A2KM-R49778	9EFDB63A-590E-4251-BBD9-08F9E8E2BF6F	Not Available	10	160	118	Not Available	10	30	5500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	DG	1	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2013	2008
TCGA-VS-A8EC	55	FEMALE	154	1415	46	19.396188227357058	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	NX	M0	Stage IIIB	G2	0	1415			TUMOR FREE		55	Not Available	Not Applicable	TCGA-VS-A8EC	AFB5442E-0249-475B-8F82-CAE4E0268AD1	Former User	Not Available	Not Available	Not Applicable	Not Available	22	-20286	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1050	46	Not Available					TCGA-VS-A8EC-D61977;TCGA-VS-A8EC-D62009	E92C9CD5-FA20-429C-9D02-ED80C876D1CB;922C203B-1B73-4D57-906F-518241AC938B	Not Available;Not Available	10;10	617;617	430;430	Carboplatin;Paclitaxel	Complete Response;Complete Response	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A8EC-F67671;TCGA-VS-A8EC-F70920	85ACF293-4595-4786-A689-4A4284D70202;DCC7226E-2391-42E7-B6EC-8FB484330A56							9;10						Not Applicable;Not Applicable	1232;1415		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	154	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8EC	1	Not Available	Not Available	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Regional site	TCGA-VS-A8EC-R61975;TCGA-VS-A8EC-R61976	81106027-A43C-4CEC-9055-CA1D06DEDB4C;D9E5B933-D2E5-48C3-9373-09C029A0C434	Not Available;Not Available	10;24	74;86	38;77	Partial Response;Partial Response	7;7	25;8	4500;1440	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T3b	Not Available	Not Available	NO	YES	VS	Unknown	4	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	46	2014	2011
TCGA-EA-A3QD	59	FEMALE	163	397	105	39.51974105160149	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IIIB	G3	0	397			TUMOR FREE		59	Not Available	Not Applicable	TCGA-EA-A3QD	9E2E29E8-D94A-499F-A98A-5B53B2C38F3B	Former User	Not Available	Not Available	Not Applicable	Not Available	30	-21655	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	33	33	Not Available					TCGA-EA-A3QD-D58164	342CF8C0-1020-45FF-9C5C-D96128CB5368	Not Available	8	109	75	Cisplatin	Complete Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	0	NOT HISPANIC OR LATINO			NO			Complete Response			Not Applicable	TCGA-EA-A3QD-F58163	72D426D0-11A1-497D-A4DF-747A601BB4B2							1						Not Applicable	397		395	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	6	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3												Not Available	1	0	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3QD	1	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-EA-A3QD-R58367	FD295AD4-9D61-4696-A332-639B379F1E45	Not Available	8	112	75	Complete Response	4	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	YES	NO	EA	1	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	105	2012	2011
TCGA-JW-A852	42	FEMALE	160	252	100	39.0625	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	N1	MX	Stage IIB	G2	1	153.0		New Primary Tumor	Unknown		42	Not Available	Not Applicable	TCGA-JW-A852	7CC8F5BD-D2D3-44E9-AFF6-FE9C9C805938	Not Available	Not Available	Not Available	Not Applicable	Not Available	12	-15682	Not Applicable	-1	Not Available	6	0	Not Available	156	13	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent																										1	0	HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent	Not Available			Progressive Disease			Not Applicable	TCGA-JW-A852-F69374	9CFF7655-444A-490E-AC40-3D2A4DC2CDFC							20						252	Not Available		Not Available	Not Available		Not Available		NO	1							Not Available	Not Available	Not Available	187	Other, specify	Not Applicable	Not Available	Distant Metastasis	Breast	Not Available	Not Available	YES		Cervical Cancer	Not Available	WITH TUMOR	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2015	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2	Not Available	Not Available	Not Available	153	Not Applicable	Biopsy	Other, specify	New Primary Tumor	Breast	NO	Not Available	YES	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A852	0	0	Pre-Adjuvant Therapy	Unknown	0	NO	NO	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	11.1	Not Available	YES	NO	JW	1	3	Not Applicable	Scheduling problems	YES	4	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4105	Not Applicable	LDR	0	Not Available	Not Applicable	Not Applicable	External beam radiation	5382	Not Available	Cervical	Alive	100	2014	2013
TCGA-UC-A7PI	44	FEMALE	Not Available	2114	64		Endometrioid Adenocarcinoma of Endocervix	Cervical	Alive	T1b1	N0	MX	Stage IB1	G1	1	778.0	Other, specify	Locoregional Recurrence	TUMOR FREE		44	Not Available	Not Applicable	TCGA-UC-A7PI	C659F1C9-F3B4-4CFE-8627-2BB716C62B96	Former User	ABSENT	Not Available	Not Applicable	Not Available	17	-16427	Not Applicable	25	Not Available	Not Available	0	Not Available	1905	27	Not Available		Unknown;Extra-Pelvic Metastatic Disease Absent;Unknown;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-UC-A7PI-F66695;TCGA-UC-A7PI-F72053	D068B38E-F895-439B-8E12-084A0287800C;1D7B745C-7F36-4F41-8429-0FC125465006							27;6						Not Applicable;Not Applicable	2050;2114		Not Available;2114	Not Available;Not Available		Not Available;1		NO;NO	10;4							YES;NO;YES;NO	YES;NO;YES;NO	799;1707;799;1707	778;1638;778;1638	Other, specify;Other, specify;Other, specify;Other, specify	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Tumor Resection;Tumor Resection;Tumor Resection;Tumor Resection	Locoregional Recurrence;Locoregional Recurrence;Locoregional Recurrence;Locoregional Recurrence	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	R0;R0;R0;R0	YES;YES		Not Available;Not Available	Not Available;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	Not Available	Endometrioid Adenocarcinoma of Endocervix	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.0	8380/3	C53.0	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	47	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G1	YES;NO	YES;NO	799;2072	778;1638	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Tumor Resection;Tumor Resection	Locoregional Recurrence;Locoregional Recurrence	vaginal apex;posterior bladder	YES;YES	Unknown;R0	YES	0	Not Available	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7PI	0	1	Preoperative	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	UC	1	1	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	64	2014	2009
TCGA-EK-A2PK	43	FEMALE	167	12	94	33.70504499982072	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB1	G3	0	12			TUMOR FREE		43	Not Available	Not Applicable	TCGA-EK-A2PK	0809BA8B-4AB6-4F43-934C-C1CCBC014A7E	Not Available	Not Available	Not Available	Not Applicable	Not Available	8	-15939	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	0	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2PK-F58250	C9644300-5774-4259-ACD7-7D1559F58796							3						Not Applicable	12		0	Not Available		1		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical Hysterectomy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	35	Not Available	Not Available	Not Available	Indeterminate (neither Pre or Postmenopausal)	12	G3												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2PK	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Stable	Cervical	Alive	94	2011	2006
TCGA-VS-A9V3	62	FEMALE	164	540	60	22.3081499107674	Cervical Squamous Cell Carcinoma	Cervical	Alive	T4	NX	MX	Stage IVB	G3	1	456.0	Other, specify	Distant Metastasis	TUMOR FREE		62	Not Available	Not Applicable	TCGA-VS-A9V3	1CB1D2CA-DFA6-4C42-9DA9-C711DC5AAB5D	Former User	Not Available	Not Available	Not Applicable	Not Available	11	-22990	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	253	-2	Not Available					TCGA-VS-A9V3-D63454	BA99CD4B-A6DE-4981-A47C-FB8A203105F1	Not Available	11	96	68	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Unknown;Progressive Disease;Stable Disease			Not Applicable;Not Applicable;Not Applicable	TCGA-VS-A9V3-F68121;TCGA-VS-A9V3-F69285;TCGA-VS-A9V3-F70883	10930BCC-55A3-4127-9B95-87645F9781FC;C5843EDB-3898-4CA0-BF15-44DDE0979554;DEEEA344-9678-4D41-A948-95A0C21E983D							13;31;10						Not Applicable;Not Applicable;Not Applicable	453;503;540		Not Available;Not Available;Not Available	Not Available;Not Available;Not Available		Not Available;Not Available;Not Available		NO;NO;NO	11;12;3							Not Available;NO;NO	Not Available;NO;NO	Not Available;Not Available;Not Available	Not Available;456;601	Not Available;Other, specify;Other, specify	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Distant Metastasis;Distant Metastasis	Not Available;Mediastinal lymph nodes;Supraclavicular lymph nodes	Not Available;NO;NO	Not Available;Not Available;Not Available	Unknown;YES;YES		Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Unknown;WITH TUMOR;WITH TUMOR	YES;YES;YES	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response									YES;YES;YES						Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	YES;YES;YES	YES;YES;YES	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Alive;Alive;Alive	2014;2014;2015	FEMALE	164	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9V3	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Primary Tumor Field;Regional site;Regional site	TCGA-VS-A9V3-R63451;TCGA-VS-A9V3-R63452;TCGA-VS-A9V3-R63453	7AA76749-F21E-4FEB-84CF-AECACEAE74F4;6F39D980-D181-472D-8C7E-C51AB4BF511F;6AE3247E-47D2-488E-82B0-200992353EEE	Not Available;Not Available;Not Available	11;11;11	156;112;161	131;64;154	Complete Response;Complete Response;Complete Response	8;8;8	4;25;5	2600;4500;900	NO;NO;NO	Internal;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	Not Available	Not Available	NO	YES	VS	1	0	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2600	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	60	2014	2013
TCGA-FU-A23K	28	FEMALE	165	372	91	33.42516069788797	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	MX	Stage IIIB	G3	0	372			TUMOR FREE		28	Not Available	Not Applicable	TCGA-FU-A23K	85abfd69-cf72-43f6-a7dd-97056f22c91b	Not Available	Not Available	Not Available	Not Applicable	Not Available	18	-10551	Not Applicable	6	Not Available	Not Available	0	Not Available	37	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										Not Available	Not Available	Not Available			NO			Complete Response			Not Applicable	TCGA-FU-A23K-F65840	3F1BCB0C-DFB1-43B7-9379-FC3138087A1D							30						Not Applicable	372		Not Available	Not Available		Not Available		YES	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8083/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	24	Common iliac	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G3												Not Available	1	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A23K	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b1	Not Available	Not Available	NO	YES	FU	1	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	91	2011	2010
TCGA-MY-A5BE	42	FEMALE	157	1066	84	34.0784616008763	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G3	0	1066			TUMOR FREE		42	Not Available	Not Applicable	TCGA-MY-A5BE	F8AB17EC-C365-41A6-A4BC-36653E84BCE5	Not Available	Unknown	Not Available	Not Applicable	Not Available	20	-15466	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-MY-A5BE-F67177	4FBAAC0C-7FFA-4469-836A-C67C296B1F05							31						Not Applicable	1066		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Pelvic (external iliac, internal iliac, obturator);Common iliac	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5BE	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	MY	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	84	2013	2011
TCGA-MA-AA3Z	43	FEMALE	160	595	84	32.8125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	GX	0	595			TUMOR FREE		43	Not Available	Not Applicable	TCGA-MA-AA3Z	BC2003B9-D489-4559-8672-D9FD2D82F2E8	Former User	Not Available	Not Available	Not Applicable	Not Available	16	-15762	Not Applicable	41	Not Available	52	0	Not Available	469	36	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	Not Available	HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-MA-AA3Z-F65480	090D11DA-8960-4B1E-AD24-8D32535CDAF5							23						Not Applicable	595		595	Not Available		0		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Other, specify	HPV Hybrid Capture II	There are several types of HPV the patient could be positive for.	Other HPV type(s)	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA3Z	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	28.8	Not Available	YES	NO	MA	1	5	Not Applicable	Not Available	YES	6	Cisplatin	70	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5040	Not Available	Cervical	Alive	84	2014	2013
TCGA-ZJ-AAXJ	43	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	MX	Stage IIB	Not Available	0	0			Unknown		43	Not Available	Not Applicable	TCGA-ZJ-AAXJ	6B60BF8E-29A1-4C6B-9EAD-AEA4DDC99064	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-16007	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXJ	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	Not Available	Not Available	NO	YES	ZJ	Unknown	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2010
TCGA-C5-A7CK	58	FEMALE	165	4086	55	20.2020202020202	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IVA	G2	0	4086			TUMOR FREE		58	Not Available	Not Applicable	TCGA-C5-A7CK	1C48393E-7DE9-42F6-A6F0-2CBFB8359316	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-21520	4086	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A7CK-D56517	BFECC70B-9153-4C18-94FB-E3CC92E38501	Not Available	11	50	15	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2014	Not Available	0	Not Evaluated			Not Available																																																																																										FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	40	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A7CK	0	0	Not Available	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Unknown;Primary Tumor Field	TCGA-C5-A7CK-R56627;TCGA-C5-A7CK-R57041	127EA116-7E46-4CAF-8797-28761E0A975B;0C7E8AB4-5A2C-4FB0-993F-704E8C798D7C	Not Available;Not Available	14;28	45;Not Available	10;Not Available	Not Available;Not Available	2;2	Not Available;Not Available	Not Available;Not Available	NO;Not Available	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	5	3	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	55	2014	2001
TCGA-EA-A5ZD	40	FEMALE	154	830	47	19.81784449316917	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	830			TUMOR FREE		40	Not Available	Not Applicable	TCGA-EA-A5ZD	35D677B6-0487-44D3-BBBA-651EAC7E0635	Unknown	ABSENT	Not Available	Not Applicable	Unknown	24	-14629	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	21	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A5ZD-F57091;TCGA-EA-A5ZD-F70877	5AEBE677-8BFF-49AB-97EC-E61CA2AAC5AF;C1E006DA-12B0-4913-99C9-C39B133D3104							3;10						Not Applicable;Not Applicable	457;830		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	3;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not Available;Unknown	Not Available;NO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	154	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5ZD	1	Not Available	Not Available	TUMOR FREE	Not Available	NO	NO	Unknown	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	1	3	Not Applicable	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	47	2013	2012
TCGA-ZJ-AAXB	42	FEMALE	163	0	97	36.50871316195566	Endocervical Adenocarcinoma of the Usual Type	Cervical	Alive	T1b2	N0	M0	Stage IB2	G3	0	0			Unknown		42	Not Available	Not Applicable	TCGA-ZJ-AAXB	88F0AA4A-6BFD-4573-B136-58F84F867F10	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-15492	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	163	Endocervical Adenocarcinoma of the Usual Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXB	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	ZJ	1	3	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	97	2014	2009
TCGA-EA-A411	50	FEMALE	176	747	74	23.889462809917354	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	747			TUMOR FREE		50	Not Available	Not Applicable	TCGA-EA-A411	84CB84D0-7C7E-453C-8CC5-65B5AF941028	Former User	ABSENT	Not Available	Not Applicable	Not Available	24	-18561	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	41	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			At last contact	TCGA-EA-A411-F66116	6AD213C2-7C8C-4591-9D86-D91B358F56DC							2						Not Applicable	747		747	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	176	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	13	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A411	0	3	Not Available	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	1	5	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	74	2012	2012
TCGA-EA-A410	51	FEMALE	160	803	80	31.25	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	M0	Stage IIA2	G2	0	803			TUMOR FREE		51	Not Available	Not Applicable	TCGA-EA-A410	7B356C12-B226-4E58-BE7F-44E50E3EEFBE	Never Used	ABSENT	Not Available	Not Applicable	Not Available	24	-18720	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	56	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			At last contact	TCGA-EA-A410-F66115	05B7E88C-9451-4560-AB5A-2DC2AFF66F00							2						Not Applicable	803		803	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	14	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A410	0	4	Not Available	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a2	Not Available	Not Available	YES	NO	EA	1	6	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	80	2012	2012
TCGA-C5-A2LT	38	FEMALE	163	2226	59	22.20633068613798	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G3	0	2226			TUMOR FREE		38	20	Not Applicable	TCGA-C5-A2LT	FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781	Current User	ABSENT	Not Available	margins free of tumor	Other Location, specify	24	-13966	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2226	14	Not Available					TCGA-C5-A2LT-D21298	D103CCB4-91ED-4A27-861D-D1AED78A279E	Not Available	8	152	115	Cisplatin	Not Available	2	6	50	mg/m2/wk	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	1	0	NOT HISPANIC OR LATINO			NO	Not Applicable	Not Applicable	Complete Response	YES	6	Not Applicable	TCGA-C5-A2LT-F20928	CE5C401A-3BF2-434B-8810-2E8581C00DDF	Not Available	Not Available	Not Applicable	Not Available	Cisplatin	50mg/m2	25	Not Applicable	Not Available	Not Available	152	115	Not Applicable	2226	Not Applicable	110	Not Applicable	Once weekly	1	Scheduled Follow-up Submission		1	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Applicable	Not Available	YES	152	115	0	Completed as Planned	5040	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Alive	2012	FEMALE	163	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	70	Other HPV type(s)	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	31	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G3												Not Available	0	0	2	19	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A2LT	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A2LT-R21299	35B9F77E-651D-4672-9BAB-BE570501128B	1	8	152	115	Not Available	2	Not Available	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	C5	2	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	59	2012	2001
TCGA-EK-A3GM	65	FEMALE	150	0	83	36.888888888888886	Endocervical Type of Adenocarcinoma	Cervical	Alive				Stage IIA	G2	0	0			Not Available		65	Not Available	Not Applicable	TCGA-EK-A3GM	CB780C10-8810-4384-B829-954AAB1C16C8	Not Available	ABSENT	Not Available	Not Applicable	Not Available	2	-23879	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	0	Not Available																												0	Not Available	HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A3GM-F58222	6D10BF75-97D0-40DE-9D5D-D640E6F35A4A							2						Not Applicable	0		0	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	150	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Evaluated	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	2	G2												Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3GM	Not Available	Not Available	Preoperative	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	1	10	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	83	2012	2006
TCGA-EK-A2RO	59	FEMALE	168	2	77	27.28174603174603	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G1	0	2			WITH TUMOR		59	Not Available	Not Applicable	TCGA-EK-A2RO	C996CFFB-8132-4973-987D-143274B6A081	Not Available	Not Available	Not Available	Not Applicable	Not Available	5	-21844	Not Applicable	Not Available	Not Available	-11	0	Not Available	2	1	Not Available																												0	Not Available	HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RO-F58270	B306158B-7F22-48F5-B1E0-1A41E1EA9DC4							3						Not Applicable	2		1	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	168	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Lymph node sampling or dissection	Keratinizing squamous cell carcinoma	Not Available	32	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G1												Not Available	0	0	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RO	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	AMERICAN INDIAN OR ALASKA NATIVE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	12	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	77	2011	2010
TCGA-EK-A2RJ	51	FEMALE	162	53	85	32.38835543362293	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	MX	Stage IB2	G3	0	53			TUMOR FREE		51	Not Available	Not Applicable	TCGA-EK-A2RJ	CCD569E9-DCBE-4280-8C21-6BFE4CE60D7A	Not Available	Not Available	Not Available	Not Applicable	Not Available	2	-18664	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	53	33	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RJ-F58265	3F70386C-1795-4493-89F1-E35A0B23CB94							3						Not Applicable	53		33	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	22	Not Available	Not Available	PRESENT	Not Available	12	G3												Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RJ	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b2	Not Available	Not Available	NO	YES	EK	Not Available	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	85	2011	2009
TCGA-VS-A9UL	79	FEMALE	149	442	56	25.224089004999776	Cervical Squamous Cell Carcinoma	Cervical	Dead	T3b	NX	MX	Stage IIIB	G3	1	336.0		Distant Metastasis	WITH TUMOR		79	Not Available	Not Applicable	TCGA-VS-A9UL	7ABACA8F-962E-4F9D-B63F-26C131BF5961	Never Used	Not Available	Not Available	Not Applicable	Not Available	5	-29033	442	Not Available	Not Available	Not Available	0	Not Available	Not Available	-1	Not Available																												1	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	149	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G3	NO	NO	Not Available	336	Not Applicable	CT scan	Other, specify	Distant Metastasis	Bone	NO	Not Available	YES	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A9UL	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A9UL-R63707;TCGA-VS-A9UL-R63709;TCGA-VS-A9UL-R63710	3B19A48B-17B9-462A-89D1-EA9467C9E17B;E35831D3-9600-4C36-8BBA-D26AB15CFDF4;A344B969-1E3A-4275-9AE7-397077AC903A	Not Available;Not Available;Not Available	15;15;15	118;131;139	79;124;119	Radiographic Progressive Disease;Radiographic Progressive Disease;Radiographic Progressive Disease	8;8;8	25;5;4	4500;900;2800	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	Not Available	Not Available	NO	YES	VS	1	5	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Dead	56	2014	2010
TCGA-BI-A20A	49	FEMALE	167	720	59	21.15529420201513	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	720			TUMOR FREE		49	Not Available	Not Applicable	TCGA-BI-A20A	f40468de-3b86-4922-9951-f8ae28da6af0	Not Available	PRESENT	Not Available	Not Applicable	Microscopic parametrial involvement	5	-18215	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	72	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-BI-A20A-F39615;TCGA-BI-A20A-F55958	52901882-F487-474D-9079-85DE04926BAE;451532F6-910D-4CDA-8CF3-C26EA0D15D18							28;22						Not Applicable;Not Applicable	462;720		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	1;1							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Not Available;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2013;2014	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	6	Not Available	Not Available	PRESENT	Not Available	10	G3												Not Available	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A20A	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	BI	Not Available	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	59	2011	2010
TCGA-EK-A2R7	45	FEMALE	165	27	75	27.548209366391184	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IB	G3	0	27			TUMOR FREE		45	Not Available	Not Applicable	TCGA-EK-A2R7	D7A75BF5-5189-4978-99D9-FCEF91C9FBD2	Current User	Not Available	Not Available	Not Applicable	Not Available	2	-16487	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	27	16	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2R7-F58254	B56ACFCB-32D4-4E0A-AE66-4A3AF16C62E6							3						Not Applicable	27		16	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	21	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G3												Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2R7	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	75	2011	2010
TCGA-EA-A3Y4	40	FEMALE	167	1122	99	35.49786654236437	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G3	0	1122			TUMOR FREE		40	Not Available	Not Applicable	TCGA-EA-A3Y4	3AC62513-B5F4-4063-AABD-DAD08A1F56FB	Not Available	ABSENT	Not Available	Not Applicable	Not Available	24	-14706	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	35	35	Not Available																												1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response;Complete Response			Not Applicable;Not Applicable;Not Applicable	TCGA-EA-A3Y4-F46396;TCGA-EA-A3Y4-F60677;TCGA-EA-A3Y4-F71527	B32D1F45-5CC7-4013-87DE-804152B81285;AC602343-A58F-4CC6-A7D3-02D681FB934B;BA304B70-77A4-413B-B7CE-6F760907A33F							7;13;26						Not Applicable;Not Applicable;Not Applicable	441;846;1122		441;Not Available;Not Available	Not Available;Not Available;Not Available		0;Not Available;Not Available		NO;NO;NO	8;6;3							Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO		Not Available;Not Available;Not Available	Post-Adjuvant Therapy;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response									YES;YES;YES						Not Applicable;Not Applicable;Not Applicable	Unknown;Unknown;Unknown	NO;NO;NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	NO;NO;NO	YES;YES;YES	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	External beam radiation;External beam radiation;External beam radiation	3740;3740;3740	Alive;Alive;Alive	2013;2014;2015	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Simple Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	12	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3Y4	0	2	Pre-Adjuvant Therapy	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-EA-A3Y4-R46398	C3FB48BA-55AD-45AE-9514-15E5E9C61531	Not Available	7	76	48	Complete Response	8	Not Available	37.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	EA	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	99	2012	2012
TCGA-VS-A94W	39	FEMALE	156	1243	79	32.462195923734384	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	MX	Stage IIB	G2	0	1243			TUMOR FREE		39	Not Available	Not Applicable	TCGA-VS-A94W	2F6A0E87-1E6C-41F3-93E0-3E505FA654B0	Never Used	Not Available	Not Available	Not Applicable	Not Available	17	-14399	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	879	0	Not Available					TCGA-VS-A94W-D70275	D1241E75-98C5-4EE9-AC69-D282F12CAE1D	Not Available	3	104	75	Cisplatin	Complete Response	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2015	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Last contact;Not Applicable	TCGA-VS-A94W-F67673;TCGA-VS-A94W-F70923	2F6388A3-7CFF-4E1D-92ED-A3EB9CFB47D9;D2694F1F-E912-416A-B8AE-FA65F3D3A195							9;10						Not Applicable;Not Applicable	1103;1243		1103;Not Available	Not Available;Not Available		1;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	47	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A94W	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Regional site	TCGA-VS-A94W-R70276;TCGA-VS-A94W-R70277	6CF4FD72-8D28-4222-A718-BE9C47DF43E4;DB29F75E-7B3F-435D-9281-4FC1274CCE69	Not Available;Not Available	3;3	137;140	126;74	Complete Response;Complete Response	2;2	4;30	2800;5400	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2015;2015	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	Not Available	Not Available	NO	YES	VS	1	2	Not Applicable	Adverse event/ complications	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	79	2014	2011
TCGA-Q1-A73R	45	FEMALE	155	567	95	39.54214360041623	Endocervical Type of Adenocarcinoma	Cervical	Alive	TX	NX	MX	Stage I	GX	0	567			Unknown		45	Not Available	Not Applicable	TCGA-Q1-A73R	D9B0AC5A-811D-4305-BB1C-A965BD389CE4	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-16701	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	190	190	Not Available																												0	Not Available	Not Evaluated			Not Available			Complete Response			Post-surgery	TCGA-Q1-A73R-F62729	147BEDE9-35B4-4ACA-A782-36ECCEB7177E							23						Not Applicable	567		335	Not Available		0		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	155	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A73R	Not Available	Not Available	Post-Adjuvant Therapy	Unknown	Not Available	NO	NO	Unknown	WHITE																			Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	YES	NO	Q1	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	95	2013	2013
TCGA-EK-A2GZ	64	FEMALE	160	383	64	25.0	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIIB	G2	1				WITH TUMOR		64	Not Available	Not Applicable	TCGA-EK-A2GZ	D7F07485-522A-49D9-B105-5A9A51ACA8F7	Not Available	Not Available	Not Available	Not Applicable	Not Available	8	-23599	Not Applicable	Not Available	Not Available	-3	0	Not Available	383	-1	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available	Not Applicable	Not Applicable	Not Available	NO	Not Available	Not Applicable	TCGA-EK-A2GZ-F31876	2A5B41D9-F23F-415F-B0F3-878278C4A055	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	10	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Applicable	383	Not Applicable	26	Not Applicable	Not Available	0	Scheduled Follow-up Submission		5	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Preoperative	WITH TUMOR	NO	Not Available	Not Available	Other	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available																				Alive	2012	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	14	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	11	G2												Not Available	Not Available	0	5	Not Available	Not Available	Not Applicable	Yes	Not Available	Not Available	Not Available	A2GZ	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	64	2011	2008
TCGA-BI-A0VS	48	FEMALE	Not Available	1735	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB	G3	0	1735			TUMOR FREE		48	Not Available	Not Applicable	TCGA-BI-A0VS	3923a64a-f8d7-4e3e-9218-cee642da21db	Not Available	Not Available	Not Available	Not Applicable	Not Available	5	-17839	Not Applicable	12	Not Available	12	0	Not Available	925	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																								Not Available	1	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO			Complete Response			Not Applicable	TCGA-BI-A0VS-F34079	AECB6E4A-174A-4D77-8DAA-3DBCD12D01BA							29						Not Applicable	1735		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	8	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3												Not Available	0	0	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0VS	0	0	Not Available	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	BI	2	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2011	2007
TCGA-VS-A9UM	39	FEMALE	160	829	75	29.296875	Cervical Squamous Cell Carcinoma	Cervical	Dead	T3b	NX	MX	Stage IVB	G2	0	829			TUMOR FREE		39	Not Available	Not Applicable	TCGA-VS-A9UM	EE2C9743-EAA1-4F0D-8D35-E96686AC3913	Never Used	Not Available	Not Available	Not Applicable	Not Available	9	-14255	829	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available					TCGA-VS-A9UM-D64650;TCGA-VS-A9UM-D64654;TCGA-VS-A9UM-D64655	5E4A789E-39EA-4751-A2C1-1CE33311769B;3B0630CF-E2D6-4CFE-B50C-B5938FFA47C7;4F2F9A4B-B3AF-4690-B6AB-F0E62933E730	Not Available;Not Available;Not Available	9;9;9	459;210;210	423;41;41	Cisplatin;Cisplatin;Paclitaxel	Complete Response;Complete Response;Complete Response	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UM	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A9UM-R64651;TCGA-VS-A9UM-R64652;TCGA-VS-A9UM-R64653	BF25C3A0-C32F-4F2C-8E4F-66CF9D8C690F;4C033A0C-8F98-46A1-820D-CDB648053615;476B2EF8-8C35-49F5-A776-C3A6DA7F2CED	Not Available;Not Available;Not Available	9;9;9	465;489;482	430;481;469	Complete Response;Complete Response;Complete Response	9;9;9	25;5;4	4500;900;2000	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	Not Available	Not Available	NO	YES	VS	1	5	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2000	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Dead	75	2014	2011
TCGA-C5-A1BN	26	FEMALE	163	166	68	25.593737061989536	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IB2	G3	1				WITH TUMOR		26	15	Not Applicable	TCGA-C5-A1BN	8a4da4f0-30f2-497e-8a7c-988fd6b813cb	Never Used	Not Available	Not Available	Not Applicable	Not Available	21	-9783	166	Not Available	Not Available	1	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A1BN-D30415	79519932-2069-4484-8A3C-2B29A74C417D	Not Available	9	67	32	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent	NO	Not Applicable	Not Applicable	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A1BN-F30414	9D32A61A-665C-48D1-86C4-F9B065E1CE19	Completed as planned	Not Available	Not Applicable	HDR	Cisplatin	Not Available	9	Not Applicable	36	85	67	32	166	Not Available	Not Applicable	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		4	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Cervical Cancer	Not Available	WITH TUMOR	YES	Progressive Disease	Not Applicable	Not Available	YES	85	36	Not Available	Completed as Planned	Not Available	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Dead	2012	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G3												Not Available	Not Available	Not Available	2	11	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BN	0	0	Not Available	WITH TUMOR	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1BN-R30416	20B79403-3BCB-42A7-9354-FE7E59DC987E	1	9	85	36	Not Available	4	Not Available	Not Available	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	17.36	Not Available	NO	YES	C5	2	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	68	2011	2007
TCGA-FU-A3WB	43	FEMALE	167	491	89	31.91222345727706	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	MX	Stage IIA2	G2	0	491			TUMOR FREE		43	16	Not Applicable	TCGA-FU-A3WB	6868BA1D-B612-454C-8146-74AF2F573D76	Former User	ABSENT	Not Available	Not Applicable	Not Available	24	-15833	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	25	0	Not Available					TCGA-FU-A3WB-D64235;TCGA-FU-A3WB-D64236	7C60D850-1A5A-45EF-BF33-1DA000A277BA;80E759F8-CE9D-4730-A538-D10A3C87F4C7	Not Available;Not Available	27;27	116;116	65;65	Cisplatin;Aloxi	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Ancillary	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	2	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-FU-A3WB-F64233	0CD063B2-65AF-4A92-80C3-243B737D95E3							27						Not Applicable	491		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available;Not Available	Cisplatin;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	D&C	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	43	Not Available	Not Available	ABSENT	Unknown	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	25	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3WB	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-FU-A3WB-R64234	F46A5BF5-D3F4-4903-AB63-8DCAA6C2A910	Not Available	27	85	65	Complete Response	8	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a2	Not Available	2012	YES	NO	FU	4	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	89	2012	2012
TCGA-C5-A3HL	76	FEMALE	Not Available	621	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	MX	Stage IB2	G2	0	621			TUMOR FREE		76	Not Available	Not Applicable	TCGA-C5-A3HL	09329A53-D58D-4480-95D8-32043E40DE6E	Never Used	ABSENT	Not Available	margins free of tumor	Other Location, specify	17	-27963	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	621	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A3HL-F30841;TCGA-C5-A3HL-F47688	A672B669-F75D-4D53-B1A8-3B30C6F47608;2C3B81F9-E092-4A3E-89FA-6DA668E96DB6	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	17;16	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	621;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;YES	4;6	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	NO;None	174;None	130;None	Not Available;None	Completed as Planned;None	Not Available;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	21	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G2												Not Available	0	0	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HL	0	1	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A3HL-R30842	F244E340-522A-4933-8D92-0677BBEF4E37	1	17	174	130	Not Available	4	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b2	Not Available	Not Available	NO	YES	C5	1	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	Not Available	2012	2007
TCGA-FU-A2QG	29	FEMALE	170	579	138	47.75086505190311	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0		Stage IB1	G2	0	579			TUMOR FREE		29	14	Not Applicable	TCGA-FU-A2QG	D5D8A818-D689-4C6F-96B0-13F2CB10C3CA	Former User	Not Available	Not Available	Not Applicable	Not Available	18	-10865	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	28	Not Available	Not Available																												1	0	NOT HISPANIC OR LATINO			NO			Complete Response			Not Applicable	TCGA-FU-A2QG-F43199	421C33C5-37FD-49D7-A2A9-242B3733FF50							15						Not Applicable	579		579	Not Available		1		NO	5							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2013	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	32	Not Available	Not Available	ABSENT	Peri (6-12 months since last menstrual period)	10	G2												Not Available	0	0	1	15	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2QG	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	Not Available	N0	T1b1	Not Available	2011	YES	NO	FU	4	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	138	2011	2011
TCGA-MU-A8JM	46	FEMALE	165	607	86	31.588613406795226	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB1	G2	0	607			TUMOR FREE		46	16	Not Applicable	TCGA-MU-A8JM	1D730565-FFA9-4CC7-A713-C4B5B7BBB29F	Unknown	Unknown	Not Available	Not Applicable	Microscopic parametrial involvement	9	-17156	Not Applicable	Not Available	Not Available	28	0	Not Available	165	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO		Unknown;Unknown;Unknown;Unknown;Unknown;Unknown	Not Available			Complete Response			postoperative	TCGA-MU-A8JM-F69302	42B2E724-26D3-4C4F-8403-DF2DE074F4F9							31						Not Applicable	607		607	Not Available		1		NO	12							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	29	Pelvic (external iliac, internal iliac, obturator);Common iliac	Not Available	Unknown	Unknown	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	30	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8JM	1	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	6.0	2012	YES	NO	MU	4	2	Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	86	2013	2013
TCGA-EK-A2RN	45	FEMALE	176	71	68	21.952479338842974	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	MX	Stage IB1	G2	1				WITH TUMOR		45	Not Available	Not Applicable	TCGA-EK-A2RN	B610D391-0C9D-4114-94D6-5E4AA4270122	Not Available	Not Available	Not Available	parametrial involvement on the right side only	Other Location, specify	5	-16487	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	71	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RN-F58269	7437CFD5-BE42-4891-970B-763B90241D2A							3						Not Applicable	71		0	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	WITH TUMOR	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	176	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Keratinizing squamous cell carcinoma	Not Available	15	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G2												Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RN	Not Available	1	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	Not Available	Not Available	NO	YES	EK	Not Available	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	68	2011	2009
TCGA-C5-A7CO	68	FEMALE	158	4482	98	39.25652940233937	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB2	G2	0	4482			TUMOR FREE		68	20	Not Applicable	TCGA-C5-A7CO	FF3808E4-EECE-4046-819B-FE1019317F8E	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-25045	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2233	Not Available	Not Available					TCGA-C5-A7CO-D56985	120E8710-FFBF-48B1-8C5B-676E7B0E3876	Not Available	27	69	34	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A7CO-F63995	8B026D23-540E-4DEC-AA92-13582026555D							22						Not Applicable	4482		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.0	8070/3	C53.0	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	38	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7CO	0	0	Not Available	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Unknown;Regional site	TCGA-C5-A7CO-R56986;TCGA-C5-A7CO-R56987	E7D98013-E4CF-413D-A6C9-AFA03DBBD504;C80F4619-134A-4339-A05B-8554D3503C29	Not Available;Not Available	27;27	78;Not Available	43;33	Not Available;Not Available	2;2	Not Available;28	Not Available;5040	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	1972	NO	YES	C5	3	5	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Alive	98	2014	2002
TCGA-MA-AA3W	54	FEMALE	155	685	84	34.96357960457856	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IB1	G3	0	685			TUMOR FREE		54	18	Not Applicable	TCGA-MA-AA3W	FC2BCE29-4685-49F5-B901-2117BF673BB8	Unknown	PRESENT	negative	Not Applicable	Not Available	15	-20066	Not Applicable	5	Not Available	65	0	Not Available	503	7	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-MA-AA3W-D64865	DE131EAB-9290-4833-8513-3BA191FBDDDC	Not Available	15	110	75	Cisplatin	Complete Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	1	HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-MA-AA3W-F65477	60299942-2D28-4F7E-A6AC-AA817A94562C							23						Not Applicable	685		685	Not Available		0		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	40	Other Location, specify	left parametrium	Unknown	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	0	4	5.7	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA3W	1	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-MA-AA3W-R64878	B85ED5DE-8A84-47F8-B3C8-75497178A3F0	Not Available	15	110	75	Complete Response	9	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	0	Not Available	YES	NO	MA	2	6	Not Applicable	Not Available	YES	5	Cisplatin	70	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Not Available	Cervical	Alive	84	2014	2012
TCGA-C5-A7UH	55	FEMALE	163	3988	56	21.077195227520797	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIIB	G3	0	3988			TUMOR FREE		55	Not Available	Not Applicable	TCGA-C5-A7UH	8328925E-3324-4188-85F1-6FFBF819D9E7	Former User	Not Available	Not Available	Not Applicable	Not Available	3	-20189	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1846	Not Available	Not Available					TCGA-C5-A7UH-D57021	984C0FC8-5951-46F4-AF25-B8163F38204D	Not Available	28	Not Available	18	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A7UH-F66737	DCB04753-169E-4034-8C9E-D7254D9C6A3B							22						Not Applicable	3988		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7UH	0	0	Not Available	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field;Regional site	TCGA-C5-A7UH-R57023;TCGA-C5-A7UH-R57024	85DB2360-4182-443F-B4A8-94DA70A8A5BD;F68974B3-7827-48CC-9179-7C87895E3D99	Not Available;Not Available	28;28	38;Not Available	24;7	Not Available;Not Available	2;2	2;Not Available	1000;Not Available	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	1	2	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Not Available	Cervical	Alive	56	2014	2003
TCGA-LP-A5U2	30	FEMALE	160	9	51	19.921875	Endocervical Adenocarcinoma of the Usual Type	Cervical	Alive	T2a	N1	MX	Stage IIIB	G3	0	9			TUMOR FREE		30	Not Available	Not Applicable	TCGA-LP-A5U2	1EF20703-3684-4B43-A31F-892073208377	Never Used	ABSENT	Not Available	Not Applicable	Not Available	3	-11049	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	9	6	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	160	Endocervical Adenocarcinoma of the Usual Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	7	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A5U2	Not Available	1	Preoperative	TUMOR FREE	Not Available	YES	YES	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2a	Not Available	Not Available	YES	NO	LP	1	1	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	51	2014	2012
TCGA-C5-A7XC	26	FEMALE	Not Available	1551	53		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB1	G2	0	1551			TUMOR FREE		26	Not Available	Not Applicable	TCGA-C5-A7XC	DEDFD5FB-3C72-40F9-A7EF-52C2176BF662	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	7	-9776	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1551	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-C5-A7XC-F66722	597F6C96-2533-4EFD-879F-DF699D912814							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	42	Not Available	Not Available	Not Available	Not Available	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7XC	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	C5	2	1	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	53	2014	2004
TCGA-FU-A3EO	55	FEMALE	165	490	64	23.507805325987142	Endocervical Type of Adenocarcinoma	Cervical	Alive	T2b	N0	MX	Stage IIB	G2	0	490			TUMOR FREE		55	15	Not Applicable	TCGA-FU-A3EO	B7F2958F-256E-4C30-9C61-11E76DDB36BA	Former User	ABSENT	Not Available	Not Applicable	Positive vaginal margin	15	-20207	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	66	14	Not Available																												1	0	NOT HISPANIC OR LATINO			NO			Complete Response			Not Applicable	TCGA-FU-A3EO-F44091	1E9AA2FE-4C00-468E-A062-DCCC9228652E							11						Not Applicable	490		394	Not Available		1		NO	6							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	1500	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2013	FEMALE	165	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	23	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	2	G2												Not Available	0	0	2	40	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3EO	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-FU-A3EO-R44094;TCGA-FU-A3EO-R44095	F3D2E004-8EF0-4BDA-8BA1-5FA95BB07132;9BCCD6FE-0399-4A33-8513-3E34602D415C	Not Available;Not Available	11;11	163;159	161;121	Complete Response;Complete Response	6;6	03;25	1500;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	Not Available	Not Available	YES	NO	FU	2	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	64	2012	2011
TCGA-VS-A9UJ	55	FEMALE	Not Available	52	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	NX	MX	Stage IIB	GX	0	52			WITH TUMOR		55	Not Available	No treatment performed	TCGA-VS-A9UJ	78C62970-4B48-4DC4-9042-5F48F42818EC	Current User	Not Available	Not Available	Not Applicable	Not Available	9	-20264	52	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available																												1	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A9UJ	Not Available	Not Available	Other	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Unknown																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	0	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	Not Available	2014	2012
TCGA-JW-A5VK	43	FEMALE	158	623	68	27.23922448325589	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	NX	MX	Stage IB2	G3	0	623			TUMOR FREE		43	33	Not Applicable	TCGA-JW-A5VK	BBB96B5A-80E8-4542-80B4-2444CF1FE51E	Never Used	Not Available	Not Available	Not Applicable	Not Available	31	-15965	Not Applicable	16	Not Available	Not Available	0	Not Available	198	9	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent																										1	0	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-JW-A5VK-F58232	07AAB628-7634-4ECF-B75F-496129738625							3						Not Applicable	623		623	Not Available		0		NO	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	Unknown	NO	Complete Remission/Response									NO						Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4725	Not Applicable	LDR	4500	Not Available	Not Applicable	Not Applicable	External beam radiation	5500	Alive	2014	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8052/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	1	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5VK	0	0	Not Available	TUMOR FREE	0	NO	Not Available	Complete Remission/Response	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1b2	Not Available	Not Available	YES	NO	JW	3	1	Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4725	Not Applicable	LDR	4500	Not Available	Not Applicable	Not Applicable	External beam radiation	5500	Not Available	Cervical	Alive	68	2013	2012
TCGA-C5-A7CM	35	FEMALE	168	619	75	26.57312925170068	Endocervical Adenocarcinoma of the Usual Type	Cervical	Alive				Stage IB2	G2	0	619			TUMOR FREE		35	Not Available	Not Applicable	TCGA-C5-A7CM	D223FF09-B80B-4368-9D80-A59DFBE4D820	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-12853	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	294	294	Not Available					TCGA-C5-A7CM-D56984	CD77064F-E9A7-42BE-B00B-4932416F1705	Not Available	27	84	47	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A7CM-F63996	8A143D38-011C-4083-8265-910AD54F15D7							22						Not Applicable	619		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	168	Endocervical Adenocarcinoma of the Usual Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7CM	Not Available	Not Available	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	Not Available	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field	TCGA-C5-A7CM-R57036;TCGA-C5-A7CM-R57037	28A7C62D-54B4-4BAE-A3C7-655C7C9FB4AD;90754288-BB0F-4097-AD31-9F82875C551B	Not Available;Not Available	28;28	92;105	56;91	Not Available;Not Available	2;2	28;5	50.4;4000	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	1997	NO	YES	C5	4	Not Available	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Alive	75	2014	2012
TCGA-DS-A0VN	47	FEMALE	165	3609	81	29.75206611570248	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB	G2	0	3609			TUMOR FREE		47	Not Available	Not Applicable	TCGA-DS-A0VN	f8d342f5-9b92-42e1-8b0d-0876cc26965d	Former User	ABSENT	Not Available	deep cervical	Other Location, specify	4	-17433	Not Applicable	8	Not Available	Not Available	0	Not Available	2910	18	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DS-A0VN-D8738	c2d25fd5-44c6-400a-8857-33092a62271c	Not Available	4	64	34	Cisplatin	Not Available	3	5	68	mg	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	340	mg	Not Available	2011	1	0	NOT HISPANIC OR LATINO			NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-DS-A0VN-F53350;TCGA-DS-A0VN-F71086	72F5D828-1650-4B50-A706-92F807C4FCAE;56D71C0C-6948-4B1D-8DEB-CA6D12FE4AA8							11;17						Not Applicable;Not Applicable	3609;2910		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;Not Available	12;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;YES	Not Available;5	Not Available;Cisplatin	Not Available;68	Not Available;Once weekly	Not Applicable;Not Applicable	YES;Not Available	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;External beam radiation	Not Available;Not Available	Alive;Alive	2013;2015	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	19	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0VN	0	2	Preoperative	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-DS-A0VN-R8739	76badcee-d596-4ccf-a333-8ffc963fd834	1	4	68	36	Not Available	3	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	DS	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	81	2011	2002
TCGA-C5-A1MJ	61	FEMALE	165	14	75	27.548209366391184	Endocervical Type of Adenocarcinoma	Cervical	Dead	T1b1	N0	MX	Stage IB1	G2	0	14			TUMOR FREE		61	Not Available	Not Applicable	TCGA-C5-A1MJ	23f011e2-c025-4494-8016-2140cc8d4bce	Not Available	ABSENT	Not Available	margins free of tumor	Other Location, specify	21	-22308	14	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	1	Not Available			NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	TCGA-C5-A1MJ-F29745	569ED21E-64AD-42A5-9E3F-33449E692460	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	28	Not Available	Not Available	Not Available	Not Available	Not Available	14	Not Available	Not Available	-69	Unknown	Not Available	1	Scheduled Follow-up Submission		3	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available													Not Available	Other, specify	Preoperative	TUMOR FREE	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available																				Dead	2012	FEMALE	165	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	18	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G2												Not Available	0	0	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1MJ	0	2	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	C5	1	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	75	2011	2005
TCGA-FU-A3YQ	35	FEMALE	160	861	101	39.453125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G1	0	861			Unknown		35	23	Not Applicable	TCGA-FU-A3YQ	6E01248B-C551-4F52-8066-CB2D26EB6394	Former User	Not Available	Not Available	Not Applicable	Not Available	4	-12816	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	107	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-FU-A3YQ-F64203	D1EA4476-03A8-4255-B40B-05F3266BA51F							27						Not Applicable	861		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not done per treating physicians discretion	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	24	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	3	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3YQ	1	Not Available	Not Available	Unknown	Not Available	NO	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	YES	NO	FU	2	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	101	2012	2012
TCGA-C5-A907	47	FEMALE	163	448	95	35.75595618954421	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB2	G2	0	448			TUMOR FREE		47	17	Not Applicable	TCGA-C5-A907	C92696BA-F549-480D-8D4A-5F23B27AA336	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-17304	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	136	Not Available	Not Available					TCGA-C5-A907-D58147	A838B6D3-A560-4453-A856-6B9D1170211F	Not Available	1	73	38	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-C5-A907-F66735;TCGA-C5-A907-F69361	E26C070D-0CCD-4372-B6E8-1F36A2DA120C;0468ACE2-5EDD-4ED5-B1C2-0497DDBCD52C							22;7						Not Applicable;Not Applicable	361;448		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	10;1							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Not Available									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A907	1	Not Available	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	WHITE	Regional site;Primary Tumor Field	TCGA-C5-A907-R58148;TCGA-C5-A907-R58149	538BADFC-CA28-462D-8620-E816DFAAED5B;8E1A0D48-0C42-4C91-BFD7-E95DD6680095	Not Available;Not Available	1;1	88;88	38;75	Not Available;Not Available	4;4	25;5	4860;550	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	2006	NO	YES	C5	4	4	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	4860	Not Available	Cervical	Alive	95	2014	2013
TCGA-Q1-A6DV	36	FEMALE	152	491	60	25.969529085872576	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	491			Unknown		36	Not Available	Not Applicable	TCGA-Q1-A6DV	C80F777E-D150-40F3-9FA9-02EF9A6D7692	Current User	ABSENT	Not Available	Not Applicable	Unknown	20	-13166	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	113	-12	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-Q1-A6DV-F62827	A674FEB3-996A-4AC8-B6E5-072DC84A12B1							25						Not Applicable	491		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	152	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.0	8482/3	C53.0	YES	Hysterectomy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	2	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A6DV	Not Available	Not Available	Preoperative	Unknown	Not Available	NO	YES	Unknown	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	Q1	1	0	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	60	2013	2013
TCGA-MU-A5YI	60	FEMALE	175	1053	101	32.97959183673469	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1a1	NX	MX	Stage IA1	G2	1	630.0	Other, specify	Distant Metastasis	TUMOR FREE		60	37	Not Applicable	TCGA-MU-A5YI	5E972E96-7271-439A-905C-6E308C1EF29E	Not Available	Unknown	Not Available	Not Applicable	Not Available	23	-21927	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Progressive Disease			Not Applicable	TCGA-MU-A5YI-F60258	8F97ECC2-B865-4097-8AC4-6606C889AFC1							4						Not Applicable	1053		1053	Not Available		2		NO	6							YES	YES	662	630	Other, specify	CT Guided biopsy	Other, specify	Distant Metastasis	Thoracic Spine	YES	Not Available	YES		Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Unknown									YES						Not Applicable	Not Available	YES	3	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	3500	Alive	2014	FEMALE	175	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Hysterectomy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	18	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	Not Available	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5YI	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Primary Tumor Field	TCGA-MU-A5YI-R66327	9532A85E-BA35-45D2-9789-5BABA2DB41C4	Not Available	9	655	636	Partial Response	10	Not Available	3500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IA1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1a1	Not Available	1991	YES	NO	MU	3	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	101	2013	2011
TCGA-C5-A1BL	32	FEMALE	168	5271	78	27.63605442176871	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB	G2	0	5271			TUMOR FREE		32	16	Not Applicable	TCGA-C5-A1BL	03c3fe57-ae85-4e45-9657-c3182ab5e124	Never Used	ABSENT	Not Available	Not Applicable	Not Available	24	-11723	Not Applicable	1	Not Available	Not Available	0	Not Available	5271	-5	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1BL-F20916;TCGA-C5-A1BL-F57887	CA8E905D-4DA3-48CC-9AA4-2F6D8B4F6506;16E2605B-0E9F-4875-B289-E459FEB70D97	Completed as planned;None	8867;None	Not Applicable;None	HDR;None	Not Available;None	Not Available;None	24;28	Not Applicable;None	33;None	54;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	5271;Not Available	Not Applicable;None	1479;Not Available	Not Applicable;Not Available	Not Available;None	1;Not Available	Scheduled Follow-up Submission;None	None;YES	1;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	On randomized study and received arm without chemotherapy;None	Other;None	NO;None	64;None	19;None	4500;None	Completed as Planned;None	5040;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	168	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	Not Available	HPV 16	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	25	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G2												Not Available	1	0	1	12	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A1BL	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1BL-R21294	225EF00D-8677-491D-B1DE-F3BF21C6C291	1	8	64	19	Not Available	2	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	1988	NO	YES	C5	4	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	78	2012	1994
TCGA-HM-A6W2	34	FEMALE	160	287	89	34.765625	Adenosquamous	Cervical	Alive	T2a	N0	M1	Stage IVB	G3	0	287			Unknown		34	27	Not Applicable	TCGA-HM-A6W2	929505F7-0270-475E-A9D6-00BF38DC78BA	Former User	Not Available	Metastases to Right Ovary	Not Applicable	Not Available	18	-12775	Not Applicable	9	Not Available	62	0	Not Available	125	28	Not Available		Unknown;Paraaortic Nodes Absent;Pelvic Nodes Absent			TCGA-HM-A6W2-D50249	B41660FF-ED31-4FF2-B0DD-57253CB818F8	Not Available	18	120	85	Cisplatin	Unknown	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	Not Available	NOT HISPANIC OR LATINO		Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-HM-A6W2-F57139	2CA7F0EA-2468-4124-BCD3-62803F6E98A4							27						Not Applicable	287		Not Available	Not Available		Not Available		NO	3							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	70mg	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Adenosquamous	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C56.9	8070/3	C56.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	7	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	8	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A6W2	Not Available	Not Available	Preoperative	Unknown	Not Available	NO	YES	Not Applicable	BLACK OR AFRICAN AMERICAN	Primary Tumor Field	TCGA-HM-A6W2-R50248	AB51DD7E-13F7-4844-A0D8-DF864A85481E	Not Available	18	120	85	Unknown	10	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	N0	T2a	Not Available	Not Available	YES	NO	HM	2	2	Not Applicable	Not Available	YES	6	Cisplatin	70mg	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Not Available	Cervical	Alive	89	2013	2013
TCGA-C5-A902	35	FEMALE	177	149	83	26.493025631204315	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB2	G3	0	149			TUMOR FREE		35	14	Not Applicable	TCGA-C5-A902	010A807F-9DC0-4E14-9533-DCF478F3D947	Not Available	Not Available	Not Available	Not Applicable	Not Available	17	-12959	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	149	Not Available	Not Available					TCGA-C5-A902-D58629	ED865073-B057-42DB-9EA8-5D0B20B591E9	Not Available	17	Not Available	63	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-C5-A902-F66734	0B1BD269-1F6C-4B54-8BB6-88BABFDC5FCC							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	Unknown	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	177	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	21	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A902	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	BLACK OR AFRICAN AMERICAN	Regional site;Primary Tumor Field	TCGA-C5-A902-R58630;TCGA-C5-A902-R58631	C4B76701-9082-42BA-87D5-96455F6099C8;32E5AE14-ACBD-43E1-BFD8-0D65C4411BF7	Not Available;Not Available	17;17	107;101	63;49	Not Available;Not Available	4;4	28;2	5040;4900	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	1	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	83	2014	2008
TCGA-C5-A7X3	70	FEMALE	160	284	79	30.859375	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G2	0	284			TUMOR FREE		70	Not Available	Not Applicable	TCGA-C5-A7X3	4ED1616E-8C62-4104-BCBE-26D7059F04D0	Never Used	Not Available	Not Available	Not Applicable	Not Available	3	-25665	284	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A7X3-D56994;TCGA-C5-A7X3-D56995;TCGA-C5-A7X3-D56996	C7862EF2-080F-499E-92D3-840E034090A5;319CE21B-32D0-4C7F-944E-E8EEFC7BB2A6;601CC8EB-C647-4BFB-930E-09527D09BDE9	Cisplatinum;5-flurouracil;Amifostine	28;28;28	26;26;16	5;5;5	Cisplatinum;5-flurouracil;Amifostine	Not Available;Not Available;Not Available	2;2;2	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	2014;2014;2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	7	Not Available	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A7X3	0	0	Not Available	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Regional site;Primary Tumor Field	TCGA-C5-A7X3-R56997;TCGA-C5-A7X3-R56998	381DE052-E255-4F03-BDE3-CACAC94B12B9;75AF9EFD-3EAE-4901-9686-2C867D1A0CC6	Not Available;Not Available	28;28	62;48	5;26	Not Available;Not Available	2;2	17;Not Available	3060;Not Available	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	1	7	Not Applicable	Not Available	YES	Not Available;Not Available	Cisplatin;Other	Not Available;Not Available	Not Available;Not Available	Not Applicable;5 fu RTOG protocol	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	3060	Not Available	Cervical	Dead	79	2014	1997
TCGA-EA-A78R	54	FEMALE	160	410	63	24.609375	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	NX	M0	Stage IB1	G2	0	410			TUMOR FREE		54	Not Available	Not Applicable	TCGA-EA-A78R	79AE5209-F476-4D65-A6C0-EBC18D7C8942	Unknown	ABSENT	Not Available	Not Applicable	Not Available	21	-19942	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	12	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-EA-A78R-F59968	DC2E85E1-8E6B-471D-9637-1F6EA7599FB4							27						Not Applicable	410		Not Available	Not Available		Not Available		NO	5							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	Unknown	Complete Remission/Response									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	PRESENT	Peri (6-12 months since last menstrual period)	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A78R	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	NO	Not Available	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1b1	Not Available	Not Available	YES	NO	EA	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	63	2013	2013
TCGA-EK-A2R8	48	FEMALE	170	44	75	25.951557093425606	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N1	MX	Stage IB2	G3	0	44			WITH TUMOR		48	Not Available	Not Applicable	TCGA-EK-A2R8	D4510801-8CE4-4F10-8B31-25C0A39B5135	Not Available	ABSENT	Not Available	Not Applicable	Not Available	2	-17692	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	40	37	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2R8-F58216	46F0F3A5-4F9A-4783-9F67-6B4DD3A91A77							2						Not Applicable	44		44	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	17	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G3												Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2R8	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b2	Not Available	Not Available	NO	YES	EK	Not Available	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	75	2011	2010
TCGA-HM-A4S6	51	FEMALE	152	454	101	43.71537396121884	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N1	MX	Stage IIIB	G3	0	454			TUMOR FREE		51	14	Not Applicable	TCGA-HM-A4S6	6BCF8B41-7ABC-4B6F-899A-1F67B4ADA765	Former User	ABSENT	Not Available	Squamous cell carcinoma in situ focallly extends to the cervical cuff margin(6-9 o'clock	Other Location, specify	27	-18903	Not Applicable	11	Not Available	24	0	Not Available	244	38	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Unknown			TCGA-HM-A4S6-D42760	D3B2B9D8-5887-4271-8C20-F368C42E0097	Not Available	30	243	223	Cisplatin	Complete Response	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	0	Not Available	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-HM-A4S6-F49848	D00AFDDF-47EC-4FE8-9332-9AA23C446A7A							11						Not Applicable	454		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Adverse event/ complications	YES	4	Cisplatin	70 mg	Once weekly	Not Applicable	YES	YES	2100	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	4500	Alive	2013	FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Tissue in the cervix during pelvic exam was passed ans sent for pathology	Other method, specify:	Not Available	Not Available	13	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	5	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A4S6	1	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Not Applicable	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-HM-A4S6-R42787;TCGA-HM-A4S6-R42817	07AD45EB-B34E-4B03-B41F-AE34B51B9B3E;3CAFC570-2B23-4CE9-B203-493C9C9B347C	Not Available;Not Available	30;30	262;277	222;263	Complete Response;Complete Response	4;4	25;6	4500;2100	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b2	Not Available	1995	YES	NO	HM	3	6	Concurent chemo RT Ongoing-treatment delayed due to postoperative complications.	Other	YES	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Other	Radiation currently ongoing- treatment delayed due to postoperative complication	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	101	2013	2012
TCGA-VS-A8QH	76	FEMALE	159	1210	73	28.87544005379534	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Dead	TX	NX	MX	Stage IB1	G2	0	1210			WITH TUMOR		76	Not Available	Not Applicable	TCGA-VS-A8QH	C4F61715-EE58-4799-A5F4-0F5E27C4093D	Unknown	Not Available	Not Available	Not Applicable	Not Available	30	-27909	1210	Not Available	Not Available	Not Available	0	Not Available	Not Available	-1	Not Available					TCGA-VS-A8QH-D62005;TCGA-VS-A8QH-D65297	BBB1806B-37D4-4DAD-BA0D-870901A18049;D1392037-BB2A-4CF5-8421-BE274E5395F2	Not Available;Not Available	10;21	98;98	62;62	Gemcitabine;Cisplatin	Partial Response;Not Available	7;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	159	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A8QH	1	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Partial Remission/Response	WHITE	Regional site;Primary Tumor Field	TCGA-VS-A8QH-R62002;TCGA-VS-A8QH-R62004	25CE8D3D-925B-4684-97BF-08B0C6CE4380;9F3D3BCE-937A-4B10-A1BA-6D3D0EAFCEC5	Not Available;Not Available	10;10	161;187	126;164	Partial Response;Partial Response	7;7	25;4	4500;2700	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Adverse event/ complications	YES	3;3	Other;Other	Not Available;Not Available	Once weekly;Once weekly	Cisplatin;Gemcitabine	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	73	2014	2010
TCGA-EK-A2IP	28	FEMALE	167	202	69	24.74093728710244	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G3	0	202			Not Available		28	Not Available	Not Applicable	TCGA-EK-A2IP	76B54726-D348-4A1B-AE26-5B08D2EFFC9D	Not Available	Not Available	Not Available	Not Applicable	Not Available	4	-10347	Not Applicable	-2	Not Available	Not Available	0	Not Available	202	8	Not Available																												0	Not Available	Not Available			Not Available	Not Applicable	Not Applicable	Not Available	NO	Not Available	Not Applicable	TCGA-EK-A2IP-F21349	D46550E1-8A64-46AC-8133-0DE773DC82BF	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	10	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Applicable	202	Not Applicable	8	Not Applicable	Not Available	0	Scheduled Follow-up Submission		2	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Preoperative	Not Available	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available																				Alive	2012	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	18	Not Available	Not Available	Not Available	Not Available	11	G3												Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2IP	1	Not Available	Preoperative	Not Available	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	69	2011	2006
TCGA-DS-A7WH	34	FEMALE	168	533	50	17.715419501133788	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b1	N0	MX	Stage IB1	G2	0	533			TUMOR FREE		34	Not Available	Not Applicable	TCGA-DS-A7WH	DADCF6D5-03EB-4090-BCC3-B9E9DC3C7E08	Former User	Not Available	Not Available	Not Applicable	Not Available	23	-12644	Not Applicable	Not Available	Not Available	5	0	Not Available	223	Not Available	Not Available					TCGA-DS-A7WH-D54774	77253106-F449-4E19-800E-3EB594A38AD4	Not Available	23	112	74	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-DS-A7WH-F63889	1FCCC802-98A3-4BF1-B63C-B1F2734D4603							20						Not Applicable	533		502	Not Available		0		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	7	Cisplatin	40 mg/m2 (62.4 mg)	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5040	Alive	2014	FEMALE	168	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8480/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	22	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7WH	1	1	Preoperative	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-DS-A7WH-R54775	43CF1C5A-D41C-41D6-AC75-DD5D28489291	Not Available	23	112	74	Complete Response	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	YES	NO	DS	1	2	Not Applicable	Not Available	YES	7	Cisplatin	40 mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Alive	50	2012	2013
TCGA-ZJ-AAX8	58	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	N1	M0	Stage IIIB	G2	0	0			Unknown		58	Not Available	Not Applicable	TCGA-ZJ-AAX8	B5F0E361-D67D-4FA9-9916-43623DAFB10F	Unknown	Not Available	Not Available	Not Applicable	Not Available	19	-21481	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAX8	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	YES	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3b	Not Available	Not Available	NO	YES	ZJ	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2009
TCGA-DR-A0ZM	61	FEMALE	158	1791	64	25.636917160711423	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIIB	G2	0	1791			TUMOR FREE		61	30	Not Applicable	TCGA-DR-A0ZM	748aada0-448f-4523-9893-3d9618fdbe18	Former User	PRESENT	Not Available	Patient had clear margins	Other Location, specify	28	-22464	Not Applicable	8	519	521	0	Not Available	1289	8	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	TCGA-DR-A0ZM-D17118	D926B906-4EC1-4D19-974E-E852936E646C	Not Available	28	Not Available	Not Available	Cisplatin	Not Available	3	6	Not Available	Not Available	ADJUVANT	Not Applicable	1	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	0	Not Available	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO	Not Applicable	Not Applicable	Complete Response	YES	6	Not Applicable	TCGA-DR-A0ZM-F17116	E8B9EB20-405A-45D8-8B1E-7DF36077563C	Not Available	Not Available	Not Applicable	Not Available	Cisplatin	Not Available	28	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Applicable	1791	Not Applicable	1289	Not Applicable	Not Available	0	Scheduled Follow-up Submission		3	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Applicable	Not Available	YES	92	55	Not Available	Completed as Planned	4500	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Alive	2011	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	58	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	3	G2												Not Available	0	0	3	15	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0ZM	1	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Regional site	TCGA-DR-A0ZM-R17117	F431B9D3-1E94-4967-B494-7A56D7D49EAC	1	28	92	55	Not Available	3	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	Not Available	NO	YES	DR	2	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	64	2011	2006
TCGA-EX-A1H5	58	FEMALE	167	619	67	24.02380867008498	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	MX	Stage IIB	G3	0	619			TUMOR FREE		58	33	Not Applicable	TCGA-EX-A1H5	6b74c07a-9932-4a80-8296-9db08d0c6964	Never Used	ABSENT	Not Available	Not Applicable	Microscopic parametrial involvement	21	-21338	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	178	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available	Not Applicable;None	Not Applicable;None	Complete Response;Complete Response	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-EX-A1H5-F20234;TCGA-EX-A1H5-F50657	0C01052A-352A-4DB4-9ECC-5AB3326BA5FF;DF3C8B2C-5F1D-4CCC-879F-1B6CEA7481AB	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	9;28	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	500;619	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;NO	1;10	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	not part of recommended treatment plan;None	Other;None	NO;None	Not Available;None	Not Available;None	Not Available;None	Completed as Planned;None	Not Available;None	YES;YES	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;NO	None;YES	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Alive	2012;2013	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	21	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3												Not Available	4	Not Available	4	12	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1H5	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	TCGA-EX-A1H5-R12368	2A62AD4E-6D75-43C6-9504-E9DA0652A430	1	31	Not Available	Not Available	Not Available	5	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	Not Available	Not Available	YES	NO	EX	2	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	67	2011	2010
TCGA-C5-A8YQ	79	FEMALE	165	715	70	25.711662075298438	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IB1	G2	0	715			WITH TUMOR		79	23	Not Applicable	TCGA-C5-A8YQ	DE3CFB81-25C3-4137-8F24-AD8AA607C158	Not Available	Not Available	Not Available	Not Applicable	Not Available	17	-28873	715	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A8YQ-D58639	ED687F1B-1E47-4D1B-AF20-7C902B7766E3	Not Available	17	Not Available	214	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	23	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	1	56	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A8YQ	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Regional site;Primary Tumor Field	TCGA-C5-A8YQ-R58640;TCGA-C5-A8YQ-R58641	23D3B1B6-FB56-4A69-8B36-B3DE8E73764F;B4D5BA3A-A2E3-4B48-8530-6AE2FA51CA93	Not Available;Not Available	17;17	Not Available;Not Available	214;214	Not Available;Not Available	4;4	Not Available;Not Available	4800;3900	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	2	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	70	2014	2006
TCGA-VS-A9UI	76	FEMALE	Not Available	1372	70		Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	NX	MX	Stage IIB	GX	0	1372			TUMOR FREE		76	Not Available	Not Applicable	TCGA-VS-A9UI	9C516D28-BEF2-4334-BDDA-97950BD95AC0	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-27838	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	953	62	Not Available																												1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A9UI-F67686;TCGA-VS-A9UI-F71210	BF9AFFC9-CEC4-4E37-AB5E-18B68AA4ACE5;2FCF6733-6B54-4E90-AEFA-5BBD8666FC78							9;23						Not Applicable;1372	1246;Not Available		Not Available;Not Available	Not Available;Cardiopulmonary arrest		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Other, specify	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Dead	2014;2015	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UI	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A9UI-R63489;TCGA-VS-A9UI-R63490;TCGA-VS-A9UI-R63491	595A9EF5-3A53-4D00-BFD4-F45E90E87BD6;E4EFC749-FA8D-48F8-9188-3A4AD3D03F96;AC999829-F513-4002-8E10-1488823B41F4	Not Available;Not Available;Not Available	11;11;11	111;120;121	71;113;100	Complete Response;Complete Response;Complete Response	8;8;8	25;5;4	4500;900;2800	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	5	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	70	2014	2011
TCGA-VS-A9UA	60	FEMALE	134	867	88	49.00868790376476	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3	NX	MX	Stage IIIA	G3	0	867			TUMOR FREE		60	Not Available	Not Applicable	TCGA-VS-A9UA	60117B70-36C0-41BB-A9FC-85DB8FA10102	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-22221	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	526	0	Not Available					TCGA-VS-A9UA-D63477	B1D0877D-E150-40BF-AD5F-ACB4BBEAC36D	Not Available	11	162	118	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response;Complete Response;Complete Response			Follow up;Not Applicable;Not Applicable;Not Applicable	TCGA-VS-A9UA-F67688;TCGA-VS-A9UA-F68177;TCGA-VS-A9UA-F69280;TCGA-VS-A9UA-F70278	A26C984F-BFC0-40D3-9373-D2B638AA4B86;5A3F43D8-97FA-498B-871E-47CADE12B14A;B70FC0A3-F25F-4469-85A0-E7F7C305AEA5;3E210D28-E4BE-41AF-9D53-51888B9C7751							9;13;31;3						Not Applicable;Not Applicable;Not Applicable;Not Applicable	648;783;821;867		648;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available		0;Not Available;Not Available;Not Available		NO;NO;NO;NO	11;11;12;2							Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO		Not Available;Not Available;Not Available;Not Available	Other;Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;YES;YES;YES	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response									YES;YES;YES;YES						Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	YES;YES;YES;YES	YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Alive;Alive;Alive;Alive	2014;2014;2014;2015	FEMALE	134	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UA	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Primary Tumor Field;Regional site	TCGA-VS-A9UA-R63475;TCGA-VS-A9UA-R63476	7E00995A-DA14-4337-BAF5-C81580C3F4AB;E1FECC82-CC45-4202-9B32-0CCA3F92AA2D	Not Available;Not Available	11;11	178;163	167;120	Complete Response;Complete Response	8;8	4;25	2400;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3	Not Available	Not Available	NO	YES	VS	1	2	Not Applicable	Not Available	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2400	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	88	2014	2012
TCGA-VS-A9UB	54	FEMALE	166	911	79	28.668892437218755	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	MX	Stage IIB	G3	0	911			TUMOR FREE		54	Not Available	Not Applicable	TCGA-VS-A9UB	CA242B4C-B879-4E13-A1E7-84C984067189	Never Used	Not Available	Not Available	Not Applicable	Not Available	1	-19737	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	562	0	Not Available					TCGA-VS-A9UB-D65878	107F4992-511B-4946-8096-D16382E92606	Not Available	1	100	65	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Follow up;Not Applicable	TCGA-VS-A9UB-F67692;TCGA-VS-A9UB-F72389	E4EFBA87-40B5-49DF-AD2D-3073562550B1;4071F64D-8956-42D7-8156-65AEBD615229							9;11						Not Applicable;Not Applicable	648;911		648;Not Available	Not Available;Not Available		2;Not Available		NO;NO	11;6							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	166	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	51	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	11	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UB	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	Unknown	Primary Tumor Field;Regional site	TCGA-VS-A9UB-R65876;TCGA-VS-A9UB-R65877	EBE9A09F-D8D1-490E-83DA-9F564A4C963D;D92AA023-7CFD-42A6-8B87-84A557CC578B	Not Available;Not Available	1;1	116;105	106;64	Complete Response;Complete Response	10;10	4;25	2800;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2b	Not Available	Not Available	NO	YES	VS	1	11	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	79	2014	2012
TCGA-DS-A0VM	51	FEMALE	163	3589	69	25.970115548195267	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IB	G3	1	868.0	Lung	Distant Metastasis	TUMOR FREE		51	Not Available	Not Applicable	TCGA-DS-A0VM	ed6d989d-da09-4818-8fed-f33d88b628af	Former User	ABSENT	Not Available	No involved margins. Margins clear as per pathology report.	Other Location, specify	7	-18839	Not Applicable	1	Not Available	Not Available	0	Not Available	2128	0	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DS-A0VM-D8642	1d3da5d7-7c94-4ba8-961d-d37ec233d318	Not Available	1	70	42	Cisplatin	Not Available	3	4	30	mg	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	120	mg	Not Available	2011	1	0	NOT HISPANIC OR LATINO			NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-DS-A0VM-F53351;TCGA-DS-A0VM-F71160	0D9FC68A-CE9A-49AD-A038-3ADE324549FF;BA24D3D4-F274-4097-9A3B-70A55810A094							11;19						Not Applicable;Not Applicable	3589;2128		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;Not Available	12;3							Not Available;NO	Not Available;NO	Not Available;907	Not Available;868	Not Available;Lung	Not Applicable;Not Applicable	Not Available;Cytology	Not Available;Distant Metastasis	Not Available;Not Available	Not Available;YES	Not Available;R0	NO;YES		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;YES	Not Available;4	Not Available;Cisplatin	Not Available;30mg/dose	Not Available;Once weekly	Not Applicable;Not Applicable	YES;Not Available	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2013;2015	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	21	Other Location, specify	Parametrial	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1	G3												Not Available	1	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0VM	0	0	Preoperative	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	DS	1	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	69	2011	2003
TCGA-VS-A8QM	47	FEMALE	163	951	53	19.948059768903608	Cervical Squamous Cell Carcinoma	Cervical	Dead	TX	NX	M1	Stage IVB	GX	0	951			WITH TUMOR		47	15	Not Applicable	TCGA-VS-A8QM	27D2B645-F1BF-4486-B0B5-273681B58625	Unknown	Not Available	Not Available	Not Applicable	Not Available	1	-17168	951	Not Available	Not Available	Not Available	0	Not Available	Not Available	-334	Not Available					TCGA-VS-A8QM-D61947;TCGA-VS-A8QM-D65296	5079FF1A-2F4B-4088-8168-7A3A3042489A;1C0DBDC1-83FA-4B53-A402-A48ABA89A4B4	Not Available;Not Available	10;21	136;81	49;49	Cisplatin;Fluorouracil	Clinical Progressive Disease;Clinical Progressive Disease	7;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	16	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A8QM	1	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	Unknown	Regional site	TCGA-VS-A8QM-R61946	7575157D-56C4-455B-85A0-E91C7CB39B21	Not Available	10	141	106	Radiographic Progressive Disease	7	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	NX	TX	Not Available	Not Available	NO	YES	VS	2	4	Not Applicable	Adverse event/ complications	YES	3;3	Cisplatin;Other	Not Available;Not Available	Once weekly;Once weekly	Not Applicable;Fluorouracil	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	53	2014	2009
TCGA-FU-A3HZ	64	FEMALE	165	1103	66	24.242424242424242	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	M0	Stage IIA2	G3	0	1103			TUMOR FREE		64	Not Available	Not Applicable	TCGA-FU-A3HZ	6FF12A54-10DA-4941-BFEA-7B66E19B4BE9	Not Available	PRESENT	Not Available	Not Applicable	Not Available	16	-23565	Not Applicable	-7	Not Available	Not Available	0	Not Available	31	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Pelvic Nodes Absent			TCGA-FU-A3HZ-D64229	11063673-DD72-418C-8090-19921AB04C0C	Not Available	27	114	53	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			Follow-up Office Visit	TCGA-FU-A3HZ-F64224	AF39509B-766F-4AB4-9356-0DF2E7CF2446							27						Not Applicable	1103		758	Not Available		0		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	1500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	curettage	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	9	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3												Not Available	0	0	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HZ	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-FU-A3HZ-R64227;TCGA-FU-A3HZ-R64228	7A0FEA98-0BD6-4438-A795-256AD101C100;5C1F64F2-6BFD-4551-9EFC-5809590AB300	Not Available;Not Available	27;27	114;120	66;106	Complete Response;Complete Response	8;8	25;3	4500;1500	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a2	Not Available	Not Available	NO	YES	FU	1	0	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	66	2012	2010
TCGA-EK-A2RM	40	FEMALE	167	50	105	37.64925239341676	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB	G3	1				WITH TUMOR		40	Not Available	Not Applicable	TCGA-EK-A2RM	C13215D9-26A8-4C8B-B4FE-5DA6AA3222AF	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-14842	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	50	0	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RM-F58215	DA301AF1-443A-4FFD-B742-E36232444EBE							2						Not Applicable	50		0	Not Available		1		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	WITH TUMOR	Unknown	Unknown									Unknown						Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	167	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Radical Hysterectomy, BSO	Other method, specify:	Not Available	Not Available	36	Not Available	Not Available	PRESENT	Not Available	12	G3												Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RM	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	105	2011	2009
TCGA-VS-A9UV	74	FEMALE	152	104	31	13.41759002770083	Cervical Squamous Cell Carcinoma	Cervical	Dead	T4	NX	MX	Stage IVA	GX	0	104			WITH TUMOR		74	Not Available	The patient did not perform treatment	TCGA-VS-A9UV	C9E4BAC6-0CAC-4FCA-A548-527DEAC5B880	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-27348	104	Not Available	Not Available	Not Available	0	Not Available	Not Available	-2	Not Available																												1	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A9UV	Not Available	Not Available	Other	WITH TUMOR	Not Available	NO	Not Available	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	Not Available	Not Available	NO	YES	VS	1	5	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	31	2014	2013
TCGA-C5-A2LS	37	FEMALE	173	1345	92	30.73941661933242	Endocervical Adenocarcinoma of the Usual Type	Cervical	Alive	T1b2	N0	M0	Stage IB2	G1	0	1345			TUMOR FREE		37	17	Not Applicable	TCGA-C5-A2LS	185E1520-92EE-4AF5-AF15-FBEEFB352C99	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	3	-13857	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1345	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-C5-A2LS-F55254	779A6701-1102-4C7F-9234-AB794E114F68							3						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available									Not Available						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	173	Endocervical Adenocarcinoma of the Usual Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8380/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	41	Not Available	Not Available	Not Available	Not Available	1	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	11	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2LS	1	0	Not Available	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	C5	2	3	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	92	2014	2005
TCGA-EA-A556	38	FEMALE	160	453	62	24.21875	Endometrioid Adenocarcinoma of Endocervix	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	453			TUMOR FREE		38	18	Not Applicable	TCGA-EA-A556	2D34E9A3-298C-4365-B7A1-A507C7F069CD	Never Used	ABSENT	Not Available	Not Applicable	Unknown	22	-13988	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	-1	Not Available																												1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			At time of last contact	TCGA-EA-A556-F53440	14840F83-5A91-4CC5-A94A-D778D9E00784							11						Not Applicable	453		453	Not Available		0		NO	12							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2013	FEMALE	160	Endometrioid Adenocarcinoma of Endocervix	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8380/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	7	Not Available	Not Available	Unknown	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	1	20	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A556	0	0	Preoperative	TUMOR FREE	0	NO	YES	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	2	1	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	62	2013	2012
TCGA-C5-A905	37	FEMALE	Not Available	4879	73		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB	G2	0	4879			TUMOR FREE		37	Not Available	Not Applicable	TCGA-C5-A905	C99F476B-E8B1-4CDD-9164-0DA450064886	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-13584	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	4879	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-C5-A905-F66740	1065AB31-DFD9-4FDA-BF9B-E86489E570BE							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	Not Available	Not Available	Not Available									Not Available						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	33	Not Available	Not Available	Not Available	Not Available	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	9	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A905	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	C5	Unknown	9	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	73	2014	1994
TCGA-EA-A3HU	43	FEMALE	162	1013	68	25.91068434689834	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	M0	Stage II	G2	0	1013			TUMOR FREE		43	Not Available	Not Applicable	TCGA-EA-A3HU	9912432E-74BC-4846-93B4-FA2BF8070BD1	Never Used	ABSENT	Not Available	Not Applicable	Not Available	17	-15909	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	81	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			At last contact	TCGA-EA-A3HU-F66112	C46E4B85-E63D-4854-8E39-66860981B916							2						Not Applicable	1013		1013	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	14	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HU	0	10	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a2	Not Available	Not Available	YES	NO	EA	1	12	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	68	2012	2011
TCGA-C5-A1BE	64	FEMALE	149	2094	76	34.232692221071126	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N1	MX	Stage IB2	G2	1	1674.0			WITH TUMOR		64	Not Available	Not Applicable	TCGA-C5-A1BE	2b6d2c15-8bcc-41ab-84d6-601442f4378b	Not Available	PRESENT	Not Available	Anterior lower uterine segment	Other Location, specify	12	-23727	2094	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A1BE-D30508;TCGA-C5-A1BE-D30509	778DACD3-1169-4B7A-8A3B-E324986427D3;A715C97A-30BE-41EA-8E32-FC40D47180B1	Not Available;Not Available	11;11	Not Available;Not Available	84;1666	Cisplatin;Cisplatin	Not Available;Not Available	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;RECURRENCE	Not Applicable;Not Applicable	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	0	Not Available			NO	YES	NO	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A1BE-F30504	CF4EB184-9FB1-4CD1-A898-455B33D22B14	Completed as planned	Not Available	Not Applicable	HDR	Cisplatin	Not Available	11	Not Available	65	90	Not Available	84	2094	Not Available	1674	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		4	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	YES													Not Available	Cervical Cancer	Not Available	WITH TUMOR	YES	Complete Remission/Response	Not Applicable	Not Available	YES	90	65	Not Available	Completed as Planned	4500	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	149	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	38	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G2												Not Available	2	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BE	1	1	Not Available	WITH TUMOR	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1BE-R30506	8835917E-89C9-4295-B37C-4B2568E94D31	1	11	90	65	Not Available	4	Not Available	4500	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b	Not Available	Not Available	NO	YES	C5	3	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	76	2011	2000
TCGA-C5-A7CH	43	FEMALE	161	4694	104	40.12190887697234	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G2	0	4694			Unknown		43	Not Available	Not Applicable	TCGA-C5-A7CH	D626A732-AF64-4DEC-B4BF-3CB761BF4C8D	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-15777	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	771	Not Available	Not Available					TCGA-C5-A7CH-D56511	797AE99C-E4D4-4EDE-8E29-0A8F3A1BE314	Not Available	11	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A7CH-F63994	878E5010-27D3-4ADA-BE19-17F47A02E806							22						Not Applicable	4694		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	161	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	8	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7CH	0	1	Not Available	Unknown	0	Not Available	Not Available	Not Available	WHITE	Unknown	TCGA-C5-A7CH-R56512	A48DA42C-C02C-4F6A-99A2-ECE67A09B79B	Not Available	11	Not Available	Not Available	Not Available	2	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	1	9	Not Applicable	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	104	2014	2001
TCGA-DS-A7WF	41	FEMALE	160	492	63	24.609375	Adenosquamous	Cervical	Dead	T1b2	N0	MX	Stage IB2	G3	1	321.0	Lung	Distant Metastasis	WITH TUMOR		41	Not Available	Not Applicable	TCGA-DS-A7WF	D02FFAA9-0403-4A89-BE01-CCE35C80DD69	Never Used	Not Available	Not Available	Not Applicable	Not Available	23	-15319	492	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-DS-A7WF-D54752	6BBFFE71-CD5D-4340-89B0-709C35F6FA63	Not Available	23	397	80	Cisplatin	Partial Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	0	HISPANIC OR LATINO			Not Available			Partial Response			Not Applicable	TCGA-DS-A7WF-F54754	DAF85478-51B5-40D7-BF0B-2B8C95C588B2							23						492	Not Available		Not Available	Not Available		1		NO	12							NO;NO;NO	YES;YES;YES	Not Available;Not Available;Not Available	321;321;321	Lung;Other, specify;Other, specify	CT scan;CT scan;CT scan	Other, specify;Other, specify;Other, specify	Distant Metastasis;Distant Metastasis;Distant Metastasis	Not Available;Liver;Brain	NO;NO;NO	Not Available;Not Available;Not Available	YES		Cervical Cancer	Preoperative	WITH TUMOR	YES	Partial Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Unknown	Other	Not Available	Not Available	Not Applicable	Not Applicable	Unknown	Not Available	Dead	2013	FEMALE	160	Adenosquamous	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8560/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	23	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G3	NO;NO;NO	YES;Not Available;Not Available	Not Available;Not Available;Not Available	321;321;321	Lung;Not Applicable;Not Applicable	CT scan;CT;CT	Other, specify;Other, specify;Other, specify	Distant Metastasis;Distant Metastasis;Distant Metastasis	Not Available;Liver;Brain	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES	0	0	1	7	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A7WF	1	1	Preoperative	WITH TUMOR	0	NO	YES	Partial Remission/Response	Unknown	Distant Recurrence;Primary Tumor Field	TCGA-DS-A7WF-R54761;TCGA-DS-A7WF-R54759	3201797C-FBBF-49A1-8831-91C71367A7E3;251B0201-5008-4AD0-8B75-62A6B717952A	Not Available;Not Available	23;23	397;387	341;80	Radiographic Progressive Disease;Partial Response	12;12	10;Not Available	3000;Not Available	NO;NO	External;Unknown	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2013;2013	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b2	Not Available	Not Available	NO	YES	DS	2	3	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Unknown	Other	Not Available	Not Available	Not Applicable	Not Applicable	Unknown	Not Available	Not Available	Cervical	Dead	63	2013	2006
TCGA-ZJ-AB0H	48	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	N1	M0	Stage IIIB	Not Available	0	0			Unknown		48	Not Available	Not Applicable	TCGA-ZJ-AB0H	F0DAF315-8909-4CDA-886D-A2770B08DB94	Unknown	Not Available	Not Available	Not Applicable	Not Available	19	-17869	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AB0H	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	YES	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3b	Not Available	Not Available	NO	YES	ZJ	Unknown	Not Available	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2006
TCGA-DG-A2KH	25	FEMALE	Not Available	34	Not Available		Adenosquamous	Cervical	Alive	T1b1	N0	M0	Stage IB1	GX	0	34			Unknown		25	Not Available	Not Applicable	TCGA-DG-A2KH	6248F2A3-0DA9-419F-AB77-C3F6F4353EB5	Unknown	ABSENT	The pelvic nodules show circumscribed area of adipose tissue with local fat necrosis. No evidence of malignancy within this pelvic nodule.	Not Applicable	Not Available	11	-9209	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	34	Not Available	Not Available																												0	Not Available	Not Evaluated			Not Available			Not Available			Not Applicable	TCGA-DG-A2KH-F49830	D6D4D2CC-35F3-435C-8DFF-F764574A1CA4							11						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available									Not Available						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2013	FEMALE	Not Available	Adenosquamous	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	12	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A2KH	Not Available	Not Available	Pre-Adjuvant Therapy	Unknown	Not Available	NO	YES	Unknown	Not Evaluated																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	DG	4	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2013	Not Available
TCGA-C5-A1BI	31	FEMALE	157	1112	59	23.936062314901214	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIIB	G2	0	1112			TUMOR FREE		31	16	Not Applicable	TCGA-C5-A1BI	91310434-2a99-4e1d-81e6-3d58d097089f	Former User	Not Available	Not Available	Not Applicable	Not Available	12	-11564	Not Applicable	1	Not Available	16	0	Not Available	1112	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-C5-A1BI-D30513	CD5F4D29-A387-4D5D-AC20-A519665F404D	Not Available	11	74	27	Cisplatin	Not Available	4	6	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	6;None	Not Applicable;Not Applicable	TCGA-C5-A1BI-F30512;TCGA-C5-A1BI-F57886	0562D545-2AE3-48DE-B2D9-33110084EA3D;C617492C-0F13-4017-B918-651A9131C72D	Completed as planned;None	Not Available;None	Not Applicable;None	HDR;None	Cisplatin;None	Not Available;None	11;28	Not Applicable;None	62;None	74;None	74;None	27;None	Not Applicable;Not Applicable	1112;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Once weekly;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;YES	4;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	YES;None	74;None	27;None	Not Available;None	Completed as Planned;None	4320;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	ECC	Other method, specify:	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G2												Not Available	Not Available	Not Available	2	15	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BI	0	1	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1BI-R30514	39962F26-55DD-4F8A-A47E-216B7B36EE89	1	11	74	27	Not Available	4	24	4320	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	59	2011	2001
TCGA-ZJ-AAX4	85	FEMALE	170	21	77	26.643598615916954	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2	N0	M0	Stage II	G3	0	21			Unknown		85	23	Not Applicable	TCGA-ZJ-AAX4	13D72130-604C-4D79-95CC-53C2E25D91B0	Never Used	Not Available	Not Available	Not Applicable	Positive vaginal margin	19	-31258	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	21	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	26	Not Available	Not Available	PRESENT	Unknown	12	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	0	3	.57	Not Available	Not Applicable	Yes	Not Available	Unknown	Not Available	AAX4	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	YES	Unknown	WHITE																			Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	1949	NO	YES	ZJ	4	3	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	77	2014	2008
TCGA-EA-A97N	38	FEMALE	160	11	60	23.4375	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G2	0	11			TUMOR FREE		38	Not Available	Not Applicable	TCGA-EA-A97N	87E701AB-ACFD-45F2-A12E-323C94E5F3D5	Never Used	ABSENT	Not Available	Not Applicable	Not Available	18	-13984	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	11	11	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-EA-A97N-F68492	285ADF1C-6702-41D7-9F9F-04207AAC5D20							24						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	11																		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available									Not Available						Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	10	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A97N	Not Available	3	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	YES	NO	EA	1	5	Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	60	2014	2013
TCGA-IR-A3LC	40	FEMALE	160	3935	64	25.0	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	3935			TUMOR FREE		40	Not Available	Not Applicable	TCGA-IR-A3LC	58BDCACE-0047-456E-A225-68953EDAFE5E	Current User	ABSENT	Not Available	Not Applicable	Not Available	13	-14697	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	3333	Not Available	Not Available					TCGA-IR-A3LC-D38296	A95DAC18-6883-4A30-9E1E-27551C9445B7	Not Available	14	Not Available	Not Available	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	0	Not Available			NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-IR-A3LC-F38289;TCGA-IR-A3LC-F68417	694A4150-6714-4693-9052-43953F0DF068;A0D9023E-0D50-4CE6-8614-691535719F14							14;17						Not Applicable;Not Applicable	3571;3935		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	12;11							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Not Available									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	6;Not Available	Cisplatin;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	0;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Unknown;Not Available	4500;Not Available	Alive;Alive	2012;2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	48	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3												Not Available	0	0	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LC	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-IR-A3LC-R38292	5388A3E1-6ACC-4CCB-B603-6F1F52810383	Not Available	14	153	Not Available	Complete Response	12	Not Available	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	IR	1	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	64	2012	2003
TCGA-C5-A2LY	30	FEMALE	160	2383	88	34.375	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	2383			TUMOR FREE		30	Not Available	Not Applicable	TCGA-C5-A2LY	E733F289-A0EC-478C-AAD9-1378AD26DDFA	Former User	ABSENT	Not Available	Not Applicable	Not Available	25	-11018	Not Applicable	12	Not Available	12	0	Not Available	2383	15	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent			TCGA-C5-A2LY-D21305	9DC32BEE-25A6-48D6-A582-A6E165A5813B	Not Available	8	106	45	Cisplatin	Not Available	2	6	40	mg/m2/wk	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	1	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent	NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	6;None	Not Applicable;Not Applicable	TCGA-C5-A2LY-F20978;TCGA-C5-A2LY-F55200	23F67F89-428E-4781-BC7C-A335192DBB21;711C6875-24AC-43F0-8A0C-04FB1AA8307E	Completed as planned;None	Not Available;None	Not Applicable;None	HDR;None	Cisplatin;None	40mg/m2;None	25;28	Not Applicable;None	78;None	106;None	106;None	45;None	Not Applicable;Not Applicable	2383;Not Available	Not Applicable;None	110;Not Available	Not Applicable;Not Available	Once weekly;None	0;Not Available	Scheduled Follow-up Submission;None	None;YES	1;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;Not Available	YES;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	YES;None	106;None	45;None	0;None	Completed as Planned;None	5040;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	Not Available	HPV 16	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	8	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G2												Not Available	0	0	1	Not Available	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A2LY	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A2LY-R21307	396BAC85-FCF8-492B-B9BE-0883FDC45685	1	8	106	45	Not Available	2	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	C5	1	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	88	2012	2002
TCGA-VS-A8EG	36	FEMALE	160	1386	66	25.78125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	NX	M0	Stage IB1	GX	0	1386			TUMOR FREE		36	Not Available	Not Applicable	TCGA-VS-A8EG	B0B293C1-BD7E-4BA8-9F44-47398488EF2C	Current User	Not Available	Not Available	Not Applicable	Not Available	22	-13166	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	883	76	Not Available																												0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A8EG-F67670;TCGA-VS-A8EG-F72387	C275017C-D8AC-49A3-AEB7-1BDB7C7C3E54;2D18C784-3DEB-4258-946D-17C4915EF92F							9;23						Not Applicable;Not Applicable	1149;1386		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;7							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	4	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8EG	1	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	Unknown	Primary Tumor Field;Regional site	TCGA-VS-A8EG-R62007;TCGA-VS-A8EG-R62008	2309252C-E26D-45DD-8779-E07F7E39249B;B9890A64-DD34-420D-9822-386D04D42922	Not Available;Not Available	10;10	154;149	133;104	Complete Response;Complete Response	7;7	7;25	2800;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T1b1	Not Available	Not Available	NO	YES	VS	1	5	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	66	2014	2011
TCGA-EK-A2RD	47	FEMALE	161	2	114	43.97978473052737	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G2	0	2			TUMOR FREE		47	Not Available	Not Applicable	TCGA-EK-A2RD	16363EF7-899D-4927-A74B-E7C03B3D8AF1	Not Available	Not Available	Not Available	Not Applicable	Not Available	5	-17191	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RD-F58262	2EF8A78A-C9A3-40F5-AABE-537638FB5556							3						Not Applicable	2		0	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	161	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Biopsy, Robotic Hysterectomy, BSO, Pelvic and periaortic LN dissection.	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	10	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G2												Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RD	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	AMERICAN INDIAN OR ALASKA NATIVE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	114	2011	2009
TCGA-MA-AA41	33	FEMALE	159	279	47	18.59103674696412	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2	N1	M1	Stage IIB	G2	1				WITH TUMOR		33	14	Not Applicable	TCGA-MA-AA41	81658CE6-D4A9-4EE0-AE8F-CF2FA8485701	Former User	Not Available	Not Available	Not Applicable	Not Available	16	-12398	Not Applicable	Not Available	Not Available	15	0	Not Available	279	0	Not Available																												1	Not Available	HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent	Not Available			Progressive Disease			Not Applicable	TCGA-MA-AA41-F65481	90250EF3-3BE9-4ECB-A234-69D7E898D782							23						Not Applicable	254		254	Not Available		4		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	159	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA41	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	NO	Progressive Disease	WHITE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	N1	T2	Not Available	Not Available	YES	NO	MA	2	3	Not Applicable	Not Available	YES	2;6;6;5	Cisplatin;Carboplatin;Other;Other	57;AUC/5;175mg/m2; 135mg/m2;15mg/kg	Once weekly;Once weekly;Once weekly;Not Available	Not Applicable;Not Applicable;Paclitaxel;Bevacizumab	YES	YES	6817	pulse dose rate	Other	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	3420	Not Available	Cervical	Alive	47	2014	2013
TCGA-C5-A8XK	30	FEMALE	Not Available	3039	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive					G3	0	3039			TUMOR FREE		30	Not Available	Not Applicable	TCGA-C5-A8XK	8AC819B3-4227-4EAE-BE03-8760B197DF9A	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-11268	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	3039	Not Available	Not Available					TCGA-C5-A8XK-D58139	3690C830-6E5E-4FA9-8B13-65AB49B74002	Not Available	1	Not Available	2	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	Not Evaluated			Not Available			Unknown			Not Applicable	TCGA-C5-A8XK-F66732	2746912D-FE59-4613-8FFE-0ECB75303A6F							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	Unknown	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8XK	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	BLACK OR AFRICAN AMERICAN	Regional site;Primary Tumor Field	TCGA-C5-A8XK-R58141;TCGA-C5-A8XK-R58142	97BA0371-8182-4011-BE8E-A55A68CA2C44;50B56FCC-899B-428D-803C-A8C0337E2A46	Not Available;Not Available	1;1	Not Available;28	2;13	Not Available;Not Available	4;4	11;2	1980;Not Available	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	Not Available	Not Available	Not Applicable	Not Available	YES	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2000
TCGA-VS-A9V5	50	FEMALE	157	494	98	39.758205201022356	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Dead	T2b	NX	MX	Stage IIB	G2	0	494			WITH TUMOR		50	Not Available	Not Applicable	TCGA-VS-A9V5	D3FF2AEB-46BE-4F54-8A8F-178EB921FBB6	Never Used	Not Available	Not Available	Not Applicable	Not Available	1	-18577	494	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available					TCGA-VS-A9V5-D65882	502961DD-9C7F-4032-BED4-F6E20D29702F	Not Available	1	124	89	Carboplatin	Clinical Progressive Disease	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	157	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9V5	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Regional site	TCGA-VS-A9V5-R65881	ACCE741D-6C77-4244-BF9E-D1259D278133	Not Available	1	136	95	Radiographic Progressive Disease	10	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	1	Not Applicable	Not Available	YES	6	Carboplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	98	2014	2011
TCGA-C5-A1M9	46	FEMALE	155	1065	49	20.395421436004163	Endocervical Type of Adenocarcinoma	Cervical	Dead	T3b	N1	M0	Stage IB1	G3	1	555.0	Lung	Distant Metastasis	WITH TUMOR		46	Not Available	Not Applicable	TCGA-C5-A1M9	a3be445a-a592-4073-815b-47ae41f9c4a0	Former User	ABSENT	Not Available	margins free of tumor	Other Location, specify	19	-17020	1065	5	Not Available	5	0	Not Available	Not Available	Not Available	Not Available		Extra-Pelvic Metastatic Disease Present;Paraaortic Nodes Present;Pelvic Nodes Present;Supraclavicular Absent			TCGA-C5-A1M9-D29231;TCGA-C5-A1M9-D29255	C5BFBED2-5160-4123-87EF-9FC20F4C7FC1;50E2A9E4-9469-4FB3-83A2-6C425255B6EB	Not Available;Not Available	12;13	116;Not Available	81;555	Cisplatin;Cisplatin	Not Available;Not Available	3;3	6;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Metastatic	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Absent;Paraaortic Nodes Present;Pelvic Nodes Present;Supraclavicular Absent	NO	YES	NO	Progressive Disease	YES	6	Not Applicable	TCGA-C5-A1M9-F29254	018631C0-1498-493F-9C17-00F3D103E683	Not Available	Not Available	Not Applicable	Not Available	Cisplatin	Not Available	13	Not Available	Not Available	Not Available	116	81	1065	Not Available	555	215	Not Applicable	Once weekly	1	Scheduled Follow-up Submission		3	Lung	CT	Other, specify	Distant Metastasis	Not Applicable	YES													Not Available	Cervical Cancer	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Not Applicable	Not Available	YES	116	76	540	Completed as Planned	4500	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	155	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	HPV 16	Not Applicable	Radical Hysterectomy	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	19	Pelvic (external iliac, internal iliac, obturator);Para-aortic;Supraclavicular	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G3												Not Available	14	Not Available	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1M9	0	1	Not Available	WITH TUMOR	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1M9-R29232	0580D63F-0356-4009-94FE-BF4C4979DD1A	1	12	116	76	Not Available	3	Not Available	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3b	Not Available	Not Available	NO	YES	C5	1	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	49	2011	2002
TCGA-C5-A1MN	42	FEMALE	165	1245	64	23.507805325987142	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G2	0	1245			TUMOR FREE		42	Not Available	Not Applicable	TCGA-C5-A1MN	287ce10e-31c8-4b10-9858-6e45451dfbe4	Former User	Not Available	Not Available	Not Applicable	Not Available	21	-15499	1245	Not Available	Not Available	1	0	Not Available	Not Available	875	Not Available					TCGA-C5-A1MN-D30193	7B3A715D-196B-44E7-9A3B-BD3C3DA17A09	Not Available	4	Not Available	25	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	1	0	NOT HISPANIC OR LATINO		Parametrium Present;Pelvic Nodes Present	NO	Not Applicable	Not Applicable	Not Available	YES	Not Available	Not Applicable	TCGA-C5-A1MN-F30192	B0B5B13E-05AA-432E-A673-026541938F57	Completed as planned	Not Available	Not Applicable	HDR	Cisplatin	Not Available	4	Not Applicable	25	Not Available	Not Available	25	1245	Not Available	Not Applicable	875	Unknown	Not Available	1	Scheduled Follow-up Submission		4	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Other, specify	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Not Applicable	Not Available	YES	Not Available	25	Not Available	Completed as Planned	Not Available	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	IMRT																				Dead	2012	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G2												Not Available	Not Available	Not Available	0	25	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1MN	0	0	Post-Adjuvant Therapy	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1MN-R30194	2505CCB6-FF3E-4433-8489-8871CCCFE10D	1	4	Not Available	25	Not Available	4	Not Available	Not Available	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	16.92	Not Available	NO	YES	C5	2	0	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Dead	64	2011	2007
TCGA-VS-AA62	51	FEMALE	156	469	67	27.531229454306377	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	NX	MX	Stage IIB	G2	0	469			WITH TUMOR		51	Not Available	Not Applicable	TCGA-VS-AA62	173174F8-9D95-40B0-9F88-A4BF4CCB521B	Current User	Not Available	Not Available	Not Applicable	Not Available	13	-18792	469	Not Available	Not Available	Not Available	0	Not Available	Not Available	-1	Not Available					TCGA-VS-AA62-D68117	98AE48EA-B27C-4014-8A6C-E1759052C4A4	Not Available	13	64	34	Cisplatin	Clinical Progressive Disease	11	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	AA62	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Primary Tumor Field;Regional site;Regional site	TCGA-VS-AA62-R68118;TCGA-VS-AA62-R68119;TCGA-VS-AA62-R68120	FA3EE9E0-6608-4FA3-8CD4-8FE22B9C249B;1B7A0A2A-F58B-41EE-A01C-82151D987F0F;5368B4FF-443A-4977-BBA0-F4335D37A120	Not Available;Not Available;Not Available	13;13;13	90;89;68	69;82;28	Radiographic Progressive Disease;Radiographic Progressive Disease;Radiographic Progressive Disease	11;11;11	4;5;25	2800;900;4500	NO;NO;NO	Internal;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Dead	67	2014	2009
TCGA-Q1-A6DW	44	FEMALE	160	534	62	24.21875	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX	Stage I	GX	0	534			Unknown		44	35	Not Applicable	TCGA-Q1-A6DW	5DBD5436-696E-40FA-881B-C2386573AC68	Unknown	ABSENT	Not Available	Not Applicable	Not Available	20	-16200	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	175	114	Not Available					TCGA-Q1-A6DW-D46940	B5C77B18-F27A-4CC5-9CF8-6107E83AAFDB	Not Available	20	114	35	Cisplatin	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-Q1-A6DW-F62829	B94C443F-87F8-4E11-868F-9D0584DA11C0							25						Not Applicable	534		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	Unknown	YES	Unknown									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	2.5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A6DW	Not Available	Not Available	Post-Adjuvant Therapy	Unknown	Not Available	NO	NO	Unknown	WHITE	Primary Tumor Field	TCGA-Q1-A6DW-R46939	688D49E9-6824-4101-9373-9A790A2915D1	Not Available	20	80	59	Unknown	8	5	2900	NO	Internal	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	2009	YES	NO	Q1	4	1	Not Applicable	Not Available	YES	5	Cisplatin	40mg	Once weekly	Not Applicable	YES	YES	2900	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	62	2013	2013
TCGA-VS-A94Z	38	FEMALE	162	1015	96	36.57978966620942	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G2	0	1015			TUMOR FREE		38	27	Not Applicable	TCGA-VS-A94Z	69BABA9F-19C2-4947-95DC-0DD3412929BA	Never Used	Not Available	Not Available	Not Applicable	Not Available	21	-14046	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	707	39	Not Available					TCGA-VS-A94Z-D62793	138D8801-6CD9-43F9-B8D3-1FB6FB9BF29A	Not Available	24	80	52	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A94Z-F67676;TCGA-VS-A94Z-F71215	5BEF7B2D-BEDE-46D6-98DE-0C30F1489169;01000CDE-DFF3-470E-8024-D77365153D78							9;23						Not Applicable;Not Applicable	742;1015		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	2	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A94Z	1	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field;Regional site	TCGA-VS-A94Z-R62790;TCGA-VS-A94Z-R62791;TCGA-VS-A94Z-R62792	B0A4DDBC-AA4F-4B77-A44C-016107A99803;DFB29CEE-AAD9-43F1-A14C-27BFF3844CFC;B5F0A292-701E-4A5D-B37D-62B61E2D7541	Not Available;Not Available;Not Available	24;24;24	87;123;122	49;100;115	Complete Response;Complete Response;Complete Response	7;7;7	25;4;5	4500;2800;900	NO;NO;NO	External;Internal;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	2010	NO	YES	VS	4	4	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	96	2014	2012
TCGA-C5-A8XI	69	FEMALE	Not Available	254	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	MX	Stage IB2	G3	0	254			TUMOR FREE		69	29	Not Applicable	TCGA-C5-A8XI	959FE574-054A-4FEF-9CBE-A801A9A355DE	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	17	-25220	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	254	Not Available	Not Available					TCGA-C5-A8XI-D58650	BCB7C41F-67F7-4B56-8448-39B7D7C61C9B	Not Available	17	Not Available	205	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	Not Evaluated			Not Available			Not Available			Not Applicable	TCGA-C5-A8XI-F66724	1C75BAD9-CCC6-4FD2-9596-59A1E0E1269D							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	10	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	4	57	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8XI	1	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Regional site	TCGA-C5-A8XI-R58651	DC4AFA65-9A4A-4713-A77A-1612F28E1412	Not Available	17	Not Available	196	Not Available	4	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b2	Not Available	Not Available	NO	YES	C5	2	5	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2008
TCGA-C5-A1M8	43	FEMALE	163	919	75	28.228386465429637	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB1	G2	0	919			TUMOR FREE		43	Not Available	Not Applicable	TCGA-C5-A1M8	110cd100-5730-4873-9fab-2ae6c8732062	Never Used	ABSENT	Not Available	margins free of tumor	Other Location, specify	19	-15848	Not Applicable	Not Available	4	Not Available	0	Not Available	919	Not Available	Not Available				Pelvic Nodes Present																								Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1M8-F29227;TCGA-C5-A1M8-F57891	2949472D-FD58-4D78-A45E-5B3146B4C2F1;642CB91E-1C75-4197-B8E5-3BE96EC03A35	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	12;28	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	919;Not Available	Not Applicable;None	-273;Not Available	Not Applicable;Not Available	Not Available;None	0;Not Available	Scheduled Follow-up Submission;None	None;YES	3;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not done per treating physicians discretion;None	NO;None	130;None	64;None	Not Available;None	Completed as Planned;None	Not Available;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Not Available	Not Available	13	Not Available	Not Available	ABSENT	Indeterminate (neither Pre or Postmenopausal)	9	G2												Not Available	0	0	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1M8	0	1	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1M8-R29228	1624463C-089A-41DB-8F72-C7324BCBD47B	1	12	130	64	Not Available	3	Not Available	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	C5	1	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	75	2011	2001
TCGA-DS-A3LQ	46	FEMALE	163	699	72	27.09925100681245	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	N1	M0	Stage IIIB	G3	0	699			Not Available		46	Not Available	Not Applicable	TCGA-DS-A3LQ	63BFFDB1-BC08-4175-8BE7-D7A056D19816	Former User	Not Available	Not Available	None	Other Location, specify	23	-16861	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	183	2	Not Available					TCGA-DS-A3LQ-D31100	64E076D2-EC46-4033-B991-A5716A6D19A7	Not Available	23	89	54	Cisplatin	Not Available	4	6	40	mg/m2	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	427	mg	Not Available	2012	1	Not Available	Not Available			NO	Not Applicable;None	Not Applicable;None	Complete Response;Complete Response	YES;None	6;None	Not Applicable;Not Applicable	TCGA-DS-A3LQ-F31099;TCGA-DS-A3LQ-F51567	40B43319-0521-4885-9AC5-A007133F5760;EF313955-358D-40A1-A039-D40D4199BA5C	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Cisplatin;None	40 mg/m2;None	23;26	Not Applicable;None	Not Available;None	Not Available;None	89;None	54;None	Not Applicable;Not Applicable	183;699	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Once weekly;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;NO	4;11	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;None	Not Available;Not Available	Not Available;Not Available	Not Available;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Applicable;None	Not Available;None	YES;None	90;None	55;None	Not Available;None	Completed as Planned;None	4500;None	YES;YES	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;YES	None;YES	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Alive	2012;2013	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	8	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3												Not Available	1	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LQ	Not Available	Not Available	Preoperative	Not Available	Not Available	Not Available	YES	Not Available	Not Available	Primary Tumor Field	TCGA-DS-A3LQ-R31101	CDA2C507-A9F4-4593-8F5A-C46423C7F228	1	23	90	55	Not Available	4	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3b	Not Available	1978	YES	NO	DS	3	7	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	72	2012	2011
TCGA-IR-A3LL	60	FEMALE	157	1106	92	37.32402937238833	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	1106			TUMOR FREE		60	Not Available	Not Applicable	TCGA-IR-A3LL	7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26	Not Available	ABSENT	Not Available	Not Applicable	Not Available	13	-22123	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	720	Not Available	Not Available					TCGA-IR-A3LL-D38340	04E0C6F4-594D-4A80-A45A-F15B5D290A01	Not Available	14	80	48	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	0	Not Available			NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-IR-A3LL-F38232;TCGA-IR-A3LL-F45361	D3D5376B-F8E7-4708-9D81-98543EC09164;0E0808F1-A33D-404D-A67C-195410A6C2CB							14;11						Not Applicable;Not Applicable	957;1106		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	12;7							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Not Available									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	5;Not Available	Cisplatin;Not Available	30mg/m2;Not Available	Once weekly;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	0;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;Not Available	5040;Not Available	Alive;Alive	2012;2013	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	15	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LL	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-IR-A3LL-R38339	A208B7AB-36CE-4936-8B81-2424F3FD1497	Not Available	14	89	48	Complete Response	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	IR	1	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	92	2012	2010
TCGA-C5-A8YR	56	FEMALE	Not Available	837	80		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N0	M0	Stage IB	G3	1	272.0		Locoregional Recurrence	Unknown		56	Not Available	Not Applicable	TCGA-C5-A8YR	BE8B1C78-8CB1-4BFF-B1FE-71ECDC454C94	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-20672	837	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	29	Not Available	Not Available	Not Available	Not Available	4	G3	Not Available	Not Available	Not Available	272	Not Applicable	Not Applicable	Not Available	Locoregional Recurrence	regional recurrence NOS	Not Available	Not Available	YES	0	Not Available	4	Not Available	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A8YR	2	Not Available	Not Available	Unknown	Not Available	NO	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	C5	1	6	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	80	2014	1994
TCGA-EK-A2RE	26	FEMALE	161	57	54	20.832529609197177	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	MX	Stage IIA	G2	0	57			TUMOR FREE		26	Not Available	Not Applicable	TCGA-EK-A2RE	9AA36AC2-8418-4109-A3C1-63CA8742BAAB	Not Available	ABSENT	Not Available	Not Applicable	Not Available	5	-9743	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	57	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RE-F58263	140918C4-B42E-4D3F-86DA-72A0BF738DFE							3						Not Applicable	57		0	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	TUMOR FREE	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	161	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	atypia positive hpv	Other HPV type(s)	Not Applicable	Not Available	C53.9	8071/3	C53.9	YES	laparoscopic-assisted radical vaginal trachelectomy with pelvic periaortic lymph node dissection and cerclage	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	21	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G2												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RE	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a2	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	54	2011	2010
TCGA-IR-A3L7	37	FEMALE	177	4483	89	28.408184110568484	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	4483			TUMOR FREE		37	17	Not Applicable	TCGA-IR-A3L7	66229DD6-C771-4455-A90C-C66FB40CF7FE	Former User	ABSENT	Not Available	Not Applicable	Not Available	13	-13559	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	3509	Not Available	Not Available					TCGA-IR-A3L7-D38291	99356D52-C28E-407A-A29D-E5A1088525CE	Not Available	14	99	67	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	0	Not Available			NO			Complete Response			Not Applicable	TCGA-IR-A3L7-F38287	05ADF82F-90EF-4187-9AE7-AF755688B2E3							14						Not Applicable	4483		Not Available	Not Available		Not Available		NO	12							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	5	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	0	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Alive	2012	FEMALE	177	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Not Available	Not Available	20	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3												Not Available	0	0	3	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3L7	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-IR-A3L7-R38290	5CD0505B-41CD-4BD5-812E-1744FE9A459A	Not Available	14	105	65	Complete Response	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	1990	NO	YES	IR	4	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	89	2012	2000
TCGA-HG-A2PA	38	FEMALE	164	773	95	35.32123735871505	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G2	1		Other, specify	Locoregional Recurrence	WITH TUMOR		38	Not Available	Not Applicable	TCGA-HG-A2PA	E2FF7CFD-A101-45B9-895F-26F403E7BDFB	Not Available	PRESENT	Not Available	Not Applicable	Not Available	23	-14025	Not Applicable	2	Not Available	Not Available	0	Not Available	773	21	Not Available		Bladder Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Present;Supraclavicular Absent			TCGA-HG-A2PA-D33512;TCGA-HG-A2PA-D33513	EE17B0E2-CE3E-43C0-80C9-57134F94BA7C;D5B1F254-E5C8-48D9-9402-A558837BF830	Not Available;Not Available	5;5	Not Available;Not Available	Not Available;Not Available	Taxol;Carboplatin	Partial Response;Partial Response	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	0	0	NOT HISPANIC OR LATINO			NO			Partial Response			Not Applicable	TCGA-HG-A2PA-F33511	231EFDE1-8D48-4D3E-AA49-90D0C9399DC8							5						773	Not Available		21	Not Available		0		NO	7							YES	NO	Not Available	Not Available	Other, specify	Not Applicable	Not Available	Locoregional Recurrence	Not Available	Unknown	Not Available	YES		Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response									NO						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2012	FEMALE	164	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	30	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G2												Not Available	0	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2PA	1	0	Preoperative	WITH TUMOR	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	HG	2	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Partial response	Cervical	Alive	95	2011	2009
TCGA-C5-A7UE	45	FEMALE	160	4738	63	24.609375	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB1	G2	1		Lung	New Primary Tumor	TUMOR FREE		45	17	Not Applicable	TCGA-C5-A7UE	DA30A845-C4D3-4C78-B8B0-210239224F8F	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-16473	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2602	Not Available	Not Available					TCGA-C5-A7UE-D57027	F8C24E83-C9C1-48FC-B371-0CCDD3B809F0	Not Available	28	83	47	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-C5-A7UE-F66716	CADE137A-46A4-4D33-8D24-7BA59B0D3F84							22						Not Applicable	4738		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Lung	Not Applicable	Not Available	New Primary Tumor	Not Available	Not Available	Not Available	YES		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	23	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	3	35	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7UE	0	1	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Regional site;Primary Tumor Field	TCGA-C5-A7UE-R57028;TCGA-C5-A7UE-R57029	3C5402B7-9A6A-493C-B61C-1C408C3C2CA8;3DC3C8CB-121F-42F9-B772-C94F2C879BC2	Not Available;Not Available	28;28	97;92	46;53	Not Available;Not Available	2;2	28;6	5040;4621	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	4	Not Applicable	Not Available	YES	6	Cisplatin	1000 ml	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	3060	Not Available	Cervical	Alive	63	2014	2001
TCGA-C5-A1MI	50	FEMALE	Not Available	1083	77		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N1	M0	Stage IB1	G2	1	805.0	Other, specify	Distant Metastasis	WITH TUMOR		50	15	Not Applicable	TCGA-C5-A1MI	941f75a1-fea4-4539-ba69-60bb11608f6d	Not Available	ABSENT	Not Available	Not Applicable	Not Available	19	-18336	1083	16	Not Available	23	0	Not Available	Not Available	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-C5-A1MI-D29734;TCGA-C5-A1MI-D29735	808E6711-8841-41A0-8B0F-DA0DD4B537CC;DFEB8D3B-38B3-424F-B0C9-9586D927E8D1	Not Available;Not Available	28;28	118;Not Available	76;812	Cisplatin;Cisplatin	Not Available;Not Available	3;3	6;Not Available	40;Not Available	mg/m2/wk;Not Available	ADJUVANT;RECURRENCE	Not Applicable;Not Applicable	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	1	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO	YES	NO	Progressive Disease	YES	6	Not Applicable	TCGA-C5-A1MI-F29733	4BC060E1-9276-4927-B7A8-AC303EEA0DF9	Completed as planned	1200	Not Applicable	HDR	Cisplatin	40mg/m2/wk	28	Not Available	83	118	118	76	1083	Not Available	805	41	Not Applicable	Once weekly	1	Scheduled Follow-up Submission		3	Other, specify	Not Applicable	Not Available	Distant Metastasis	distant recurrence multiple sites	YES													Not Available	Cervical Cancer	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	Not Applicable	Not Available	YES	125	76	Not Available	Completed as Planned	5040	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	17	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Peri (6-12 months since last menstrual period)	9	G2												Not Available	1	Not Available	2	35	Not Available	Not Applicable	No	Not Available	Other, specify	Herpes	A1MI	2	2	Not Available	WITH TUMOR	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1MI-R29736	034E2EB2-AE1A-434C-9368-40C04BCA883B	1	28	125	76	Not Available	3	28	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	C5	2	7	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	77	2011	2004
TCGA-EK-A3GJ	51	FEMALE	171	3	96	32.83061454806607	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0		Stage IB1	G3	0	3			Discrepancy		51	Not Available	Not Applicable	TCGA-EK-A3GJ	DEDA68DD-E9AD-45CC-9DBB-1C5836EF6519	Not Available	ABSENT	Not Available	Not Applicable	Not Available	3	-18630	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	3	-1	Not Available																												1	Not Available	Not Available			Not Available			Unknown			Not Applicable	TCGA-EK-A3GJ-F58271	E17BEEB6-96C2-49FA-BC0A-E375EAEBC545							3						Not Applicable	3		-1	Not Available		1		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Discrepancy	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	171	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Radical hysterectomy with bso and pnd	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	24	Not Available	Not Available	ABSENT	Not Available	2	G3												Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3GJ	Not Available	Not Available	Preoperative	Discrepancy	Not Available	Not Available	YES	Not Available	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	N0	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	10	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	96	2012	2010
TCGA-EA-A5FO	59	FEMALE	162	815	58	22.100289590001523	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	815			TUMOR FREE		59	Not Available	Not Applicable	TCGA-EA-A5FO	ED17685C-B706-41E4-8A76-11CB0E6700CD	Unknown	ABSENT	Not Available	Not Applicable	Not Available	22	-21561	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	45	45	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A5FO-F58802;TCGA-EA-A5FO-F67795	7EAF6131-D355-45F3-B3EC-7FE86709A529;D4C21843-1FFF-49B2-9932-ADBE99F2254D							23;11						Not Applicable;Not Applicable	427;815		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	4;11							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Unknown;Not Available	NO;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	3500;Not Available	Not Applicable;Not Applicable	LDR;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;Not Available	4200;Not Available	Alive;Alive	2014;2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	21	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5FO	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Unknown	WHITE	Primary Tumor Field;Regional site	TCGA-EA-A5FO-R58803;TCGA-EA-A5FO-R59526	D3EED5E1-168B-4E40-A537-D5AB08DD7E8F;8938785C-E94B-4EF1-B8D9-9078E21A398F	Not Available;Not Available	14;14	129;129	68;68	Complete Response;Complete Response	5;5	Not Available;Not Available	35;42	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	58	2013	2012
TCGA-JX-A3Q0	63	FEMALE	166	6375	57	20.685150239512264	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3	N0	M0	Stage III	G2	0	6375			TUMOR FREE		63	24	Not Applicable	TCGA-JX-A3Q0	20280122-A66A-4C83-8F25-0B9D97558DC2	Never Used	Not Available	Not Available	Not Applicable	Not Available	17	-23313	Not Applicable	-1	Not Available	Not Available	0	Not Available	5957	89	Not Available		Extra-Pelvic Metastatic Disease Present																										1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Followup visit;Follow-up	TCGA-JX-A3Q0-F60570;TCGA-JX-A3Q0-F71655	58DCD37D-73D7-4BEE-8FC3-5A41F5500322;F90B111D-4073-4206-92D4-529E0FB35A19							11;27						Not Applicable;Not Applicable	5957;6375		5957;6369	Not Available;Not Available		0;0		NO;NO	6;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Other	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;Discrepancy						Not Applicable;Not Applicable	Not Available;Not Available	NO;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;Discrepancy	6545;Not Available	Not Applicable;Not Applicable	LDR;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;Not Available	5040;Not Available	Alive;Alive	2014;2015	FEMALE	166	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	20	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A3Q0	0	0	Post-Adjuvant Therapy	TUMOR FREE	0	NO	NO	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Primary Tumor Field;Primary Tumor Field	TCGA-JX-A3Q0-R63619;TCGA-JX-A3Q0-R63620	048C0326-8D7C-405B-80D6-BA00AFFB9185;BDA2FC44-EB35-41EC-BC97-15EA7AFB8665	Not Available;Not Available	14;14	75;75	45;61	Complete Response;Complete Response	8;8	11;Not Available	1980;6545	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3	Not Available	1997	NO	YES	JX	4	2	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	3300	Implants-tandem and ovoids	Other	Not Available	Not Available	Not Applicable	Whole pelvis split field	Other	3060	Not Available	Cervical	Alive	57	2014	1997
TCGA-Q1-A5R2	64	FEMALE	160	499	76	29.6875	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX		G3	0	499			WITH TUMOR		64	Not Available	Not Applicable	TCGA-Q1-A5R2	F3CBADB3-3B83-47CD-B8A0-B0E10343A295	Former User	Unknown	Not Available	Not Applicable	Not Available	26	-23523	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	105	105	Not Available					TCGA-Q1-A5R2-D48279	56934D77-B222-4F09-B296-CCA334AAD2D7	N/A	11	48	5	Cisplatin	Partial Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Post-operative	TCGA-Q1-A5R2-F56898	6CF1ABFF-816F-43CB-B856-C2501185B8B0							25						Not Applicable	499		406	Not Available		0		NO	2							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	YES	Unknown									YES						Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	300	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Unknown	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A5R2	Not Available	Not Available	Post-Adjuvant Therapy	WITH TUMOR	Not Available	NO	NO	Not Applicable	WHITE	Primary Tumor Field	TCGA-Q1-A5R2-R48280	391BD273-80E2-428A-B0B6-657D0F7CACE2	Not Available	11	198	51	Partial Response	9	5	600	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	YES	NO	Q1	1	2	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	300	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	76	2013	2012
TCGA-UC-A7PF	44	FEMALE	Not Available	2859	210		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N1	M0	Stage IB1	G2	0	2859			Unknown		44	Not Available	Not Applicable	TCGA-UC-A7PF	1451821E-DD49-41FA-A52E-32F8524FFE82	Unknown	PRESENT	Not Available	Not Applicable	Not Available	4	-16412	2859	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	2	Not Evaluated			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Not Available	Not Available	30	Pelvic (external iliac, internal iliac, obturator);Other Location, specify	anterior parametrium	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	5	Not Available	2	Not Available	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A7PF	0	0	Not Available	Unknown	0	NO	YES	Not Available	Not Evaluated																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	UC	2	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	210	2014	1999
TCGA-UC-A7PD	21	FEMALE	Not Available	355	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N0	M0	Stage IB	G2	1	202.0		Locoregional Recurrence	WITH TUMOR		21	13	Not Applicable	TCGA-UC-A7PD	0F18EF74-019B-478D-AECD-60CC715BFDB7	Former User	Unknown	Not Available	perineural space invasion	Other Location, specify	4	-7855	355	Not Available	Not Available	Not Available	0	Not Available	Not Available	-1	Not Available																												1	0	Not Evaluated			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	tumor resection	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	11	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G2	Not Available	Not Available	Not Available	202	Not Applicable	Not Applicable	Not Available	Locoregional Recurrence	vaginal cuff	Not Available	Not Available	YES	0	0	4	1.75	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A7PD	0	1	Preoperative	WITH TUMOR	0	YES	YES	Complete Remission/Response	AMERICAN INDIAN OR ALASKA NATIVE	Regional site;Unknown	TCGA-UC-A7PD-R56386;TCGA-UC-A7PD-R56385	7C69ED8C-99A2-4631-BBF7-679D9CC6E7A3;4404C793-63DD-43BE-9FA4-B3F6DA90FB00	Not Available;Not Available	4;4	140;140	18;18	Unknown;Unknown	2;2	Not Available;25	Not Available;Not Available	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	UC	2	5	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	vaginal implant	Other	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Not Available	Cervical	Dead	Not Available	2014	1997
TCGA-DG-A2KK	51	FEMALE	157	2496	64	25.96454217209623	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IIIB	G3	0	2496			TUMOR FREE		51	27	Not Applicable	TCGA-DG-A2KK	8DBCB17D-0396-4FAA-9B32-8E2566424BFF	Unknown	ABSENT	Not Available	Not involved	Other Location, specify	11	-18834	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1544	Not Available	Not Available		Bladder Absent;Unknown;Parametrium Absent;Unknown;Pelvic Nodes Present		Bladder Absent;Unknown;Parametrium Absent;Unknown;Pelvic Nodes Present;Unknown	TCGA-DG-A2KK-D49823	C7F19426-0D49-41B9-AF8D-EBE3FA652802	Not Available	11	149	121	Cisplatin	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2013	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Endocrinology and Metabolism Clinical Note	TCGA-DG-A2KK-F49821;TCGA-DG-A2KK-F65463	060A7350-49E1-445A-A42C-C53C1589CFC8;DA39DECB-A19D-435E-9463-5F35AAFC9924							11;23						Not Applicable;Not Applicable	1544;2496		Not Available;Not Available	Not Available;Not Available		0;0		NO;NO	10;9							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown		Not Available;Not Available	Pre-Adjuvant Therapy;Other	TUMOR FREE;Unknown	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;YES	5;5	Cisplatin;Cisplatin	Not Available;Not Available	Not Available;Once weekly	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;External beam radiation	4500;4500	Alive;Alive	2013;2014	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	28	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	Not Available	25	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2KK	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	YES	Complete Remission/Response	Not Evaluated	Regional site	TCGA-DG-A2KK-R49822	FEDBEFBD-DF56-419E-8AB1-BB0B0D612089	Not Available	11	156	116	Not Available	10	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	2007	NO	YES	DG	4	0	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	64	2013	2007
TCGA-MA-AA42	75	FEMALE	140	259	63	32.142857142857146	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIB	G3	0	259			TUMOR FREE		75	Not Available	Not Applicable	TCGA-MA-AA42	DA5FCB99-16B4-4F9E-8602-D6A6192875EF	Unknown	Not Available	Not Available	Not Applicable	Not Available	22	-27460	Not Applicable	Not Available	14	19	0	Not Available	168	0	Not Available				Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																								1	Not Available	HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Complete Response			Not Applicable	TCGA-MA-AA42-F65482	5E31E84E-DB8A-47B3-944F-37FFF1EE966E							23						Not Applicable	259		259	Not Available		0		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	140	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	6	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA42	2	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	18.5	Not Available	YES	NO	MA	1	8	Not Applicable	Not Available	YES	5	Cisplatin	62	Once weekly	Not Applicable	YES	YES	3100	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5040	Not Available	Cervical	Alive	63	2014	2013
TCGA-EA-A3HS	35	FEMALE	169	959	54	18.90690101887189	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G1	0	959			TUMOR FREE		35	Not Available	Not Applicable	TCGA-EA-A3HS	753EE373-FBCF-4349-B9B2-5A41936E27E9	Never Used	ABSENT	Not Available	Not Applicable	Not Available	20	-13117	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	40	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			At last contact	TCGA-EA-A3HS-F66110	B80D6700-2AF3-412B-BEB6-31FD381D05CF							2						Not Applicable	959		959	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	169	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Keratinizing squamous cell carcinoma	Not Available	10	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G1												Not Available	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HS	0	1	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	EA	1	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	54	2011	2011
TCGA-C5-A1BF	46	FEMALE	Not Available	570	76		Cervical Squamous Cell Carcinoma	Cervical	Dead	TX	N0	MX	Stage IB	G1	1	93.0	Other, specify	Distant Metastasis	WITH TUMOR		46	Not Available	Not Applicable	TCGA-C5-A1BF	262311a0-7a10-4934-8fba-11ee581ad738	Not Available	Not Available	Not Available	Not Applicable	Not Available	12	-16975	570	13	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available		Bladder Present;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-C5-A1BF-D30724	484070B1-FD8E-46A3-B031-DA66D5641485	Not Available	16	Not Available	181	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	RECURRENCE	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	Not Available			NO	YES	YES	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A1BF-F30729	A728C808-CE08-48FA-8887-CCEEE2FD28C9	Not Available	Not Available	Not Applicable	HDR	Not Available	Not Available	16	Not Available	Not Available	Not Available	Not Available	Not Available	570	Not Available	93	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		4	Other, specify	CT/Core Biopsy	Other, specify	Distant Metastasis	Lung, Sternum	YES													Not Available	Cervical Cancer	Not Available	WITH TUMOR	NO	Complete Remission/Response	Not Applicable	Not done per treating physicians discretion	NO	69	26	Not Available	Completed as Planned	4500	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	HPV 18	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	33	Not Available	Not Available	Not Available	Not Available	9	G1												Not Available	0	0	4	30	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BF	1	Not Available	Not Available	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Distant Recurrence	TCGA-C5-A1BF-R30730;TCGA-C5-A1BF-R30732	468D0D3E-A2CF-4746-B74D-C1148394ED70;F9D73AD1-B58E-415A-9566-A867B6ABD221	1;2	16;16	69;Not Available	26;Not Available	Not Available;Not Available	4;4	Not Available;Not Available	4500;Not Available	NO;NO	COMBINATION;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;RECURRENCE	Not Available;Not Available	cGy;Not Available	2012;2012	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	TX	Not Available	Not Available	NO	YES	C5	2	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	76	2011	1997
TCGA-C5-A1ME	40	FEMALE	165	1756	69	25.34435261707989	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G1	0	1756			TUMOR FREE		40	18	Not Applicable	TCGA-C5-A1ME	a0598331-79e1-418d-b50c-fd945b843506	Former User	ABSENT	Not Available	margins free of tumor	Other Location, specify	19	-14970	Not Applicable	13	Not Available	Not Available	0	Not Available	132	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable	Not Applicable	Complete Response	NO	Not Available	Not Applicable	TCGA-C5-A1ME-F29281	B23DA17C-E16E-4CD1-8390-28726BB9EBC0	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	13	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Applicable	1756	Not Applicable	69	Not Applicable	Not Available	0	Scheduled Follow-up Submission		3	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Applicable	Not Available																				Alive	2012	FEMALE	165	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	HPV 16	Not Applicable	Radical Hysterectomy	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	27	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G1												Not Available	0	0	1	22	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1ME	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	2003	NO	YES	C5	4	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	69	2011	2003
TCGA-ZJ-A8QR	38	FEMALE	Not Available	582	58		Cervical Squamous Cell Carcinoma	Cervical	Dead	TX	NX	MX	Stage I	GX	0	582			Unknown		38	36	Not Applicable	TCGA-ZJ-A8QR	DB44488E-4ED0-4082-BCA0-BBFD22FF0537	Unknown	Not Available	Not Available	Not Applicable	Not Available	25	-14225	582	Not Available	Not Available	Not Available	0	Not Available	Not Available	-2	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	0.4	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A8QR	Not Available	Not Available	Preoperative	Unknown	Not Available	NO	NO	Unknown	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER																			Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	2009	NO	YES	ZJ	2	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	58	2014	2007
TCGA-MU-A51Y	27	FEMALE	Not Available	854	31		Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a1	N0	MX	Stage IIA1	G2	0	854			TUMOR FREE		27	Not Available	Not Applicable	TCGA-MU-A51Y	77DA506B-E726-409F-B3EB-D41242862982	Not Available	Not Available	Not Available	uninvolved margins	Other Location, specify	14	-10199	Not Applicable	Not Available	Not Available	52	0	Not Available	422	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available			Complete Response			Not Applicable	TCGA-MU-A51Y-F69301	152EB6D4-360D-490C-B68B-05325803AB2F							31						Not Applicable	854		854	Not Available		1		NO	12							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Other, specify	Hybrid Capture 2	High risk	Other HPV type(s)	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	17	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A51Y	Not Available	3	Not Available	TUMOR FREE	Not Available	Not Available	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IIA1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a1	6.47	Not Available	YES	NO	MU	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	31	2012	2012
TCGA-FU-A5XV	32	FEMALE	157	321	69	27.99302202929125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N1	MX	Stage IIIB	G3	0	321			Unknown		32	14	Not Applicable	TCGA-FU-A5XV	9DBA5A81-3587-4F5A-8D19-E0B0AED0A677	Unknown	Unknown	Not Available	Not Applicable	Not Available	12	-11692	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	60	55	Not Available																												1	1	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-FU-A5XV-F66004	E435B69A-2868-48A8-8947-33067F3A471F							1						Not Applicable	321		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	1500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Alive	2014	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	63	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	2	18	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A5XV	Not Available	Not Available	Preoperative	Unknown	Not Available	NO	YES	Unknown	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-FU-A5XV-R66005;TCGA-FU-A5XV-R66006	EB8F1F3C-3F18-4F28-907D-D3BDE96F966C;3235BAE8-6443-4AF1-B2C2-193D3FC9F2C5	Not Available;Not Available	1;1	148;168	106;154	Complete Response;Complete Response	10;10	25;3	4500;1500	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b2	Not Available	Not Available	YES	NO	FU	2	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	69	2013	2012
TCGA-C5-A3HE	44	FEMALE	Not Available	548	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G3	1	252.0	Cervix	Locoregional Recurrence	Unknown		44	Not Available	Not Applicable	TCGA-C5-A3HE	BC63DD2A-B8F6-4B30-A8D7-CE193BCD17F1	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	3	-16139	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	548	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-C5-A3HE-F55255	B756F543-72E1-431A-B4B4-AFA174CD9396							3						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available									Not Available						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G3	Not Available	Not Available	447	252	Cervix	Not Applicable	Not Available	Locoregional Recurrence	Not Available	YES	Not Available	YES	Not Available	Not Available	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HE	0	1	Not Available	Unknown	0	Not Available	NO	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A3HE-R55256	B2DDDD94-15B1-4C65-B8C8-2E8D6B4EE0C1	Not Available	3	Not Available	76	Unknown	1	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	C5	1	1	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Not Available	Cervical	Alive	Not Available	2014	2006
TCGA-C5-A2M2	56	FEMALE	Not Available	1011	Not Available		Endocervical Type of Adenocarcinoma	Cervical	Dead				Stage IB2	G2	0	1011			Not Available		56	24	Not Applicable	TCGA-C5-A2M2	77D53D4D-3B07-4C79-86FE-6AC812968F39	Former User	Not Available	Not Available	Not Applicable	Not Available	4	-20480	Not Applicable	Not Available	Not Available	18	0	Not Available	25	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO		Bladder Absent;Parametrium Absent;Paraaortic Nodes Present;Pelvic Nodes Present;Supraclavicular Absent	NO	Not Applicable;None	Not Applicable;None	Not Available;Unknown	Not Available;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A2M2-F30196;TCGA-C5-A2M2-F55539	8EB75FD7-24CE-4238-953C-78282DB9E8CD;4F642F34-DCC7-4172-8284-CC46FCA4BE63	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	4;3	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;1011	25;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;NO	4;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	Not Available;None	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Available;Unknown	Not Available;Not Available	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Unknown	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Unknown	None;Unknown	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Dead	2012;2014	FEMALE	Not Available	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8140/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G2												Not Available	Not Available	Not Available	1	8	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2M2	0	0	Not Available	Not Available	0	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	2003	NO	YES	C5	4	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2012	2009
TCGA-EX-A1H6	38	FEMALE	158	241	74	29.642685467072585	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G1	0	241			TUMOR FREE		38	Not Available	Not Applicable	TCGA-EX-A1H6	1FE594D9-4240-49EE-8AFD-C7D16A377181	Current User	ABSENT	Not Available	Not Applicable	Not Available	25	-14214	Not Applicable	24	Not Available	Not Available	0	Not Available	241	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent																										Not Available	Not Available	Not Evaluated			Not Available			Not Available			Not Applicable	TCGA-EX-A1H6-F38911	F9390D9E-9E74-4F92-A6D4-36D291AE25BE							8						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available									Not Available						Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2013	FEMALE	158	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8140/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Not Available	Not Available	20	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	6	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1H6	Not Available	1	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	EX	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	74	2012	2009
TCGA-EK-A3GK	33	FEMALE	165	15	73	26.813590449954088	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G3	0	15			TUMOR FREE		33	Not Available	Not Applicable	TCGA-EK-A3GK	D07D0A56-A25E-426B-8384-9D49E6545527	Current User	ABSENT	Not Available	Not Applicable	Not Available	2	-12207	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	15	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A3GK-F58272	42226CB4-3D23-416E-801F-55BDC325783D							3						Not Applicable	15		0	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	TUMOR FREE	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	165	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	HPV 16	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Radical hysterectomy, BSO, Bilateral pelvic LND, upper vaginectomy, omental and cecal biopsy.	Other method, specify:	Not Available	Not Available	22	Not Available	Not Available	PRESENT	Not Available	2	G3												Not Available	0	0	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3GK	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	0	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	73	2012	2009
TCGA-VS-A8Q8	26	FEMALE	166	978	92	33.386558281318045	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N0	MX	Stage IB	G2	1	488.0		Locoregional Recurrence	WITH TUMOR		26	Not Available	Not Applicable	TCGA-VS-A8Q8	6C3C8219-74AB-4E54-81F5-84D4D5884252	Former User	Not Available	Not Available	Not Applicable	Not Available	31	-9571	978	Not Available	Not Available	Not Available	0	Not Available	Not Available	-84	Not Available																												0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	166	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Radical trachelectomy and pelvic lymphadenectomy	Other	C53.9	8070/3	C53.9	YES	Surgery	Other method, specify:	Not Available	Not Available	11	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G2	YES;YES	YES;YES	508;508	488;508	Not Applicable;Not Applicable	Biopsy;Not Applicable	Other, specify;Tumor Resection	Locoregional Recurrence;Distant Metastasis	Pelvis;Paracaval lymph nodes	YES;YES	Not Available;R1	YES	0	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Unknown	Not Available	A8Q8	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	NO	YES	Progressive Disease	WHITE	Regional site;Regional site	TCGA-VS-A8Q8-R61989;TCGA-VS-A8Q8-R61990	762A0FE1-3498-4113-ADB4-8D9C6446EF31;45B2DC77-5D9D-47D5-97C2-8D848FBC675F	Not Available;Not Available	10;10	594;612	558;605	Radiographic Progressive Disease;Radiographic Progressive Disease	7;7	25;5	4500;900	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	VS	1	0	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	Not Available	Not Available	Cervical	Dead	92	2014	2010
TCGA-FU-A3TX	78	FEMALE	Not Available	45	67		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IB2	G3	0	45			Unknown		78	20	Not Applicable	TCGA-FU-A3TX	B75644C2-B515-41CE-9B03-842EF5208A17	Not Available	Not Available	Not Available	Not Applicable	Not Available	6	-28825	Not Applicable	8	Not Available	8	0	Not Available	45	Not Available	Not Available		Unknown;Unknown;Unknown;Unknown;Unknown;Unknown																										Not Available	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Keratinizing squamous cell carcinoma	Not Available	30	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	3	Not Available	Not Available	Not Applicable	Yes	Not Available	Unknown	Not Available	A3TX	Not Available	Not Available	Not Available	Unknown	Not Available	NO	YES	Unknown	Not Evaluated																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	1993	YES	NO	FU	4	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	67	2012	2012
TCGA-IR-A3LA	60	FEMALE	157	4172	101	40.97529311533936	Endometrioid Adenocarcinoma of Endocervix	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	4172			TUMOR FREE		60	Not Available	Not Applicable	TCGA-IR-A3LA	7B8C04D7-824D-493D-8F2C-9ED87A907192	Never Used	ABSENT	Not Available	Not Applicable	Not Available	24	-21949	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	3780	Not Available	Not Available					TCGA-IR-A3LA-D39484;TCGA-IR-A3LA-D39485	879222E5-1EFD-4436-A977-13BB90006308;B61E901D-3B92-401F-AC6A-999C175C46A5	Not Available;Not Available	24;24	148;151	81;81	Cisplatin;Fluorouracil (5-FU)	Complete Response;Complete Response	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-IR-A3LA-F53750;TCGA-IR-A3LA-F56115	4CFA99DB-7051-4AEF-9160-3F87EE54381B;83D414B6-2D49-445D-8803-B212811E8E74							13;28						Not Applicable;Not Applicable	4078;4172		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	12;1							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Not Available									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2013;2014	FEMALE	157	Endometrioid Adenocarcinoma of Endocervix	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Simple Hysterectomy	C53.9	8384/3	C53.9	YES	Dilation & curettage	Other method, specify:	Not Available	Not Available	18	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LA	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-IR-A3LA-R39483	CD1DC818-63E5-4EC8-9ED5-4820E37B8434	Not Available	24	124	81	Complete Response	1	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	IR	1	2	Not Applicable	Not Available	YES	4;4	Cisplatin;Other	70 mg/m2;750 mg/m2	Not Available;Not Available	Not Applicable;Fluorouracil (5-FU)	YES	YES	Not Available	Not Applicable	Not Available	0	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Alive	101	2013	2002
TCGA-ZJ-AAXT	54	FEMALE	165	0	76	27.915518824609734	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	N1	M0	Stage IIIB	G2	0	0			Unknown		54	20	Not Applicable	TCGA-ZJ-AAXT	5916AF71-0262-42CF-AF4B-EAC830A8B419	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-19847	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	3	0.2	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXT	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T3b	Not Available	1982	NO	YES	ZJ	4	3	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	76	2014	2009
TCGA-EA-A44S	31	FEMALE	182	369	83	25.05736022219539	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N1	M0	Stage IIIB	G2	0	369			TUMOR FREE		31	Not Available	Not Applicable	TCGA-EA-A44S	CFB61FD8-0BCA-40B4-878C-CC914A289792	Never Used	ABSENT	Not Available	Not Applicable	Not Available	19	-11621	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	9	9	Not Available					TCGA-EA-A44S-D49901;TCGA-EA-A44S-D49902;TCGA-EA-A44S-D49903;TCGA-EA-A44S-D49905;TCGA-EA-A44S-D49907	354F8B4C-1002-4F0A-B507-FAD0C8C1C3A5;051D1E1E-D001-4288-B8F9-C4119DC36A1A;D4AEB293-B03B-47C2-A043-2EF0415A0447;B4FFE834-F2D2-4DB7-8EF5-4FD29B245D21;C564DE36-51A0-4F7B-AE3D-900803489E96	Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14	155;155;369;369;369	20;20;299;299;299	Carboplatin;Bleomycin;Gemcitabine;Doxorubicin;Bleomycin	Stable Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease	10;10;10;10;10	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2013;2013;2013;2013;2013	1	0	NOT HISPANIC OR LATINO			Not Available			Stable Disease			Not Applicable	TCGA-EA-A44S-F49899	2313546B-AC1A-47DB-8F4E-2B2F40C603E1							14						Not Applicable	369		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	Unknown	YES	Stable Disease									YES						Not Applicable	Not Available	YES	Not Available;Not Available;Not Available;Not Available	Carboplatin;Other;Other;Other	Not Available;Not Available;Not Available;Not Available	Unknown;Unknown;Unknown;Unknown	Not Applicable;Bleomycin;Gemcitabine;Doxorubicin	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	3470	Alive	2013	FEMALE	182	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	10	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A44S	0	0	Preoperative	TUMOR FREE	0	NO	YES	Unknown	WHITE	Primary Tumor Field	TCGA-EA-A44S-R49900	A7674A6E-6C1A-42FC-88F0-4E9DF994CC18	Not Available	14	68	41	Stable Disease	10	Not Available	37.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a2	Not Available	Not Available	YES	NO	EA	1	1	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	83	2012	2012
TCGA-VS-A9U7	30	FEMALE	157	1472	82	33.2670696579983	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N1	M0	Stage IB1	G3	0	1472			TUMOR FREE		30	Not Available	Not Applicable	TCGA-VS-A9U7	6D01421E-D533-4967-8422-97FBC0FB0895	Current User	Not Available	Not Available	Not Applicable	Not Available	11	-11210	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1108	0	Not Available					TCGA-VS-A9U7-D63460	188BFB3C-D196-47B2-9C99-4FACCD06ADE7	Not Available	11	220	192	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A9U7-F67667;TCGA-VS-A9U7-F70919	8BA6A375-77C1-4162-93E1-9E1C482BAEF0;78120651-56B6-424D-A962-53860854BA74							9;10						Not Applicable;Not Applicable	1290;1472		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Not Available;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	18	Pelvic (external iliac, internal iliac, obturator)	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9U7	2	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field;Regional site	TCGA-VS-A9U7-R63461;TCGA-VS-A9U7-R63462	0D18A598-CDF0-4EC1-9B9C-CE251CA5864D;D39D51C6-DADA-409F-B2A0-884F714B1F55	Not Available;Not Available	11;11	245;230	226;190	Complete Response;Complete Response	8;8	4;25	2800;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	82	2014	2011
TCGA-EK-A2RC	33	FEMALE	170	129	72	24.913494809688583	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB1	G3	0	129			TUMOR FREE		33	Not Available	Not Applicable	TCGA-EK-A2RC	AC0AE100-8072-47CC-81D9-8B52B1BF9236	Not Available	Not Available	Not Available	Not Applicable	Positive vaginal margin	7	-12353	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	129	120	Not Available																												0	Not Available	Not Available			NO			Unknown			after surgery	TCGA-EK-A2RC-F58260	1AAF985E-FB66-409A-AB1F-10C81A5AA92C							3						Not Applicable	129		125	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Other	TUMOR FREE	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Biopsy and endocervical curettage	Other method, specify:	Not Available	Not Available	16	Not Available	Not Available	PRESENT	Not Available	12	G3												Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RC	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	Not Available																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	72	2011	2009
TCGA-EK-A2H1	20	FEMALE	160	799	62	24.21875	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB2	G3	0	799			TUMOR FREE		20	Not Available	Not Applicable	TCGA-EK-A2H1	690A7B2A-7DC5-4504-9372-70C8B55E81C7	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-7649	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	799	44	Not Available					TCGA-EK-A2H1-D21355	47D3FA29-395F-42C6-9004-5FE997C50FD9	Not Available	10	70	70	Cetuximab	Not Available	2	1	400	mg/m2	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	640	mg	Not Available	2012	0	Not Available	Not Available			Not Available	Not Applicable	Not Applicable	Not Available	YES	Not Available	Not Applicable	TCGA-EK-A2H1-F21350	6CFC3772-C9D7-4B67-BFDE-EB01348E205E	Not Available	Not Available	Not Applicable	Not Available	Other	Not Available	10	Not Applicable	Not Available	Not Available	Not Available	70	Not Applicable	799	Not Applicable	44	Not Applicable	Not Available	0	Scheduled Follow-up Submission		2	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Cetuximab	Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	Not Applicable	Not Available	YES	Not Available	70	Not Available	Not Available	Not Available	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available																				Alive	2012	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Endocervical curettage, cervical cone biopsy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	G3												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2H1	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	TCGA-EK-A2H1-R21356	0553564C-5A5C-4B16-A08C-A1B80C999CD1	Not Available	10	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	62	2011	2007
TCGA-EA-A1QS	46	FEMALE	164	1203	60	22.3081499107674	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G2	0	1203			TUMOR FREE		46	Not Available	Not Applicable	TCGA-EA-A1QS	6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA	Never Used	ABSENT	Not Available	Not Applicable	Not Available	6	-16923	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	40	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			At last contact	TCGA-EA-A1QS-F66103	01CA5F75-C68A-49A7-B2F8-1050796C0CAA							2						Not Applicable	1203		1203	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	164	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	18	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1QS	0	4	Not Available	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	1	6	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	60	2012	2010
TCGA-VS-A8EL	38	FEMALE	166	1992	78	28.30599506459573	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	M0	Stage IIB	G3	0	1992			TUMOR FREE		38	Not Available	Not Applicable	TCGA-VS-A8EL	E0A5D99B-B58B-4301-B2DC-A767D90059B1	Former User	Not Available	Not Available	Not Applicable	Not Available	22	-14162	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1628	-9	Not Available					TCGA-VS-A8EL-D64589	B38CCD33-80D7-4EDA-B3C7-28F024DC880D	Not Available	5	81	46	Cisplatin	Complete Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A8EL-F67669;TCGA-VS-A8EL-F71214	610391F8-F961-4C1A-8B2B-973601BA9E65;CE02FCD8-135B-4841-B141-D2401B8A1397							9;23						Not Applicable;Not Applicable	1810;1992		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	166	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8EL	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Regional site;Primary Tumor Field	TCGA-VS-A8EL-R61987;TCGA-VS-A8EL-R61988	C071FCDE-F24A-4383-BA80-62368BE4AF60;242BD00C-9395-4403-B907-C0A221DBB345	Not Available;Not Available	10;10	80;109	39;86	Complete Response;Complete Response	7;7	25;4	4500;2800	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2b	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	78	2014	2009
TCGA-DS-A0VK	45	FEMALE	165	1118	52	19.100091827364555	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N1	M0	Stage IB	G3	1	209.0	Other, specify	Distant Metastasis	WITH TUMOR		45	Not Available	Not Applicable	TCGA-DS-A0VK	5ed3c95a-10d0-4cd5-a54d-523e81587fb1	Never Used	ABSENT	Not Available	Not Applicable	Positive vaginal margin	3	-16792	1118	-1	Not Available	Not Available	0	Not Available	Not Available	-71	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DS-A0VK-D8640	e74bdcd2-ccde-4ffd-96f8-9707f96b17c4	Not Available	1	398	209	Carboplatin	Not Available	3	6	588	mg	RECURRENCE	Not Applicable	1	IV	NO	Chemotherapy	Not Available	3528	mg	Not Available	2011	1	0	NOT HISPANIC OR LATINO			NO			Progressive Disease			Not Applicable	TCGA-DS-A0VK-F71138	C02BBDD4-D2D7-49F5-B308-24B974932404							18						1118	Not Available		-71	Renal failure		1		Not Available	3							YES	YES	209	209	Other, specify	Not Applicable	Tumor Resection	Distant Metastasis	Vagina	Not Available	RX	YES		Other, specify	Preoperative	WITH TUMOR	Not Available	Progressive Disease									NO						Not Applicable	Participant refusal	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	NO	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2015	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Surgery	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	16	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2	G3												Not Available	1	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0VK	0	3	Preoperative	WITH TUMOR	0	Not Available	Not Available	Not Available	WHITE	Local Recurrence	TCGA-DS-A0VK-R8641	d370e1f5-d2ff-4717-a8b3-91c9beac7470	1	1	272	229	Not Available	3	25	4500	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2011	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	NO	YES	DS	4	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Progression	Cervical	Dead	52	2011	1996
TCGA-DS-A0VL	25	FEMALE	170	1692	86	29.757785467128027	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N0	M0	Stage IB	G2	0	1692			TUMOR FREE		25	Not Available	Not Applicable	TCGA-DS-A0VL	dfd30f94-19e3-4838-95df-14a3763419af	Never Used	ABSENT	Not Available	Posterior radical soft tissue	Other Location, specify	7	-9186	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	81	0	Not Available																												0	0	Not Available			NO			Unknown;Complete Response			Not Applicable;Not Applicable	TCGA-DS-A0VL-F53634;TCGA-DS-A0VL-F71085	0D657680-5DBE-4106-9A15-CD9976AE700A;126FEA22-F84C-4738-AF33-D7CE6B31FFFE							14;17						1692;Not Applicable	Not Available;81		Not Available;81	Not Available;Not Available		Not Available;0		NO;Not Available	12;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Unknown;Not Available		Unknown;Not Available	Not Available;Pre-Adjuvant Therapy	Unknown;TUMOR FREE	NO;Not Available	Complete Remission/Response;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;NO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;Not Available	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Dead;Alive	2013;2015	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	8	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G2												Not Available	0	0	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0VL	1	0	Preoperative	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	DS	1	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	86	2011	2001
TCGA-ZJ-AAXU	51	FEMALE	165	5	70	25.711662075298438	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N0	M0	Stage IIB	G2	0	5			Unknown		51	15	Not Applicable	TCGA-ZJ-AAXU	DDD4B6D2-5BE0-4EDD-977A-A795EEA3C738	Unknown	Not Available	Not Available	Not Applicable	Not Available	19	-18773	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	5	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	52.86	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXU	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Unknown	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2b	Not Available	Not Available	NO	YES	ZJ	2	0	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	70	2014	2010
TCGA-C5-A8YT	36	FEMALE	Not Available	633	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IB1	G3	1				WITH TUMOR		36	16	Not Applicable	TCGA-C5-A8YT	CECAECB4-51EF-407D-A882-0E4B444B0A77	Never Used	Not Available	Not Available	Not Applicable	Not Available	17	-13253	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	186	Not Available	Not Available					TCGA-C5-A8YT-D58633	023568BE-29CA-47DC-A39F-9E562969725B	Not Available	17	Not Available	62	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-C5-A8YT-F66723	9883E718-B278-4F06-ACF6-5DDCFD26F1DD							22						633	Not Available		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Not Available	WITH TUMOR	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	20	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8YT	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	Not Available	NO	Not Available	WHITE	Primary Tumor Field;Regional site	TCGA-C5-A8YT-R58634;TCGA-C5-A8YT-R58635	BE6A194A-440E-4C26-AE60-168DE9ABC978;809DD439-6442-407C-AFDE-2C98EFAC1CF2	Not Available;Not Available	17;17	104;104	55;55	Not Available;Not Available	4;4	Not Available;28	3600;5040	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2008
TCGA-C5-A1M7	37	FEMALE	165	1409	69	25.34435261707989	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB	G2	0	1409			TUMOR FREE		37	16	Not Applicable	TCGA-C5-A1M7	e8e16aaf-3621-4ce8-b02a-7893dd656e4d	Never Used	ABSENT	Not Available	margins free of tumor	Other Location, specify	24	-13808	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1409	-33	Not Available																												1	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	NO;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1M7-F20922;TCGA-C5-A1M7-F57890	C5F8DD5F-5904-4119-A0AE-6441FA7B8031;388FEB61-988C-4B2C-9E78-F9A048B0D489	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	24;28	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	1409;Not Available	Not Applicable;None	228;Not Available	Not Applicable;Not Available	Not Available;None	1;Not Available	Scheduled Follow-up Submission;None	None;YES	1;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;Not Available	Other;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	Not Available	HPV 18	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Radical Hysterectomy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	30	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G2												Not Available	0	0	4	26	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A1M7	0	0	Preoperative	TUMOR FREE	1	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	C5	2	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	69	2012	1999
TCGA-C5-A8XH	39	FEMALE	163	1394	60	22.58270917234371	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N0	MX	Stage IB1	Not Available	0	1394			TUMOR FREE		39	Not Available	Not Applicable	TCGA-C5-A8XH	183E8D87-3476-46BC-A989-ED4B09809227	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	17	-14444	1394	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	33	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	20	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A8XH	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	2007	NO	YES	C5	4	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	60	2014	2007
TCGA-EK-A2R9	58	FEMALE	162	4	185	70.49230300259107	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0		Stage IB1	G3	0	4			WITH TUMOR		58	Not Available	Not Applicable	TCGA-EK-A2R9	00AD0FFE-2105-4829-A495-1C2ACEB5BB31	Not Available	ABSENT	Not Available	Not Applicable	Not Available	7	-21242	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	4	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2R9-F58255	B7035727-5282-454B-AC18-BA317E344D00							3						Not Applicable	4		4	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Not Available	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical Total Abdominal Hysterectomy and BSO	Other method, specify:	Not Available	Not Available	14	Not Available	Not Available	PRESENT	Not Available	12	G3												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2R9	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	N0	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	185	2011	2011
TCGA-EA-A439	50	FEMALE	160	965	47	18.359375	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a1	N0	M0	Stage IIA1	G3	1	316.0	Cervix	Locoregional Recurrence	TUMOR FREE		50	Not Available	Not Applicable	TCGA-EA-A439	3EDB62C1-25AD-4DEB-A005-E881A887D06A	Not Available	PRESENT	No pelvic spread	Not Applicable	Not Available	20	-18529	Not Applicable	12	Not Available	Not Available	0	Not Available	20	Not Available	Not Available		Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent																										Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A439-F45847;TCGA-EA-A439-F68884	333C5C38-B7D2-4711-AB8D-1DFB724BD4DA;7AB5807B-E29E-41C3-9576-44C2FF3E8C79							23;24						Not Applicable;Not Applicable	441;965		441;965	Not Available;Not Available		0;0		NO;NO	7;12							NO;Not Available	NO;Not Available	321;Not Available	316;Not Available	Cervix;Not Available	Not Applicable;Not Applicable	Cytology;Not Available	Locoregional Recurrence;Not Available	Not Available;Not Available	YES;Not Available	R0;Not Available	YES;NO		Not Available;Not Available	Post-Adjuvant Therapy;Post-Adjuvant Therapy	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Unknown	NO;NO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	4000;4000	Not Applicable;Not Applicable	LDR;LDR	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2013;2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	11	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A439	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	ASIAN	Primary Tumor Field	TCGA-EA-A439-R69589	3CD9595F-69FF-48B5-BDE5-0F9BDE711BD5	Not Available	14	91	46	Complete Response	1	Not Available	40	NO	Internal	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Stage IIA1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a1	Not Available	Not Available	YES	NO	EA	1	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	47	2012	2012
TCGA-C5-A8ZZ	41	FEMALE	Not Available	636	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G2	0	636			TUMOR FREE		41	21	Not Applicable	TCGA-C5-A8ZZ	33BC6504-D9AB-4B64-A87C-012915F36644	Not Available	Not Available	Not Available	Not Applicable	Not Available	17	-15262	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	636	Not Available	Not Available					TCGA-C5-A8ZZ-D58625	13436EC9-48A3-4CEB-9EFE-93F42CB6EA2D	Not Available	17	Not Available	Not Available	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available			Not Available			Not Applicable	TCGA-C5-A8ZZ-F66736	6FBB6F43-C0DD-4991-8522-0D294CD3FF87							22						Not Applicable	Not Available		Not Available	Not Available		Not Available		YES	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Unknown	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8071/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	20	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8ZZ	0	0	Not Available	TUMOR FREE	0	Not Available	Unknown	Not Available	WHITE	Not Available;Regional site	TCGA-C5-A8ZZ-R58626;TCGA-C5-A8ZZ-R58627	B7C720D6-84AD-42A0-BE23-35DEF510559F;739BA4A2-7858-47D8-9048-7E9E2249AFF6	Not Available;Not Available	17;17	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Internal;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2005
TCGA-C5-A1BQ	65	FEMALE	147	604	69	31.93113980285992	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G2	0	604			TUMOR FREE		65	12	Not Applicable	TCGA-C5-A1BQ	E77C3F70-08D1-40D3-B038-F09A519423CC	Not Available	Not Available	Not Available	Not Applicable	Not Available	7	-24018	604	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A1BQ-D34132	A9F43408-7749-4CDF-9C60-6D3B1C4AE50F	Not Available	30	47	11	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A1BQ-F34245	B04B5A51-6D6D-48AF-A668-732CD51F1A07							7						604	Not Available		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Unknown	Not Available	TUMOR FREE	YES	Partial Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Dead	2012	FEMALE	147	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	6	25	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A1BQ	3	0	Not Available	TUMOR FREE	1	NO	Not Available	Partial Remission/Response	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-C5-A1BQ-R34133;TCGA-C5-A1BQ-R34134	ACE47F29-9561-4D9D-BC3C-DB41E3203DC7;5DA1ED8F-DE27-4E50-8EB2-8F9735DDA20C	Not Available;Not Available	30;30	69;60	7;1	Complete Response;Complete Response	7;7	Not Available;Not Available	Not Available;Not Available	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	1999	NO	YES	C5	4	10	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Not Available	Cervical	Dead	69	2012	2002
TCGA-EA-A5ZE	54	FEMALE	153	829	55	23.49523687470631	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	1	425.0	Other, specify	Distant Metastasis	TUMOR FREE		54	Not Available	Not Applicable	TCGA-EA-A5ZE	5E39485A-AC6B-496D-9984-2EA8075F6A9B	Former User	ABSENT	Not Available	Not Applicable	Unknown	24	-19868	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	22	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A5ZE-F57092;TCGA-EA-A5ZE-F70881	6B55DF86-539C-415F-8785-AB7E0D902025;BAAFF3CC-EBA5-42F4-A37C-7B888D7C3504							3;10						Not Applicable;Not Applicable	456;829		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	3;3							Unknown;Not Available	NO;Not Available	425;Not Available	425;Not Available	Other, specify;Not Available	Not Applicable;Not Applicable	Tumor Resection;Not Available	Distant Metastasis;Not Available	Lymph node, inguinal;Not Available	YES;Not Available	R0;Not Available	YES;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									Unknown;Unknown						Not Applicable;Not Applicable	Not Available;Unknown	Not Available;NO	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	Unknown;Unknown	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	153	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Peri (6-12 months since last menstrual period)	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5ZE	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	ASIAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	EA	1	3	Not Applicable	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	55	2013	2012
TCGA-EK-A2RK	67	FEMALE	165	13	101	37.09825528007346	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IA2	G3	0	13			Not Available		67	Not Available	Not Applicable	TCGA-EK-A2RK	ACBFEB99-2B6B-4232-9AB5-A58549C6BC3A	Not Available	Not Available	Not Available	Not Applicable	Positive vaginal margin	2	-24541	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	13	0	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Unknown			Not Applicable	TCGA-EK-A2RK-F58268	F2FF4121-2857-47A6-A8C4-FA6F3ECA9EC5							3						Not Applicable	13		0	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Unknown	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical hysterectomy, BSO, bilateral pelvic lymphadenectomy	Other method, specify:	Non-keratinizing squamous cell carcinoma	Not Available	27	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G3												Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RK	1	Not Available	Preoperative	Not Available	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	101	2011	2009
TCGA-C5-A1BM	78	FEMALE	171	2520	56	19.151191819705208	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2	N1	MX	Stage IB	G2	0	2520			TUMOR FREE		78	Not Available	Not Applicable	TCGA-C5-A1BM	7fb8e7be-4118-41f8-b785-5cbb0afdb8b7	Not Available	PRESENT	Not Available	Not Applicable	Positive vaginal margin	21	-28815	2520	22	Not Available	102	0	Not Available	Not Available	Not Available	Not Available																												Not Available	0	Not Available		Extra-Pelvic Metastatic Disease Present	NO	Not Applicable	Not Applicable	Complete Response	YES	Not Available	Not Applicable	TCGA-C5-A1BM-F30745	762A4263-A5CB-4E7B-8502-9E2963A29FE0	Completed as planned	Not Available	Not Applicable	HDR	Not Available	Not Available	16	Not Applicable	171	186	Not Available	Not Available	2520	Not Available	Not Applicable	Not Available	Unknown	Not Available	Not Available	Scheduled Follow-up Submission		4	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Other, specify	Not Available	TUMOR FREE	NO	Complete Remission/Response	Not Applicable	Not Available	NO	Not Available	154	Not Available	Completed as Planned	Not Available	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Dead	2012	FEMALE	171	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	23	Pelvic (external iliac, internal iliac, obturator);Other Location, specify	perigastric	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	9	G2												Not Available	8	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BM	1	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Primary Tumor Field	TCGA-C5-A1BM-R30746	7FD3BFBF-823C-4A8F-81A1-A8A13B938783	1	16	Not Available	154	Not Available	4	Not Available	Not Available	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2	Not Available	Not Available	NO	YES	C5	4	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	56	2011	1997
TCGA-C5-A7X5	72	FEMALE	163	414	59	22.20633068613798	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IVB	G3	0	414			WITH TUMOR		72	Not Available	Not Applicable	TCGA-C5-A7X5	AED93A3A-7DCB-4BA9-84C0-BC735CBD545F	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-26542	414	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A7X5-D56988;TCGA-C5-A7X5-D56989	03521B1B-810A-4BE9-9B34-207EE2D821DC;07EDF1F2-521E-473D-B227-ED8038C74D39	Not Available;Not Available	27;27	202;202	93;93	CarboPlatinum;Taxol	Not Available;Not Available	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A7X5	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Regional site;Primary Tumor Field	TCGA-C5-A7X5-R56990;TCGA-C5-A7X5-R56991	AA42007D-0D7F-4910-9E9D-DFA8892A85AF;F5932A55-7523-41D1-8F00-3B6441C8DCEB	Not Available;Not Available	27;27	76;92	48;92	Not Available;Not Available	2;2	20;Not Available	5000;2476.5	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	Not Available	Not Available	Not Applicable	Not Available	YES	Not Available;Not Available	Carboplatin;Other	Not Available;Not Available	Not Available;Not Available	Not Applicable;Taxol	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	59	2014	2003
TCGA-MY-A5BF	68	FEMALE	170	634	74	25.60553633217993	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a2	N0	MX	Stage IIA2	G1	0	634			TUMOR FREE		68	Not Available	Not Applicable	TCGA-MY-A5BF	4F4E8834-A716-42E6-BD51-60D80A619202	Not Available	Unknown	Not Available	Not Applicable	Not Available	20	-25082	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	132	Not Available	Not Available					TCGA-MY-A5BF-D67173	F8BD8AE2-4E5B-4FC7-895D-D907C6A45730	Not Available	31	188	160	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-MY-A5BF-F67160	687A0961-9280-4D80-B16E-1B0ADC441AB0							31						Not Applicable	634		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Stable Disease									YES						Not Applicable	Not Available	YES	5	Cisplatin	40mg	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	IMRT	45	Alive	2014	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	robotic	Other	C53.9	8071/3	C53.9	YES	Not Applicable	Lymph node sampling or dissection	Not Available	Not Available	6	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	6	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5BF	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Regional site	TCGA-MY-A5BF-R67174	DF8515B5-83C5-4328-AD33-0B7F7F0E1942	Not Available	31	193	158	Complete Response	10	25	45	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T2a2	Not Available	Not Available	YES	NO	MY	1	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	74	2013	2012
TCGA-C5-A2LX	54	FEMALE	165	2526	65	23.875114784205692	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2	N1	MX	Stage IB1	G2	0	2526			TUMOR FREE		54	18	Not Applicable	TCGA-C5-A2LX	B82F4C6D-530F-4B0E-8F33-995633CB254A	Former User	ABSENT	severe squamous dysplasia (CIN3) extending to the vaginal margin of excision	Not Applicable	Positive vaginal margin	8	-20070	Not Applicable	Not Available	Not Available	31	0	Not Available	491	52	Not Available					TCGA-C5-A2LX-D21317	85A0C61D-EA35-4F65-96E7-BA0F109F33E8	Not Available	8	134	77	Cisplatin	Not Available	2	6	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	1	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO	Not Applicable;None	Not Applicable;None	Complete Response;Complete Response	YES;None	6;None	Not Applicable;Not Applicable	TCGA-C5-A2LX-F21316;TCGA-C5-A2LX-F57087	89B791FE-03B7-448A-AE43-A612EEA957C6;D773F4CA-F971-475C-BFCD-1D415C0212BD	Completed as planned;None	Not Available;None	Not Applicable;None	HDR;None	Cisplatin;None	Not Available;None	8;3	Not Applicable;None	77;None	134;None	134;None	77;None	Not Applicable;Not Applicable	491;2526	Not Applicable;None	73;Not Available	Not Applicable;Not Available	Once weekly;None	1;Not Available	Scheduled Follow-up Submission;None	None;NO	2;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;None	Not Available;Not Available	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	YES;None	134;None	93;None	Not Available;None	Completed as Planned;None	5120;None	YES;YES	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	IMRT;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;YES	None;YES	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Alive	2012;2014	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR	Not Applicable	Not Available	HPV 16	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	39	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	2	G2												Not Available	3	0	4	35	GP5+/GP6+	Not Applicable	No	Not Available	Not Available	Not Available	A2LX	0	0	Pre-Adjuvant Therapy	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A2LX-R21319	CE937AB7-D24C-409F-BB01-2B70D49B83CE	1	8	134	77	Not Available	2	Not Available	5120	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2	Not Available	Not Available	NO	YES	C5	2	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	65	2012	2007
TCGA-C5-A8XJ	74	FEMALE	160	4467	114	44.53125	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IB	Not Available	0	4467			TUMOR FREE		74	Not Available	Not Applicable	TCGA-C5-A8XJ	E89D0CB1-6EC2-43EE-A6D9-B922B680AF34	Not Available	Not Available	Not Available	Not Applicable	Not Available	17	-27087	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2305	Not Available	Not Available					TCGA-C5-A8XJ-D58645	3FCF68B3-E355-4DA0-9C94-B6149603DF9A	Not Available	17	77	42	Cisplatinum	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A8XJ-F66731	1C09EDD6-08C3-4436-A080-FBA75F7FDE18							22						Not Applicable	4467		Not Available	Not Available		Not Available		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	Yes	Not Available	Not Available	Not Available	A8XJ	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	NO	Not Available	WHITE	Regional site;Primary Tumor Field	TCGA-C5-A8XJ-R58646;TCGA-C5-A8XJ-R58647	DE52AD8A-FFAC-4A67-9540-1552C80DE3AC;80E9C986-2729-4B4A-B5D5-372575B57EBB	Not Available;Not Available	17;17	Not Available;83	37;69	Not Available;Not Available	4;4	28;2	5040;6102	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2014;2014	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	1	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	114	2014	2002
TCGA-VS-A8QA	44	FEMALE	160	1099	67	26.171875	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	GX	0	1099			TUMOR FREE		44	Not Available	Not Applicable	TCGA-VS-A8QA	1A3D5555-7013-4F06-878A-98944F075B63	Unknown	Not Available	Not Available	Not Applicable	Positive vaginal margin	30	-16072	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	708	0	Not Available																												0	Not Available	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-VS-A8QA-F67672	445DE3B3-4D85-4603-840C-8FA190404E07							9						Not Applicable	1099		Not Available	Not Available		Not Available		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	26	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	3	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8QA	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	Unknown	Regional site	TCGA-VS-A8QA-R61993	B0D9DCA4-0F41-44A5-8B66-1C702A70C6DB	Not Available	10	165	129	Complete Response	7	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	VS	1	2	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	67	2014	2011
TCGA-IR-A3LB	53	FEMALE	168	2032	94	33.30498866213152	Endocervical Type of Adenocarcinoma	Cervical	Dead	T1b1	N0	M0	Stage IB1	G3	1	317.0	Lung	Distant Metastasis	WITH TUMOR		53	17	Not Applicable	TCGA-IR-A3LB	E7C7783C-1D0F-4F42-A4CF-518825E91D91	Never Used	ABSENT	Not Available	Not Applicable	Not Available	24	-19374	2032	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-IR-A3LB-D39501;TCGA-IR-A3LB-D39503;TCGA-IR-A3LB-D39505;TCGA-IR-A3LB-D39507	7E1FA50E-B5AD-448C-8001-B6D877993913;2DAC5EBB-CAE7-49CB-A810-509E31040F63;F04625F9-2C4F-4B6F-944D-C730D8BB68AC;694F1C43-677B-4B42-AB0F-DF306C5C99EA	Not Available;Not Available;Not Available;Not Available	24;24;24;24	138;141;500;500	72;72;363;363	Cisplatin;Fluorouracil (5-FU);Carboplatin;Paclitaxel	Complete Response;Complete Response;Stable Disease;Stable Disease	1;1;1;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	168	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Radical trachelectomy	Other	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	29	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1	G3	YES	NO	346	317	Lung	Not Applicable	Tumor Resection	Distant Metastasis	Not Available	YES	R0	YES	0	0	2	2.5	Not Available	Not Applicable	No	Unknown	Not Available	Not Available	A3LB	Not Available	Not Available	Not Available	WITH TUMOR	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-IR-A3LB-R39500	D80114DF-760E-41E8-8B3B-C47DAA42DE50	Not Available	24	118	72	Complete Response	1	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	1972	NO	YES	IR	3	4	Not Applicable	Not Available	YES	4;4	Cisplatin;Other	70mg/m2;1000mg/m2	Not Available;Not Available	Not Applicable;Fluorouracil (5-FU)	YES	YES	Not Available	Not Applicable	Not Available	0	Not Available	Not Applicable	Not Applicable	External beam radiation	5040	Not Available	Cervical	Dead	94	2013	2002
TCGA-XS-A8TJ	41	FEMALE	146	890	51	23.925689622818542	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IB1	G2	0	890			TUMOR FREE		41	Not Available	Not Applicable	TCGA-XS-A8TJ	FFD8D31F-BC4B-4E19-BBAF-0E26E9F3A107	Former User	ABSENT	Not Available	FREE MARGINS	Other Location, specify	28	-15298	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	890	0	Not Available					TCGA-XS-A8TJ-D63711;TCGA-XS-A8TJ-D63712	B4F2E7FC-3BE4-456A-9C73-7E967A8E4987;350F7016-7FBD-47FB-B090-E4F49213D592	Not Available;Not Available	15;15	155;155	155;155	Cisplatin;Gemcitabine	Unknown;Unknown	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	0	1	HISPANIC OR LATINO			Not Available																																																																																										FEMALE	146	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	20	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8TJ	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Primary Tumor Field	TCGA-XS-A8TJ-R63706	62CC0EDB-0CC0-484C-BFF5-CEB516FB595D	Not Available	15	155	153	Unknown	8	2	540	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	YES	NO	XS	5	2	Not Applicable	Participant refusal	YES	1	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	51	2014	2012
TCGA-JW-A5VI	45	FEMALE	158	747	59	23.634033007530846	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G3	1	558.0	Lung	Distant Metastasis	WITH TUMOR		45	26	Not Available	TCGA-JW-A5VI	53EB4C4E-0719-476F-9B2B-279D438D7710	Former User	Not Available	Not Available	Not Applicable	Not Available	3	-16444	Not Applicable	6	Not Available	Not Available	0	Not Available	506	6	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Present;Pelvic Nodes Present			TCGA-JW-A5VI-D45006	C5AD3DD1-DB8E-4106-97BE-4CA01A2B0480	Not Available	16	623	571	Topotecan	Clinical Progressive Disease	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	0	HISPANIC OR LATINO			Not Available			Partial Response			Not Applicable	TCGA-JW-A5VI-F58233	5E07D81C-5522-4731-9C8A-82BAB9D34D6C							3						Not Applicable	747		747	Not Available		1		NO	4							YES	NO	Not Available	558	Lung	Lung Biopsy	Other, specify	Distant Metastasis	Not Available	NO	Not Available	YES		Not Available	Post-Adjuvant Therapy	WITH TUMOR	NO	Discrepancy									NO						Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4644	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	6	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	10	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5VI	0	0	Other	WITH TUMOR	0	NO	NO	Complete Remission/Response	AMERICAN INDIAN OR ALASKA NATIVE	Primary Tumor Field	TCGA-JW-A5VI-R45008	C5E09278-557A-432F-B083-9581A6E071CC	Not Available	16	75	29	Complete Response	10	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	JW	2	2	Not Applicable	Not Available	YES	5	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4644	Not Applicable	LDR	0	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Alive	59	2013	2012
TCGA-VS-A9UR	53	FEMALE	161	793	64	24.69040546275221	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T2a	NX	MX	Stage IIA	GX	1	675.0	Other, specify	Distant Metastasis	TUMOR FREE		53	Not Available	Not Applicable	TCGA-VS-A9UR	ADC60720-AC20-4E73-9C37-3AD3119C07D6	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-19688	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	455	0	Not Available					TCGA-VS-A9UR-D63470	5160FB3B-17E6-47A9-B589-32D895E197B2	Not Available	11	90	45	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Unknown;Progressive Disease			Follow up;Not Applicable	TCGA-VS-A9UR-F67684;TCGA-VS-A9UR-F72067	7DAABB56-D4E2-49D7-95DC-42116E9B527B;187D3464-768A-417A-808A-9CC5DF8B0859							9;9						Not Applicable;Not Applicable	611;793		591;Not Available	Not Available;Not Available		1;Not Available		NO;NO	11;4							Not Available;YES	Not Available;NO	Not Available;Not Available	Not Available;675	Not Available;Other, specify	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Distant Metastasis	Not Available;Retroperitoneal	Not Available;NO	Not Available;Not Available	Unknown;YES		Not Available;Not Available	Other;Not Available	Unknown;WITH TUMOR	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	161	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	8	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UR	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A9UR-R63467;TCGA-VS-A9UR-R63468;TCGA-VS-A9UR-R63469	C295A01A-6806-476B-8A32-656961CDC03E;DC4C2E2D-7373-4754-B7F7-7D881203103C;3E86B8D4-A687-4C9C-AE26-085A4E7D5D44	Not Available;Not Available;Not Available	11;11;11	85;108;127	44;99;92	Complete Response;Complete Response;Complete Response	8;8;8	25;5;4	4500;900;2800	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2a	Not Available	Not Available	NO	YES	VS	1	5	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	64	2014	2013
TCGA-C5-A7X8	35	FEMALE	170	83	74	25.60553633217993	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T2a	N1	M0	Stage IB1	G2	0	83			TUMOR FREE		35	25	Not Applicable	TCGA-C5-A7X8	57902B91-BE42-441D-8807-A5EA9C21B214	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	3	-12977	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	83	Not Available	Not Available					TCGA-C5-A7X8-D57044	5D6C5633-842A-4C8C-9FC6-7C9489484FEA	Not Available	28	Not Available	83	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	170	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	27	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	2	5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7X8	1	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Regional site	TCGA-C5-A7X8-R57045	379FBCE0-0222-4170-A3E4-B9C173A48989	Not Available	28	Not Available	80	Not Available	2	Not Available	Not Available	Not Available	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2a	Not Available	Not Available	NO	YES	C5	2	3	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	720	Not Available	Cervical	Alive	74	2014	2003
TCGA-VS-A8Q9	79	FEMALE	150	1630	49	21.77777777777778	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX	Stage IB1	G2	0	1630			TUMOR FREE		79	Not Available	Not Applicable	TCGA-VS-A8Q9	5798D741-C198-4C14-BCC2-E3B17CAF1BE3	Unknown	Not Available	Not Available	Not Applicable	Not Available	30	-28881	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1400	90	Not Available																												1	Not Available	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-VS-A8Q9-F68140	5A6EDEEE-06D1-4DEC-833E-9C2D9C44A2E6							13						Not Applicable	1630		Not Available	Not Available		Not Available		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	150	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	3	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	8	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A8Q9	4	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field	TCGA-VS-A8Q9-R61991;TCGA-VS-A8Q9-R61992	D47A0DC6-C250-4800-A3B3-B22276DFAE84;9513135F-D7A4-4C40-98A2-3B4BA0AB9308	Not Available;Not Available	10;10	148;170	107;149	Complete Response;Complete Response	7;7	25;4	4500;2700	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	NO	YES	VS	1	12	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2700	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	49	2014	2010
TCGA-DS-A1OB	45	FEMALE	152	861	72	31.16343490304709	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b2	N1	M0	Stage IB	G2	1	652.0	Head & Neck	Distant Metastasis	WITH TUMOR		45	Not Available	Not Applicable	TCGA-DS-A1OB	29a48c93-bade-4346-a901-de35a6537337	Never Used	ABSENT	Not Available	None	Other Location, specify	4	-16685	861	Not Available	Not Available	Not Available	0	Not Available	Not Available	29	Not Available					TCGA-DS-A1OB-D20933;TCGA-DS-A1OB-D20934;TCGA-DS-A1OB-D20935;TCGA-DS-A1OB-D20936;TCGA-DS-A1OB-D20938;TCGA-DS-A1OB-D20937;TCGA-DS-A1OB-D20939	D77BC3EB-E2ED-4F2E-9745-CC8A783CCA61;1CEA0147-C6E4-4882-9525-206987056730;7A4F7393-7B23-4A22-A621-AC7A98C0AB8F;4A846040-97B3-454E-A090-73D8365E21CF;EB18139A-43D7-4750-A63E-307C69FB7F89;E42B0F05-014E-43DA-B1F9-063B4E5E0C28;37C3D41D-9AF7-4B0A-84D2-94254659365C	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24;24	Not Available;Not Available;710;710;800;765;800	Not Available;Not Available;675;675;784;745;784	Carboplatin;Taxol;Carboplatin;Taxol;Irinotecan;Gemzar;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1	3;3;6;6;2;4;2	Not Available;Not Available;1.5;60;60;300;1.7	Not Available;Not Available;AUC;mg/m2;mg/m2;mg;AUC	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;2;4;3;4	Not Available;Not Available;Not Available;IV;IV;IV;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;1008;660;200;1500;400	Not Available;Not Available;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012;2012	1	Not Available	NOT HISPANIC OR LATINO			NO	YES	NO	Complete Response	YES	3	Not Applicable	TCGA-DS-A1OB-F19926	EC3961B6-4727-43CC-B85C-6E816B3B80FC	Not Available	Not Available	Not Applicable	Not Available	Carboplatin;Other	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	861	Not Available	652	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		1	Head & Neck	Not Evaluated	Other, specify	Distant Metastasis	Not Applicable	YES													Taxol	Cervical Cancer	Not Available	WITH TUMOR	YES	Complete Remission/Response	Not Applicable	Not Available	YES	121	70	Not Available	Completed as Planned	5040	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	31	Pelvic (external iliac, internal iliac, obturator);Common iliac;Para-aortic	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1	G2												Not Available	16	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1OB	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-DS-A1OB-R19931;TCGA-DS-A1OB-R19929	252A4500-F0D6-4800-A8FE-DBF9D36BB189;E616CE5E-3EF9-4FDC-AF2B-842FBACEB2D5	2;1	4;4	814;121	798;70	Not Available;Not Available	1;1	13;25	2340;5040	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	PALLIATIVE;ADJUVANT	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b2	Not Available	Not Available	NO	YES	DS	Not Available	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Progression	Cervical	Dead	72	2012	2007
TCGA-DS-A1O9	75	FEMALE	132	266	32	18.365472910927455	Cervical Squamous Cell Carcinoma	Cervical	Dead	T4	N0	M0	Stage IVA	G3	1				WITH TUMOR		75	Not Available	Not Applicable	TCGA-DS-A1O9	b8eae533-2ad6-4dcf-98af-0fe7ff23a879	Never Used	PRESENT	Not Available	Not Applicable	Positive vaginal margin	12	-27433	266	-18	Not Available	Not Available	0	Not Available	Not Available	10	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Present;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										1	0	NOT HISPANIC OR LATINO			NO	Not Applicable	Not Applicable	Not Available	NO	Not Available	Not Applicable	TCGA-DS-A1O9-F15174	28BF1FA0-4650-45CB-91D2-9D7106C45522	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	12	Not Applicable	Not Available	Not Available	Not Available	Not Available	266	266	Not Applicable	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		8	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Cervical Cancer	Not Available	WITH TUMOR	NO	Not Available	Not Applicable	Not done per treating physicians discretion	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Participant refusal	Not Applicable	Not Applicable	Not Applicable	Not Available																				Dead	2011	FEMALE	132	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	19	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G3												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1O9	0	0	Preoperative	WITH TUMOR	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T4	Not Available	Not Available	NO	YES	DS	2	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Dead	32	2011	1999
TCGA-EK-A2IR	48	FEMALE	160	3442	61	23.828125	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB2	G3	0	3442			TUMOR FREE		48	Not Available	Not Applicable	TCGA-EK-A2IR	A04CB81E-53BD-4686-9626-52EE87E3E261	Not Available	ABSENT	Not Available	Not Applicable	Not Available	8	-17581	Not Applicable	Not Available	Not Available	4	0	Not Available	2679	-7	Not Available																												0	Not Available	Not Available			Not Available	Not Applicable	Not Applicable	Complete Response	NO	Not Available	Not Applicable	TCGA-EK-A2IR-F21345	E51E74C5-FC7B-4C26-ACFF-57D95AE7C4EE	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	10	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Applicable	3442	Not Applicable	-7	Not Applicable	Not Available	0	Scheduled Follow-up Submission		2	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available																				Alive	2012	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Retroperitoneal pelvic and para-aortic lymph node dissection, radical hysterectomy and BSO.	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	24	Not Available	Not Available	PRESENT	Not Available	11	G3												Not Available	Not Available	Not Available	1	18	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2IR	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	EK	Not Available	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	61	2011	1997
TCGA-EA-A1QT	47	FEMALE	163	1243	68	25.593737061989536	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G2	0	1243			Not Available		47	Not Available	Not Applicable	TCGA-EA-A1QT	970b619f-2eb5-4557-a7b8-5def35943c58	Never Used	ABSENT	Not Available	Not Applicable	Not Available	3	-17475	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	8	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Not Available;Complete Response	NO;None	Not Available;None	Not Applicable;Not Applicable	TCGA-EA-A1QT-F29729;TCGA-EA-A1QT-F65806	DE174934-0AAA-4CE9-90ED-2D5DDDAA39F5;0B295AA7-2A78-466B-BFD7-5CCF391D98B3	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	28;30	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	376;1243	Not Applicable;None	376;376	Not Applicable;Not Available	Not Available;None	0;0	Scheduled Follow-up Submission;None	None;NO	3;9	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;None	Not Available;Not Available	Preoperative;Preoperative	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;NO	Not done per treating physician discretion;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;NO	None;NO	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Alive	2012;2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	18	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1QT	0	3	Not Available	Not Available	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	EA	1	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	68	2011	2011
TCGA-VS-A8QC	51	FEMALE	152	350	90	38.95429362880886	Cervical Squamous Cell Carcinoma	Cervical	Dead	TX	NX	MX	Stage IVA	G2	1	263.0		Distant Metastasis	WITH TUMOR		51	Not Available	Not Applicable	TCGA-VS-A8QC	CB695FDD-381E-4C00-836E-0BA27E32176B	Unknown	Not Available	Not Available	Not Applicable	Not Available	30	-18743	350	Not Available	Not Available	Not Available	0	Not Available	Not Available	-1	Not Available					TCGA-VS-A8QC-D61994	31286449-EDE9-4BC3-ADA7-30943A71494A	Not Available	10	175	35	Paclitaxel	Clinical Progressive Disease	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	3	G2	NO	NO	Not Available	263	Not Applicable	Not Applicable	Not Available	Distant Metastasis	Liver	NO	Not Available	YES	Not Available	Not Available	7	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A8QC	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Regional site;Regional site	TCGA-VS-A8QC-R61995;TCGA-VS-A8QC-R61996	B286FE72-2A2C-4C9C-9539-6C42D19FAF82;C128E534-B651-4EE3-BD4F-CCA23A3856CE	Not Available;Not Available	10;10	175;208	137;176	Radiographic Progressive Disease;Radiographic Progressive Disease	7;7	25;9	4500;1620	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	NO	YES	VS	2	7	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	90	2014	2009
TCGA-EA-A6QX	49	FEMALE	154	730	49	20.66115702479339	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1	M0	Stage IIIB	G3	0	730			TUMOR FREE		49	Not Available	Not Applicable	TCGA-EA-A6QX	A300DB40-E0B8-4C45-ABBD-D7AA06211E9C	Unknown	ABSENT	Not Available	Not Applicable	Unknown	16	-18035	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	19	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-EA-A6QX-F59802;TCGA-EA-A6QX-F71637	869A8173-31B1-4AF8-AE89-4ECB528D045B;D02F903A-D6CE-4F61-93CB-30FE1A0FB8A7							27;27						Not Applicable;Not Applicable	413;730		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	5;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									Unknown;Unknown						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	Unknown;Unknown	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	154	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	3	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Peri (6-12 months since last menstrual period)	10	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A6QX	Not Available	2	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	ASIAN																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T1b1	Not Available	Not Available	YES	NO	EA	1	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	49	2013	2013
TCGA-LP-A7HU	53	FEMALE	155	406	58	24.141519250780437	Endocervical Type of Adenocarcinoma	Cervical	Alive	T2	N0	M0	Stage II	G3	0	406			TUMOR FREE		53	Not Available	Not Applicable	TCGA-LP-A7HU	7067B7DA-FB1B-4827-8FE6-9433ED672D3B	Never Used	ABSENT	Not Available	Not Applicable	Not Available	3	-19595	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	6	Not Available	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-LP-A7HU-F69614	CD3416F6-16C9-4E22-9292-CDA1DF92B95E							15						Not Applicable	406		406	Not Available		1		NO	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	5000	Alive	2015	FEMALE	155	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Simple Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	2	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A7HU	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Not Available	ASIAN	Primary Tumor Field	TCGA-LP-A7HU-R69615	AFB5434D-33D3-44C3-9E78-55B303B85C89	Not Available	15	78	53	Complete Response	1	25	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2	Not Available	Not Available	YES	NO	LP	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	58	2014	2013
TCGA-EK-A3GN	47	FEMALE	160	27	83	32.421875	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX		Stage IIIB	G3	1				WITH TUMOR		47	Not Available	Not Applicable	TCGA-EK-A3GN	F727FCB9-E457-4643-9468-F739133B7E9C	Not Available	ABSENT	Not Available	Not Applicable	Not Available	2	-17425	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1	0	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	TCGA-EK-A3GN-F21156	6236D3CC-531E-4C3C-BE0B-EE982129BF18	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	27	Not Available	0	Not Applicable	Not Available	1	Scheduled Follow-up Submission		4	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available													Not Available	Not Available	Preoperative	WITH TUMOR	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Applicable	Not Applicable	Not Available	Not Available																				Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	ABSENT	Not Available	2	G3												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3GN	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	NX	TX	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	83	2012	2005
TCGA-C5-A1BK	36	FEMALE	151	5385	82	35.963334941449936	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB	G2	0	5385			TUMOR FREE		36	Not Available	Not Applicable	TCGA-C5-A1BK	7df6c297-f2d6-43ef-973b-1f95676b0cc4	Not Available	ABSENT	Not Available	margins free of tumor	Other Location, specify	23	-13297	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	5385	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	NO;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1BK-F30418;TCGA-C5-A1BK-F62484	87B84680-9113-478E-8E40-C95347345EEA;2B7F0D78-1749-4EA9-BC13-F0F929D0D713	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	9;17	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	5385;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;YES	4;7	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Participant refusal;None	NO;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;Not Available	Not done per treating physician discretion;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	151	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	52	HPV 16;Other HPV type(s)	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	ECC	Other method, specify:	Keratinizing squamous cell carcinoma	Not Available	20	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	G2												Not Available	0	0	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1BK	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	C5	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	82	2011	1994
TCGA-FU-A3NI	45	FEMALE	162	638	57	21.719250114311844	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N1	MX	Stage IB1	G2	0	638			TUMOR FREE		45	Not Available	Not Applicable	TCGA-FU-A3NI	DAC27C24-CDBF-4527-9214-178FDE3D098A	Not Available	Not Available	Not Available	Not Applicable	Not Available	17	-16533	Not Applicable	14	Not Available	Not Available	0	Not Available	44	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										Not Available	Not Available	NOT HISPANIC OR LATINO			NO			Unknown			Not Applicable	TCGA-FU-A3NI-F65839	57AAFF5F-2A05-4F2C-AF93-9256F68E63FD							30						638	Not Available		Not Available	Not Available		Not Available		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Unknown	Not Available	Unknown	YES	Unknown									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	29	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2												Not Available	2	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3NI	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b1	Not Available	Not Available	NO	YES	FU	2	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	57	2012	2010
TCGA-MA-AA3X	50	FEMALE	170	617	73	25.259515570934255	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	NX	MX	Stage IIIB	G2	0	617			TUMOR FREE		50	12	Not Applicable	TCGA-MA-AA3X	ADB7C5C8-4AFD-40DC-89F1-571FBD88E4F9	Unknown	Not Available	Not Available	Not Applicable	Not Available	15	-18412	Not Applicable	83	1	77	0	Not Available	617	0	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent		Unknown;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	TCGA-MA-AA3X-D64892	10F27E3D-3267-4B36-A08A-A46F8A6D8FD0	Not Available	15	140	92	Cisplatin	Complete Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	NOT HISPANIC OR LATINO		Bladder Absent;Unknown;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Unknown	Not Available			Complete Response			Not Applicable	TCGA-MA-AA3X-F65478	05FBA44C-3968-4E81-A1E3-DD0A815C11DC							23						Not Applicable	595		595	Not Available		0		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	7	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	9.5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	AA3X	1	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Primary Tumor Field	TCGA-MA-AA3X-R64893	0B1E56C2-01B9-4ED5-85E2-6298F03082A2	Not Available	15	140	85	Complete Response	9	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	Not Available	Not Available	YES	NO	MA	2	3	Not Applicable	Not Available	YES	5	Cisplatin	70	Once weekly	Not Applicable	YES	YES	2900	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5040	Not Available	Cervical	Alive	73	2014	2012
TCGA-VS-A954	67	FEMALE	160	1714	58	22.65625	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	NX	MX	Stage IIIB	G2	0	1714			TUMOR FREE		67	Not Available	Not Applicable	TCGA-VS-A954	9BA72A77-AEF0-4788-8072-60C28902E55D	Never Used	Not Available	Not Available	Not Applicable	Not Available	21	-24498	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1295	92	Not Available					TCGA-VS-A954-D62797	31C84693-FA3B-435F-8746-78CEA4D4B89F	Not Available	24	122	94	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A954-F67678;TCGA-VS-A954-F71212	CB50A808-3E20-4D67-BD61-CCE32AA34DF3;47D2DC83-4E6B-4A00-984D-4CE0DD34050B							9;23						Not Applicable;Not Applicable	1540;1714		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	10	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A954	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	Unknown	Regional site;Regional site;Primary Tumor Field	TCGA-VS-A954-R62794;TCGA-VS-A954-R62795;TCGA-VS-A954-R62796	1ABEFBF9-DEA3-49A3-B217-9612E75EBD5C;C18A2AC7-3A17-4CE2-BF84-371E71953308;A8F5BAB6-E226-4668-9C8E-21F569FAC7E8	Not Available;Not Available;Not Available	24;24;24	139;155;160	97;148;140	Complete Response;Complete Response;Complete Response	7;7;7	25;5;4	4500;900;2700	NO;NO;NO	External;External;Internal	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	Not Available	Not Available	NO	YES	VS	1	10	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2700	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	58	2014	2010
TCGA-HM-A3JK	64	FEMALE	165	632	94	34.52708907254362	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	MX	Stage IIA2	G3	0	632			TUMOR FREE		64	Not Available	Not Applicable	TCGA-HM-A3JK	7C4CD55F-750E-4941-A9F3-0632A75D6531	Never Used	Not Available	carcinoma involves all sections of the cervix with direct extension into the myometrial wall, parametrial tissues and upper vagina.	Not Applicable	Not Available	17	-23618	Not Applicable	17	Not Available	17	0	Not Available	168	21	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-HM-A3JK-D21788	8143DAE6-E257-403E-BB9D-38884E600FF7	Not Available	20	107	79	Cisplatin	Not Available	2	5	70	mg	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	350	mg	Not Available	2012	0	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-HM-A3JK-F33102;TCGA-HM-A3JK-F41748	0A076A54-3E0E-4BF4-9811-5231F0BB51F7;10C0B738-982C-4C8A-9358-383BD8E6DE7E							21;27						Not Applicable;Not Applicable	351;632		21;Not Available	Not Available;Not Available		0;Not Available		NO;NO	6;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Preoperative;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	5;Not Available	Cisplatin;Not Available	70 mg;Not Available	Once weekly;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	3D conformal;Not Available	4500;Not Available	Alive;Alive	2012;2013	FEMALE	165	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	51	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	2	G3												Not Available	1	Not Available	0	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3JK	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-HM-A3JK-R21787	1AD07537-6479-4A45-861A-7303ADEFC69B	1	20	113	79	Not Available	2	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIA2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	13.8	2008	YES	NO	HM	4	0	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	94	2012	2011
TCGA-VS-A9UP	43	FEMALE	155	1444	68	28.30385015608741	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T2a	NX	MX	Stage IIA	G3	1	352.0	Other, specify	Distant Metastasis	WITH TUMOR		43	34	Not Applicable	TCGA-VS-A9UP	F0CFAACC-30E5-4E54-B33A-F0FD5DAD620E	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-15849	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1150	54	Not Available					TCGA-VS-A9UP-D63458	82CD6A7E-AD39-4A38-A53F-0AD1EABE3268	Not Available	11	119	92	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Progressive Disease;Unknown;Partial Response			Not Applicable;Not Applicable;Not Applicable	TCGA-VS-A9UP-F67674;TCGA-VS-A9UP-F69282;TCGA-VS-A9UP-F72390	C345FB70-D1A0-44D1-8679-5ECBEE5C3340;8B5320E4-8475-48BF-AA74-7ED73811B4BF;44680F30-BD0D-4B1C-9CDE-A458739C03A1							13;31;11						Not Applicable;Not Applicable;Not Applicable	1316;1365;1444		Not Available;Not Available;Not Available	Not Available;Not Available;Not Available		Not Available;Not Available;Not Available		NO;NO;NO	11;12;6							Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;1360	Not Available;Not Available;Other, specify	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Distant Metastasis	Not Available;Not Available;Brain	Not Available;Not Available;YES	Not Available;Not Available;Not Available	NO;NO;YES		Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response									YES;YES;YES						Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	YES;YES;YES	YES;YES;YES	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Alive;Alive;Alive	2014;2014;2015	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	8	G3	YES	NO	Not Available	352	Other, specify	MRI	Other, specify	Distant Metastasis	Paraortic lymph nodes	NO	Not Available	YES	Not Available	Not Available	4	1	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UP	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Complete Remission/Response	Unknown	Regional site;Primary Tumor Field	TCGA-VS-A9UP-R63456;TCGA-VS-A9UP-R63457	0E31C757-007D-4848-8051-7386AE7E7A92;8533DD0D-C740-484C-9D6E-11D354352A19	Not Available;Not Available	11;11	124;146	90;125	Complete Response;Complete Response	8;8	25;4	4500;2800	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2a	Not Available	Not Available	NO	YES	VS	2	4	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	68	2014	2011
TCGA-IR-A3LI	48	FEMALE	169	2493	71	24.859073561850074	Endocervical Type of Adenocarcinoma	Cervical	Alive	T2b	N1	M1	Stage IVB	G2	0	2493			TUMOR FREE		48	Not Available	Not Applicable	TCGA-IR-A3LI	75BC22D8-738D-45F8-B6C0-C664F5FEF47C	Never Used	ABSENT	Not Available	Not Applicable	Microscopic parametrial involvement	13	-17741	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2445	Not Available	Not Available					TCGA-IR-A3LI-D38329;TCGA-IR-A3LI-D38330;TCGA-IR-A3LI-D38331;TCGA-IR-A3LI-D38332	6FD64D29-1926-459E-B5DA-816D3F97CCFE;F1DBA871-99FD-4D4C-AB21-A146ACDE4608;01E813AD-1807-4B08-BC61-73BEB8C5C916;2FAF8699-6739-49AC-85ED-333A8BA1E0CF	Not Available;Not Available;Not Available;Not Available	14;14;14;14	73;73;211;211	52;52;135;135	Cisplatin;Paclitaxel;Topotecan HCl;Cisplatin	Complete Response;Complete Response;Complete Response;Complete Response	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	0	Not Available			NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-IR-A3LI-F38327;TCGA-IR-A3LI-F68426	196DEBEF-6C15-4C07-9917-01B07185421A;58746A15-CD77-4542-9F73-496B4ACEC3A9							14;17						Not Applicable;Not Applicable	2493;2493		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;YES	12;11							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Not Available									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	4;4;4;4;Not Available	Cisplatin;Other;Other;Cisplatin;Not Available	40mg/m2;40mg/m2;0.75mg/m2;50mg/m2;Not Available	Once weekly;Once weekly;Not Available;Not Available;Not Available	Not Applicable;Paclitaxel;Topotecan HCl;Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	0;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	IMRT;Not Available	5040;Not Available	Alive;Alive	2012;2014	FEMALE	169	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Surgical resection	Other method, specify:	Not Available	Not Available	25	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Peri (6-12 months since last menstrual period)	4	G2												Not Available	1	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LI	0	2	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-IR-A3LI-R38328	BEFA8E3B-0722-4DC2-BF91-60882B3F193E	Not Available	14	91	50	Complete Response	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	N1	T2b	Not Available	Not Available	NO	YES	IR	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	71	2012	2005
TCGA-VS-A953	63	FEMALE	155	477	47	19.562955254942768	Cervical Squamous Cell Carcinoma	Cervical	Dead	T4	NX	MX	Stage IVA	GX	0	477			WITH TUMOR		63	Not Available	Not Applicable	TCGA-VS-A953	DA901E97-3A1D-4952-8254-9C4E60D2812C	Never Used	Not Available	Not Available	Not Applicable	Not Available	17	-23277	477	Not Available	Not Available	Not Available	0	Not Available	Not Available	0	Not Available																												0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	11	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Unknown	Not Available	A953	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Partial Remission/Response	Unknown																			Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	Not Available	Not Available	NO	YES	VS	1	11	Not Applicable	Adverse event/ complications	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Dead	47	2014	2010
TCGA-EK-A2PI	44	FEMALE	162	586	53	20.195092211553117	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIIB	G2	0	586			WITH TUMOR		44	Not Available	Not Applicable	TCGA-EK-A2PI	BFD82578-8B60-4C23-85A1-FC14A1CF5F12	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-16324	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	0	Not Available																												0	Not Available	Not Available			Not Available			Unknown;Complete Response			Not Applicable;Not Applicable	TCGA-EK-A2PI-F58244;TCGA-EK-A2PI-F63394	865D0E1E-D126-4A56-BFEC-7E3BBC42884D;FA9BAF59-91C3-4E9F-828A-DAB9BA64182A							3;7						Not Applicable;Not Applicable	42;586		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		YES;NO	4;8							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Unknown;NO		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Unknown;NO	Not Available;Not Available									Unknown;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Unknown;NO	Unknown;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	G2												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2PI	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	53	2011	2009
TCGA-EA-A3HT	68	FEMALE	163	954	83	31.239414355075464	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	M0	Stage IB	G1	0	954			TUMOR FREE		68	Not Available	Not Applicable	TCGA-EA-A3HT	3C5B2452-014B-495F-B86A-F522ED84BC3B	Never Used	ABSENT	Not Available	Not Applicable	Not Available	20	-25138	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	19	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			At last contact	TCGA-EA-A3HT-F66111	A8B887B0-1A67-4630-82D0-75E0FDE37471							2						Not Applicable	954		954	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Keratinizing squamous cell carcinoma	Not Available	9	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G1												Not Available	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HT	0	2	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	YES	NO	EA	1	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	83	2011	2011
TCGA-C5-A7CL	48	FEMALE	163	471	103	38.76698407919003	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G2	0	471			WITH TUMOR		48	29	Not Applicable	TCGA-C5-A7CL	BAE2AF5E-484A-44F7-AD6B-66137CDAE300	Not Available	Not Available	Not Available	Not Applicable	Not Available	3	-17869	471	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A7CL-D56981	271171D5-3179-4158-AE53-56A570CA3C73	Not Available	27	77	35	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	0	Not Evaluated			Not Available																																																																																										FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	20	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A7CL	0	0	Not Available	WITH TUMOR	0	Not Available	Not Available	Not Available	WHITE	Unknown;Regional site	TCGA-C5-A7CL-R56982;TCGA-C5-A7CL-R56983	904E48FD-3E51-4F68-9727-7A7E4CE305D8;10FAC1CA-0C59-4184-9FFA-3BFC8B3099FC	Not Available;Not Available	27;27	Not Available;Not Available	27;27	Not Available;Not Available	2;2	6;Not Available	650;61.2	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Gy	2014;2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	3	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	103	2014	2002
TCGA-VS-A9UH	53	FEMALE	Not Available	1427	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T4	NX	MX	Stage IVA	GX	0	1427			TUMOR FREE		53	Not Available	Not Applicable	TCGA-VS-A9UH	6949C03E-067A-49A5-B48D-E9380A1B0B27	Never Used	Not Available	Not Available	Not Applicable	Not Available	20	-19454	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1120	139	Not Available					TCGA-VS-A9UH-D63870	5ECDA20A-D998-4660-A6B2-F178C7B054EE	Not Available	20	133	90	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	Not Available	Not Evaluated			Not Available			Complete Response			Follow up	TCGA-VS-A9UH-F68149	AC89FC95-D632-406F-853D-1076576B05F7							13						Not Applicable	1427		1216	Not Available		1		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A9UH	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Regional site;Regional site	TCGA-VS-A9UH-R63871;TCGA-VS-A9UH-R63872	29065FD8-D8F9-4241-B700-7DE74A76F9E0;0403B71C-6087-4CF6-A25A-828BAEE72488	Not Available;Not Available	20;20	145;160	100;149	Complete Response;Complete Response	8;8	25;5	4500;900	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	Not Available	2014	2010
TCGA-C5-A1MK	79	FEMALE	155	74	63	26.222684703433924	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G3	1				WITH TUMOR		79	Not Available	Not Applicable	TCGA-C5-A1MK	b726f18b-b996-4978-9f27-b3a540e06270	Not Available	Not Available	Not Available	Not Applicable	Not Available	21	-28939	74	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-C5-A1MK-D30184	2B5D6306-B757-4481-AAFD-9C8DBDBBECFB	Not Available	4	74	41	Carboplatin	Not Available	4	5	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	0	NOT HISPANIC OR LATINO		Paraaortic Nodes Present;Pelvic Nodes Present	NO	Not Applicable	Not Applicable	Progressive Disease	YES	5	Not Applicable	TCGA-C5-A1MK-F30183	0665FA73-B8EF-4766-9686-34C75DBA21C9	Treatment not completed	Not Available	Not Applicable	HDR	Carboplatin	Not Available	4	Not Applicable	41	74	74	41	74	Not Available	Not Applicable	Not Available	Not Applicable	Once weekly	Not Available	Scheduled Follow-up Submission		4	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Cervical Cancer	Not Available	WITH TUMOR	YES	Progressive Disease	Not Applicable	Not Available	YES	74	41	2200	Treatment not completed	1980	YES	Not Available	Not Applicable	Not Applicable	Not Applicable	External beam radiation																				Dead	2012	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	58	Other HPV type(s)	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	G3												Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1MK	0	2	Not Available	WITH TUMOR	1	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A1MK-R30185	2C339BD1-F900-4BBC-98A6-149D92140C32	1	4	74	41	Not Available	4	Not Available	4180	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	1	5	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	63	2011	2005
TCGA-Q1-A73P	45	FEMALE	173	483	82	27.39817568244846	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b	N0	MX	Stage IB1	G1	0	483			Unknown		45	Not Available	Not Applicable	TCGA-Q1-A73P	3A3A9B5E-12A1-41F5-A54C-D4C1E0ECCB9E	Former User	ABSENT	Not Available	Not Applicable	Not Available	31	-16450	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	146	146	Not Available																												0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Post-surgery	TCGA-Q1-A73P-F62731	0E6D79E8-4E08-4F5B-8FA1-DE962881BC67							23						Not Applicable	483		295	Not Available		0		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	173	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	17	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A73P	Not Available	Not Available	Post-Adjuvant Therapy	Unknown	Not Available	NO	YES	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	YES	NO	Q1	1	6	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	82	2013	2013
TCGA-EA-A3HQ	60	FEMALE	160	1136	88	34.375	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a	N0	M0	Stage II	G2	0	1136			TUMOR FREE		60	Not Available	Not Applicable	TCGA-EA-A3HQ	6BF00B63-89F8-420C-8D36-F680FB0908B1	Never Used	ABSENT	Not Available	Not Applicable	Not Available	17	-21966	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	65	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO			Complete Response			At last contact	TCGA-EA-A3HQ-F66107	8C3E59CF-540E-4096-B7EE-E522C000F765							2						Not Applicable	1136		1136	Not Available		0		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	13	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	2	G2												Not Available	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HQ	0	2	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a	Not Available	Not Available	YES	NO	EA	1	4	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	88	2012	2011
TCGA-VS-A9V1	46	FEMALE	155	157	45	18.730489073881373	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Dead	T3b	NX	MX	Stage IVB	G2	1	58.0		Distant Metastasis	WITH TUMOR		46	24	Not Applicable	TCGA-VS-A9V1	A6A07BC7-AB1B-429D-81ED-D7A890C88E51	Never Used	Not Available	Not Available	Not Applicable	Not Available	5	-17001	157	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available					TCGA-VS-A9V1-D64593	70591F56-179A-43E5-BC9C-587884B78384	Not Available	5	49	21	Cisplatin	Clinical Progressive Disease	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	9	G2	NO	NO	Not Available	58	Not Applicable	Chest CT	Other, specify	Distant Metastasis	Retroperitoneo	NO	Not Available	YES	Not Available	Not Available	3	2.4	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A9V1	1	Not Available	Not Available	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Regional site	TCGA-VS-A9V1-R64592	05F87958-0746-4CAF-9AF2-C28A02340E27	Not Available	5	52	20	Radiographic Progressive Disease	9	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3b	Not Available	Not Available	NO	YES	VS	2	4	Not Applicable	Not Available	YES	5	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	45	2014	2013
TCGA-VS-A8EK	65	FEMALE	153	829	50	21.35930624973301	Cervical Squamous Cell Carcinoma	Cervical	Dead	T4	NX	M0	Stage IVA	G2	0	829			WITH TUMOR		65	Not Available	Not Applicable	TCGA-VS-A8EK	D9C2CA21-F1A6-4CF4-BE28-6C2492DD38E5	Unknown	Not Available	Not Available	Not Applicable	Not Available	22	-23817	829	Not Available	Not Available	Not Available	0	Not Available	Not Available	58	Not Available					TCGA-VS-A8EK-D62778	4608A3B1-2585-4E69-8194-33D9CA824C35	Not Available	24	104	58	Cisplatin	Partial Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	153	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A8EK	1	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Partial Remission/Response	WHITE	Regional site	TCGA-VS-A8EK-R61985	6CEF663F-8D0D-45A0-B1BF-1080E350C15D	Not Available	10	113	64	Partial Response	7	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T4	Not Available	Not Available	NO	YES	VS	Unknown	6	Not Applicable	Not Available	YES	7	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	50	2014	2008
TCGA-WL-A834	57	FEMALE	162	791	79	30.102118579484834	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N1			G3	0	791			TUMOR FREE		57	43	Not Applicable	TCGA-WL-A834	48D81B1E-CD75-4B55-A0B2-C331BE2A88AE	Former User	Not Available	Not Available	Not Applicable	Microscopic parametrial involvement	6	Not Available	Not Applicable	0	0	Not Available	0	Not Available	549	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	TCGA-WL-A834-D57161;TCGA-WL-A834-D57162;TCGA-WL-A834-D59852	8DFC71FE-774C-44C3-A87B-0B7EA8DBCE27;F7763EE1-727F-4DC9-815E-8C90D2949DD2;C4A9B575-CD38-4852-9E4E-DEA6B8843115	Not Available;Not Available;Not Available	19;19;19	Not Available;92;Not Available	61;92;61	Paclitaxel;Cisplatin;Carboplatin	Not Applicable;Not Available;Not Applicable	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;YES	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-WL-A834-F66179	DBBEC886-B242-46E1-9979-250C7CF7AA51							3						Not Applicable	791		791	Not Available		1		NO	10							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Partial Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	vaginal cuff	Other	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	Not Available	Alive	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	28	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	Not Available	2	6.5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A834	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	WHITE	Regional site;Primary Tumor Field	TCGA-WL-A834-R57163;TCGA-WL-A834-R66386	653A4F63-7BE3-46DA-B0D9-16E3FAB675CF;41319F06-0085-4C8E-BC6D-8AEA9429855C	Not Available;Not Available	19;14	92;122	61;122	Not Available;Complete Response	6;10	25;3	45;Not Available	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Not Available	2014;2014	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	N1	T1b1	Not Available	2012	NO	YES	WL	4	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	79	2014	2012
TCGA-VS-A8EB	41	FEMALE	153	305	64	27.339911999658252	Cervical Squamous Cell Carcinoma	Cervical	Dead	T3b	NX	M1	Stage IIIB	GX	0	305			WITH TUMOR		41	Not Available	Not Applicable	TCGA-VS-A8EB	2C736C5C-9D32-4522-ACFD-6620BC291ACE	Never Used	Not Available	Not Available	Not Applicable	Not Available	22	-15215	305	Not Available	Not Available	Not Available	0	Not Available	Not Available	28	Not Available																												1	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	153	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Evaluated	Not Available	A8EB	1	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Progressive Disease	WHITE	Regional site	TCGA-VS-A8EB-R61978	99BE0B65-9928-4DB6-92FF-8B12330D72DF	Not Available	10	72	31	Radiographic Progressive Disease	7	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	NX	T3b	Not Available	Not Available	NO	YES	VS	2	4	Not Applicable	Not Available	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	64	2014	2010
TCGA-Q1-A73O	37	FEMALE	152	428	76	32.89473684210526	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX	Stage IB2	GX	0	428			Unknown		37	Not Available	Not Applicable	TCGA-Q1-A73O	D0CBE668-5C95-4261-A1E8-CEF55093A0F7	Unknown	ABSENT	Not Available	Not Applicable	Not Available	31	-13601	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	146	146	Not Available					TCGA-Q1-A73O-D50840	0CBEB31F-1EFD-41EB-8D76-26FF440332EA	Not Available	31	89	54	Cisplatin	Complete Response	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	Not Available	HISPANIC OR LATINO			Not Available			Complete Response			Post-surgery	TCGA-Q1-A73O-F62831	50124CF3-240C-4382-AAB5-FF23B783B1F6							25						Not Applicable	428		425	Not Available		0		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A73O	Not Available	Not Available	Post-Adjuvant Therapy	Unknown	Not Available	NO	NO	Unknown	Not Evaluated	Primary Tumor Field	TCGA-Q1-A73O-R50842	AB92587C-C118-40D6-A9CF-CB7DC167FC54	Not Available	31	124	48	Complete Response	10	25	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	YES	NO	Q1	1	Not Available	Not Applicable	Not Available	YES	6	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	76	2013	2013
TCGA-ZJ-A8QQ	24	FEMALE	158	2056	71	28.440954975164235	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N0	M0	Stage IIB	GX	0	2056			TUMOR FREE		24	11	Not Applicable	TCGA-ZJ-A8QQ	B12DEB95-6AA1-49CB-A3C5-A711D42D6FB9	Never Used	Not Available	Not Available	Not Applicable	Not Available	25	-8918	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2056	845	Not Available					TCGA-ZJ-A8QQ-D56891	D9393162-CBD7-4C44-926C-6511920A4C85	Not Available	25	90	54	Cisplatin	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	0	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	158	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	2	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	Not Available	20	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A8QQ	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-ZJ-A8QQ-R56892	B88ED042-AC57-4287-A19D-4AE529F3502E	Not Available	25	100	79	Complete Response	2	5	3000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b2	Not Available	Not Available	NO	YES	ZJ	2	0	Not Applicable	Not Available	YES	6	Cisplatin	40mg/m2	Once weekly	Not Applicable	YES	YES	3000	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	71	2014	2007
TCGA-VS-A9UQ	32	FEMALE	160	1263	72	28.125	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b	N0	MX	Stage IB	G2	1	561.0	Other, specify	Distant Metastasis	TUMOR FREE		32	Not Available	Not Applicable	TCGA-VS-A9UQ	2C600A58-98ED-4572-9B6F-EDBA2719790C	Current User	Not Available	Not Available	Not Applicable	Not Available	11	-11853	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	920	Not Available	Not Available																												Not Available	Not Available	Not Evaluated			Not Available			Progressive Disease;Unknown;Complete Response;Complete Response			Follow up;Not Applicable;Not Applicable;Not Applicable	TCGA-VS-A9UQ-F68152;TCGA-VS-A9UQ-F69283;TCGA-VS-A9UQ-F72068;TCGA-VS-A9UQ-F72391	0C2D3862-AD3C-4E68-88E8-7C6152352F0D;7DABF485-5CE4-4430-B84C-EBE1D47090B9;15AE0004-D63D-48A2-81EC-303B14BBFA3D;8358CE9C-A187-49F4-9DA0-3A88CE73A887							13;31;9;11						Not Applicable;Not Applicable;Not Applicable;Not Applicable	1094;1148;1204;1263		1071;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available		1;Not Available;Not Available;Not Available		NO;NO;NO;NO	11;12;4;6							YES;Not Available;Not Available;Not Available	NO;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	988;Not Available;Not Available;Not Available	Other, specify;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Distant Metastasis;Not Available;Not Available;Not Available	Paraortic lymph node;Not Available;Not Available;Not Available	NO;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO		Not Available;Not Available;Not Available;Not Available	Other;Not Available;Not Available;Not Available	WITH TUMOR;Unknown;TUMOR FREE;TUMOR FREE	NO;NO;NO;NO	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response;Complete Remission/Response									YES;YES;YES;YES						Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	NO;NO;NO;NO	YES;YES;YES;YES	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Alive;Alive;Alive;Alive	2014;2014;2015;2015	FEMALE	160	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Wertheim Meiggs	Other	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	22	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	8	G2	NO	NO	585	561	Other, specify	Not Applicable	Not Available	Distant Metastasis	Ovary	YES	RX	YES	0	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UQ	4	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	Unknown	Primary Tumor Field;Regional site	TCGA-VS-A9UQ-R63448;TCGA-VS-A9UQ-R63449	4744DCE7-AFC7-4471-B796-F5C9CC1BB1FF;F695D9CA-26D0-4A3F-8A03-B38756A05CBC	Not Available;Not Available	11;11	184;200	161;154	Complete Response;Complete Response	8;8	4;25	2000;4500	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	2000	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	72	2014	2011
TCGA-C5-A3HF	24	FEMALE	Not Available	543	Not Available		Mucinous Adenocarcinoma of Endocervical Type	Cervical	Dead				Stage IB2	G2	1	450.0	Other, specify	Distant Metastasis	WITH TUMOR		24	16	Not Applicable	TCGA-C5-A3HF	085DF27C-9BC2-425A-9A49-547D692EA028	Not Available	Not Available	Not Available	Not Applicable	Not Available	16	-9115	543	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	NO	NO	Progressive Disease	YES	Not Available	Not Applicable	TCGA-C5-A3HF-F30756	10EA26AD-B1EF-4B7A-8EDE-CA543994E994	Completed as planned	Not Available	Not Applicable	HDR	Not Available	Not Available	16	Not Available	71	88	Not Available	Not Available	543	Not Available	450	Not Available	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission		4	Other, specify	CT	Other, specify	Distant Metastasis	Pelvis	YES													Not Available	Cervical Cancer	Not Available	WITH TUMOR	NO	Not Available	Not Applicable	Not done per treating physicians discretion	NO	101	57	5040	Completed as Planned	5040	YES	Not Available	Not Applicable	Not Applicable	Not Available	External beam radiation																				Dead	2012	FEMALE	Not Available	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	32	Pelvic (external iliac, internal iliac, obturator);Para-aortic	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2												Not Available	11	Not Available	1	9	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HF	0	0	Not Available	WITH TUMOR	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A3HF-R30757	F2985061-C716-475E-A0F3-929708760102	1	16	101	57	Not Available	4	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	Not Available	2012	1996
TCGA-VS-A9V4	63	FEMALE	161	132	52	20.06095443848617	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Dead	T4	NX	MX	Stage IVA	G2	1	100.0		New Primary Tumor	WITH TUMOR		63	15	Not Applicable	TCGA-VS-A9V4	778389BA-C2E9-47D4-B133-6F4D0E689B34	Not Available	Not Available	Not Available	Not Applicable	Not Available	1	-23334	132	Not Available	Not Available	Not Available	0	Not Available	Not Available	-1	Not Available					TCGA-VS-A9V4-D63703	DCD18A3F-9FC6-43E2-8376-4A4E7D24C11C	Not Available	15	107	79	Cisplatin	Unknown	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	2	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	161	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	10	G2	Not Available	Not Available	Not Available	100	Not Available	Colonoscopy	Other, specify	New Primary Tumor	Sigmoid colon	NO	Not Available	YES	Not Available	Not Available	3	30	Not Available	Not Applicable	Yes	Cervical Cancer	Not Evaluated	Not Available	A9V4	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	Not Available	Unknown	WHITE	Regional site	TCGA-VS-A9V4-R65896	4C70FDE3-B84A-4F01-B471-252B661F12B1	Not Available	1	113	79	Unknown	10	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IVA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T4	Not Available	2013	NO	YES	VS	4	3	Not Applicable	Not Available	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	52	2014	2013
TCGA-FU-A3TQ	55	FEMALE	152	795	59	25.536703601108034	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	MX	Stage IIIB	G2	0	795			TUMOR FREE		55	30	Not Applicable	TCGA-FU-A3TQ	7218AA6F-3345-484F-A329-A3B6169A67C7	Unknown	PRESENT	Not Available	Not Applicable	Not Available	6	-20302	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	48	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-FU-A3TQ-F65841	A8E1920F-2401-4B89-A530-73BE8F08562A							30						Not Applicable	795		Not Available	Not Available		Not Available		YES	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	152	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cone Biopsy / LEEP	Non-keratinizing squamous cell carcinoma	Not Available	12	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	2	Not Available	3	50	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3TQ	0	0	Not Available	TUMOR FREE	0	NO	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	Not Available	Not Available	NO	YES	FU	2	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	59	2012	2010
TCGA-JW-A5VH	53	FEMALE	163	100	80	30.11027889645828	Cervical Squamous Cell Carcinoma	Cervical	Dead	T4	NX	M1	Stage IVB	G2	1	94.0	Other, specify	Distant Metastasis	WITH TUMOR		53	Not Available	N/A	TCGA-JW-A5VH	6813C53C-B256-4115-AD90-24D75328779E	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-19423	100	7	Not Available	Not Available	0	Not Available	Not Available	5	Not Available		Extra-Pelvic Metastatic Disease Present;Pelvic Nodes Present			TCGA-JW-A5VH-D46358;TCGA-JW-A5VH-D69368	1A8782DE-A9E9-4CE0-A472-584BE2B1272C;D7A732E4-CD7C-47F1-853A-26C9493EB66C	Not Available;Not Available	6;7	48;48	27;27	carboplatinum;Paclitaxel	Clinical Progressive Disease;Clinical Progressive Disease	8;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2015	2	0	HISPANIC OR LATINO			Not Available			Progressive Disease			Not Applicable	TCGA-JW-A5VH-F69375	EF326607-5867-4973-BD0D-B7231C1ED63D							20						100	Not Available		Not Available	Not Available		Not Available		YES	1							Not Available	Not Available	Not Available	94	Other, specify	Not Applicable	Not Available	Distant Metastasis	Brain	Not Available	Not Available	YES		Cervical Cancer	Not Available	WITH TUMOR	YES	Not Available									YES						Not Applicable	Not Available	Not Available	Not Available;Not Available	Carboplatin;Cisplatin	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Other	Deceased	Not Applicable	Not Available	Not Available	Dead	2015	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2	Not Available	Not Available	Not Available	94	Other, specify	Imaging Only	Other, specify	Distant Metastasis	Brain	NO	Not Available	YES	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A5VH	0	0	Other	WITH TUMOR	0	NO	NO	Progressive Disease	AMERICAN INDIAN OR ALASKA NATIVE	Regional site	TCGA-JW-A5VH-R58230	75638237-6786-4852-91D2-E2A9D4BFE755	Not Available	3	46	40	Radiographic Progressive Disease	4	5	1900	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IVB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	NX	T4	Not Available	Not Available	NO	YES	JW	1	2	Not Applicable	Not done per treating physicians discretion	NO	2	Carboplatin	Not Available	Once weekly	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	0	Other	Brain and Pulmonary Metastases leading to death	Not Applicable	External beam radiation	1900	Not Available	Cervical	Dead	80	2013	2012
TCGA-VS-A958	46	FEMALE	151	1525	61	26.753212578395683	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	MX	Stage IIB	G2	0	1525			TUMOR FREE		46	Not Available	Not Applicable	TCGA-VS-A958	97CF3268-9756-4659-9E98-F200F96A91F4	Never Used	Not Available	Not Available	Not Applicable	Not Available	21	-16905	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1333	0	Not Available					TCGA-VS-A958-D62804	4B8E9E37-3369-4E1F-9D37-45B1B326F4A0	Not Available	24	83	69	Cisplatin	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-VS-A958-F68144	474A10B1-AA49-45D8-95C1-B0F5B110814B							13						Not Applicable	1525		Not Available	Not Available		Not Available		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	151	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A958	Not Available	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Primary Tumor Field;Regional site;Regional site	TCGA-VS-A958-R62801;TCGA-VS-A958-R62802;TCGA-VS-A958-R62803	006F9146-ABD4-4819-90AD-257B558FA8FB;5CE93E0F-FDC6-4616-A032-53DA339F6AE3;0E594200-A7D3-49BA-B219-A05F3F0934FF	Not Available;Not Available;Not Available	24;24;24	129;128;106	118;119;70	Complete Response;Complete Response;Complete Response	7;7;7	4;5;25	2800;900;4500	NO;NO;NO	Internal;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Adverse event/ complications	YES	4	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2800	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	5400	Not Available	Cervical	Alive	61	2014	2010
TCGA-LP-A4AU	35	FEMALE	153	343	49	20.932120124738347	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2	N1	M0	Stage IIIB	G3	0	343			TUMOR FREE		35	Not Available	Not Applicable	TCGA-LP-A4AU	E15D92A1-6925-4B58-A494-D6F665F67B83	Unknown	Not Available	Not Available	Not Applicable	Unknown	12	-13074	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	3	Not Available	Not Available					TCGA-LP-A4AU-D58086;TCGA-LP-A4AU-D58087	17273461-E423-4C32-93D2-7A05ABAEDB1C;36DCFD67-54B3-451B-BF22-25FE9393781B	Not Available;Not Available	31;31	307;307	91;91	Cisplatin;5FU	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Not Available;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Date of Contact	TCGA-LP-A4AU-F58081	0DEC8F9D-F9CC-45C9-892A-1CE7F40CF7E7							31						Not Applicable	343		343	Not Available		3		NO	3							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	YES	Not Available									YES						Not Applicable	Not Available	YES	Not Available;Not Available	Cisplatin;Other	Not Available;750 mg/m2	Unknown;Unknown	Not Applicable;5FU	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	6500	Alive	2014	FEMALE	153	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Simple Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A4AU	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	ASIAN	Primary Tumor Field	TCGA-LP-A4AU-R60812	16B40533-1E57-49D9-9A3E-10A1BDA3567A	Not Available	19	135	104	Complete Response	6	33	65	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2	Not Available	Not Available	YES	NO	LP	1	1	Not Applicable	Not Available	YES	Not Available;Not Available	Cisplatin;Other	75 mg/m2;750 MG/M2	Not Available;Not Available	Not Applicable;5FU	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	External beam radiation	6500	Not Available	Cervical	Alive	49	2013	2011
TCGA-EX-A3L1	32	FEMALE	160	463	57	22.265625	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a1	N0	M0	Stage IIA1	G3	0	463			TUMOR FREE		32	Not Available	Not Applicable	TCGA-EX-A3L1	F5D90810-8C4B-4CED-9360-383E42CB54B3	Current User	ABSENT	Not Available	Not Applicable	Not Available	19	-11943	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	211	Not Available	Not Available					TCGA-EX-A3L1-D38133	D5445E7B-B1F0-466E-9421-73072DDC7669	Not Available	11	131	96	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2012	Not Available	Not Available	NOT HISPANIC OR LATINO			NO			Complete Response			Not Applicable	TCGA-EX-A3L1-F38130	B0AE48F2-2B6A-4AA1-8B25-6C5664A9527D							11						Not Applicable	463		Not Available	Not Available		Not Available		NO	12							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	41mg/kg	Once weekly	Not Applicable	YES	YES	1500	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2012	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	22	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3												Not Available	0	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3L1	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	Not Available	YES	Not Available	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-EX-A3L1-R38135;TCGA-EX-A3L1-R38136	7C271570-A4A4-4551-80D7-126DFB0DA4BF;CB690BF4-776F-4608-A783-02F991091941	Not Available;Not Available	11;11	130;152	84;137	Complete Response;Complete Response	12;12	25;3	4500;1500	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Stage IIA1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a1	Not Available	Not Available	YES	NO	EX	1	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	57	2012	2011
TCGA-DS-A1OD	49	FEMALE	155	3874	89	37.04474505723205	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	3874			TUMOR FREE		49	Not Available	Not Applicable	TCGA-DS-A1OD	ec609ebe-2db9-4b95-a154-512fdfa9038f	Never Used	ABSENT	Not Available	None	Other Location, specify	12	-17954	Not Applicable	2	Not Available	Not Available	0	Not Available	3097	5	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DS-A1OD-D15186	5FF927AF-D6B8-41A8-984D-219DC466B2A9	Not Available	12	96	75	Cisplatin	Not Available	8	4	70	mg	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	280	mg	Not Available	2011	1	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Complete Response	YES;None	4;None	Not Applicable;Not Applicable	TCGA-DS-A1OD-F15184;TCGA-DS-A1OD-F51565	FA00B4C7-F906-47F6-AF70-A08A4A734B6A;257F3F61-5662-4AAA-AC37-CFA1F6AE7D00	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Cisplatin;None	70 mg;None	12;26	Not Applicable;None	Not Available;None	Not Available;None	96;None	75;None	Not Applicable;Not Applicable	3097;3874	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Once weekly;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;NO	8;11	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	Not Applicable;None	Not Available;None	YES;None	96;None	71;None	4500;None	Completed as Planned;None	4500;None	YES;YES	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;YES	None;YES	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Alive	2011;2013	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	16	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	8	G3												Not Available	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1OD	0	0	Preoperative	TUMOR FREE	0	Not Available	YES	Not Available	WHITE	Primary Tumor Field	TCGA-DS-A1OD-R15185	9E893DCD-3762-4ED4-972D-49C9E7280DB2	1	12	96	71	Not Available	8	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	DS	4	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	89	2011	2003
TCGA-LP-A4AX	45	FEMALE	Not Available	380	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB1	G3	0	380			TUMOR FREE		45	Not Available	Not Applicable	TCGA-LP-A4AX	3223FEC6-1D35-419A-8EE9-7C5885B8BE1E	Unknown	Not Available	Not Available	Not Applicable	Unknown	12	-16544	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-LP-A4AX-F69765	4C42B9D9-6C2F-4B0C-BB5C-97D25DDB8355							19						Not Applicable	380		380	Not Available		1		NO	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2015	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Simple Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	2	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	3	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A4AX	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	ASIAN	Regional site	TCGA-LP-A4AX-R69767	74D7D053-F9AE-4CB3-B6BF-B00EBA95FF72	Not Available	19	94	60	Complete Response	1	25	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	YES	NO	LP	1	2	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2013	2011
TCGA-C5-A3HD	51	FEMALE	170	1582	83	28.719723183391004	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G2	0	1582			TUMOR FREE		51	16	Not Applicable	TCGA-C5-A3HD	12427B02-6E3F-461C-B271-6AB230F628E7	Former User	Not Available	Not Available	Not Applicable	Not Available	17	-18690	Not Applicable	Not Available	Not Available	3	0	Not Available	1582	0	Not Available					TCGA-C5-A3HD-D30835	C267EDF4-0C73-4C1D-96C6-355B2287ADA9	Not Available	17	Not Available	17	Cisplatin	Not Available	4	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	1	0	NOT HISPANIC OR LATINO		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	YES;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A3HD-F30834;TCGA-C5-A3HD-F55537	D0271336-A856-4CC2-9BB5-439CAA421A6D;BA2B1EFC-106C-4F08-9330-971790EC9552	Completed as planned;None	Not Available;None	Not Applicable;None	HDR;None	Cisplatin;None	Not Available;None	17;3	Not Applicable;None	13;None	Not Available;None	Not Available;None	17;None	Not Applicable;Not Applicable	1582;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;YES	4;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	YES;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not Available;None	YES;None	Not Available;None	13;None	Not Available;None	Completed as Planned;None	5040;None	YES;Not Available	Not Available;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	External beam radiation;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	G2												Not Available	Not Available	Not Available	2	27	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3HD	0	0	Preoperative	TUMOR FREE	0	Not Available	Not Available	Not Available	WHITE	Primary Tumor Field	TCGA-C5-A3HD-R30837	385A69DB-EAE9-43CC-AC53-8BD88BAD1E04	1	17	Not Available	13	Not Available	4	Not Available	5040	NO	COMBINATION	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	1995	NO	YES	C5	4	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	83	2012	2004
TCGA-DR-A0ZL	53	FEMALE	155	2669	57	23.72528616024974	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	M0	Stage IB	G3	0	2669			TUMOR FREE		53	Not Available	Not Applicable	TCGA-DR-A0ZL	36605f5f-245c-41e5-a9db-705373da7923	Never Used	ABSENT	Not Available	Not Applicable	Not Available	28	-19384	Not Applicable	9	Not Available	Not Available	0	Not Available	2155	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable	Not Applicable	Complete Response	NO	Not Available	Not Applicable	TCGA-DR-A0ZL-F17115	6522F451-A23D-4743-81CE-4ED2142BE30F	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	28	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Applicable	2669	Not Applicable	4	Not Applicable	Not Available	0	Scheduled Follow-up Submission		3	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	NO													Not Available	Not Available	Preoperative	TUMOR FREE	NO	Complete Remission/Response	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Other	Not Applicable	Not Applicable	Not Applicable	Not Available																				Alive	2011	FEMALE	155	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	24	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	3	G3												Not Available	0	0	1	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0ZL	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	ASIAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b1	Not Available	Not Available	NO	YES	DR	1	1	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	57	2011	2004
TCGA-BI-A0VR	53	FEMALE	Not Available	1505	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	M0	Stage IIIB	G3	0	1505			TUMOR FREE		53	22	Not Applicable	TCGA-BI-A0VR	39a3120c-0889-4a10-816a-e07528a35f7a	Not Available	PRESENT	Not Available	Not Applicable	Not Available	1	-19473	Not Applicable	15	Not Available	Not Available	0	Not Available	1505	Not Available	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent																										Not Available	1	NOT HISPANIC OR LATINO			NO			Complete Response			Not Applicable	TCGA-BI-A0VR-F34080	6A8F1959-567A-4D04-94D5-2ECEC883AAFA							29						Not Applicable	1505		Not Available	Not Available		Not Available		NO	7							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	YES	Not Available									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2012	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Non-keratinizing squamous cell carcinoma	Not Available	43	Pelvic (external iliac, internal iliac, obturator)	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G3												Not Available	1	Not Available	0	20	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A0VR	2	Not Available	Not Available	TUMOR FREE	3	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	M0	N1	T2b	Not Available	1995	NO	YES	BI	4	6	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2011	2006
TCGA-EK-A2RL	32	FEMALE	154	1453	89	37.527407657277784	Endocervical Type of Adenocarcinoma	Cervical	Dead	T1b1	N1	MX	Stage IB	G2	1	1143.0	Cervix	Locoregional Recurrence	TUMOR FREE		32	Not Available	Not Applicable	TCGA-EK-A2RL	61EB08D0-EA01-45E7-884B-AC3D6070172A	Not Available	PRESENT	Not Available	Not Applicable	Not Available	1	-12047	Not Applicable	20	Not Available	Not Available	0	Not Available	721	24	Not Available					TCGA-EK-A2RL-D58212	74B640D3-522E-4D42-9C30-BA9132FDE318	Not Available	2	968	912	Taxol	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Progressive Disease			Not Applicable	TCGA-EK-A2RL-F58210	2581A1BD-9D81-4102-9D22-BC4A42C3056A							2						1453	Not Available		29	Not Available		0		NO	4							Not Available	Not Available	Not Available	1143	Cervix	Radiographic	Other, specify	Locoregional Recurrence	Not Available	Not Available	Not Available	YES		Cervical Cancer	Preoperative	WITH TUMOR	YES	Progressive Disease									NO						Not Applicable	Unknown	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Dead	2014	FEMALE	154	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8384/3	C53.9	YES	biopsy and endocervical curettage	Other method, specify:	Not Available	Not Available	33	Pelvic (external iliac, internal iliac, obturator)	Not Available	ABSENT	Not Available	12	G2												Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2RL	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b1	Not Available	Not Available	NO	YES	EK	Not Available	Not Available	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	89	2011	2009
TCGA-Q1-A5R3	56	FEMALE	162	485	50	19.051973784484073	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX		G2	0	485			TUMOR FREE		56	Not Available	Not Applicable	TCGA-Q1-A5R3	73AA428A-4288-45F8-8A53-CEC173DCC61F	Former User	Unknown	Not Available	Not Applicable	Not Available	26	-20574	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	178	178	Not Available					TCGA-Q1-A5R3-D48282	C5C29ED4-F72E-4232-ACC3-915430D476E6	N/A	11	56	21	Cisplatin	Partial Response	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	YES	2013	0	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-Q1-A5R3-F56894	94A5F763-7C6E-4DBD-ADE1-59B405CE2B96							25						Not Applicable	485		485	Not Available		0		NO	2							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	3000	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	162	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Unknown	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	4	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A5R3	Not Available	Not Available	Post-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-Q1-A5R3-R48281	42602371-D418-4494-B07E-CFB77B73B3E4	Not Available	11	80	43	Partial Response	9	5	3000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	Not Available	Not Available	YES	NO	Q1	1	5	Not Applicable	Not Available	YES	Not Available	Cisplatin	Not Available	Not Available	Not Applicable	YES	YES	3000	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	50	2013	2012
TCGA-JW-A5VL	37	FEMALE	160	474	71	27.734375	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	NX	MX	Stage IB2	G1	0	474			TUMOR FREE		37	Not Available	N/A	TCGA-JW-A5VL	D1A5B028-EC79-456B-81A1-69838E2922DF	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-13604	Not Applicable	14	Not Available	Not Available	0	Not Available	88	-4	Not Available		Pelvic Nodes Present																										1	0	HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-JW-A5VL-F58247	4D37F72D-5FD1-462F-AD32-91A161F475F7							3						Not Applicable	474		474	Not Available		0		NO	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	YES	4	Cisplatin	40mg/m2	Once weekly	Not Applicable	NO	NO	4620	Not Applicable	LDR	540	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Alive	2014	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5VL	0	0	Other	TUMOR FREE	0	NO	Not Available	Complete Remission/Response	AMERICAN INDIAN OR ALASKA NATIVE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T1b2	Not Available	Not Available	YES	NO	JW	1	2	Not Applicable	Not Available	YES	4	Cisplatin	40 mg/m2	Once weekly	Not Applicable	NO	NO	4620	Not Applicable	LDR	540	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Alive	71	2013	2012
TCGA-VS-A952	66	FEMALE	155	1778	65	27.05515088449532	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b	N0	MX	Stage IB1	G2	0	1778			TUMOR FREE		66	Not Available	Not Applicable	TCGA-VS-A952	9FA42FE6-CCD0-4850-B08B-97B20ECEB8DF	Never Used	Not Available	Not Available	Not Applicable	Not Available	21	-24345	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1365	0	Not Available																												0	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Follow up;Not Applicable	TCGA-VS-A952-F67682;TCGA-VS-A952-F72388	B6B67772-7E04-4CDE-ABA6-FC02F080B6B4;E001B4F1-CAB7-4324-A415-27992C3AF2E9							9;11						Not Applicable;Not Applicable	1547;1778		1547;Not Available	Not Available;Not Available		0;Not Available		NO;NO	11;6							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Other;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									NO;NO						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	NO;NO	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	15	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A952	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	VS	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	65	2014	2010
TCGA-VS-A9UD	73	FEMALE	161	739	64	24.69040546275221	Cervical Squamous Cell Carcinoma	Cervical	Alive	T3a	NX	MX	Stage IIIA	G2	0	739			TUMOR FREE		73	Not Available	Not Applicable	TCGA-VS-A9UD	60CFA29F-4770-4EE4-AA37-787F53155662	Never Used	Not Available	Not Available	Not Applicable	Not Available	11	-26815	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	417	-1	Not Available					TCGA-VS-A9UD-D63434	535F5BEE-B950-4EE1-89A0-C45F7565B1B7	Not Available	11	89	55	Cisplatin	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	Not Evaluated			Not Available			Complete Response;Unknown			Not Applicable;Not Applicable	TCGA-VS-A9UD-F67685;TCGA-VS-A9UD-F70279	62DE1494-3440-4432-AE5D-534F48BBF283;247FABB7-FFFD-4E91-B770-3D935C158370							9;3						Not Applicable;Not Applicable	599;739		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;2							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Unknown		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Unknown	YES;YES	Not Available;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	161	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	9	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UD	5	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	NO	Not Available	Complete Remission/Response	WHITE	Regional site;Primary Tumor Field	TCGA-VS-A9UD-R63432;TCGA-VS-A9UD-R63433	8402AECA-469A-47A6-B9BD-327FEAD5BF75;C5DA058C-27F8-4E62-8068-1FFE89616693	Not Available;Not Available	11;11	90;123	54;104	Complete Response;Complete Response	8;8	25;4	4500;2400	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T3a	Not Available	Not Available	NO	YES	VS	1	14	Not Applicable	Not Available	YES	6	Cisplatin	Not Available	Once weekly	Not Applicable	YES	YES	2400	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	64	2014	2013
TCGA-C5-A7CG	55	FEMALE	169	6408	94	32.91201288470292	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB	G2	0	6408			TUMOR FREE		55	Not Available	Not Applicable	TCGA-C5-A7CG	F2C901D1-2039-4046-89B5-C2D45BCF10C3	Never Used	Not Available	Not Available	margins free of tumor	Other Location, specify	3	-20242	Not Applicable	20	Not Available	Not Available	0	Not Available	5564	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-C5-A7CG-F63991	AD654A5B-6601-4D68-A8B7-C112A53C2D8E							22						Not Applicable	6408		Not Available	Not Available		Not Available		NO	8							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Not Available									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	169	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	47	Not Available	Not Available	Not Available	Not Available	1	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7CG	0	0	Not Available	TUMOR FREE	1	Not Available	YES	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	C5	1	6	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	94	2014	1997
TCGA-ZJ-AB0I	25	FEMALE	173	0	78	26.061679307694877	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	N1	MX	Stage IIB	Not Available	0	0			Unknown		25	13	Not Applicable	TCGA-ZJ-AB0I	A4F13656-A941-498A-9AC9-F020ED559B35	Never Used	Unknown	Not Available	Not Applicable	Unknown	19	-9486	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	173	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Unknown	Not Available	Unknown	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	4	13	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AB0I	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	YES	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T2b	Not Available	2006	NO	YES	ZJ	4	4	Not Applicable	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	78	2014	2006
TCGA-DS-A5RQ	80	FEMALE	148	512	61	27.848794740686632	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b1	N0	MX	Stage IB1	G2	0	512			TUMOR FREE		80	27	Not Applicable	TCGA-DS-A5RQ	B16469AF-A721-43E9-A4D7-C39B94D1139F	Unknown	ABSENT	Not Available	Not Applicable	Not Available	15	-29526	Not Applicable	32	Not Available	Not Available	0	Not Available	208	0	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent			TCGA-DS-A5RQ-D43181	20A70A61-B65B-4EE9-BA68-1B3738C291A3	Not Available	15	98	63	Cisplatin	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	1	0	NOT HISPANIC OR LATINO			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-DS-A5RQ-F43182;TCGA-DS-A5RQ-F53355	968C0997-3D1A-42D0-803C-2C145FA8C622;1FBF7E6E-778A-4990-82E3-DDD2271EF7ED							15;11						Not Applicable;Not Applicable	208;512		208;Not Available	Not Available;Not Available		0;Not Available		NO;NO	5;12							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Post-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	6;Not Available	Cisplatin;Not Available	60 mg;Not Available	Once weekly;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;Not Available	4500;Not Available	Alive;Alive	2013;2013	FEMALE	148	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	42	Not Available	Not Available	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	3	35	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A5RQ	0	0	Preoperative	TUMOR FREE	0	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-DS-A5RQ-R43183	78B0CB54-8D7A-4A44-941C-EF102F4B60A6	Not Available	15	103	62	Complete Response	5	30	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	YES	NO	DS	2	3	Not Applicable	Not Available	YES	6	Cisplatin	60 mg	Once weekly	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Alive	61	2013	2012
TCGA-C5-A1MP	34	FEMALE	Not Available	109	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b2	N1	MX	Stage IB2	G3	0	109			TUMOR FREE		34	Not Available	Not Applicable	TCGA-C5-A1MP	08a52bcf-d2e9-497b-938a-4660c332e914	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	21	-12692	Not Applicable	7	Not Available	7	0	Not Available	109	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			NO	Not Applicable;None	Not Applicable;None	Complete Response;Not Available	NO;None	Not Available;None	Not Applicable;Not Applicable	TCGA-C5-A1MP-F29224;TCGA-C5-A1MP-F57086	10E45440-0CEC-43CC-8DD7-3F53BDFCC1A3;79CD330E-9771-4D9D-AC39-4DAD789CC2D7	Not Available;None	Not Available;None	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Applicable;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Applicable;Not Applicable	109;Not Available	Not Applicable;None	Not Available;Not Available	Not Applicable;Not Available	Not Available;None	Not Available;Not Available	Scheduled Follow-up Submission;None	None;YES	3;3	Not Applicable;None	Not Available;None	Not Applicable;None	Not Applicable;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	Not Available;None	Not Available;Not Available	Not Available;Not Available	TUMOR FREE;Not Available	NO;Not Available	Complete Remission/Response;Not Available	Not Applicable;None	Not done per treating physicians discretion;None	NO;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;Not Available	Not done per treating physician discretion;None	Not Applicable;None	Not Applicable;None	Not Applicable;None	Not Available;None	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Available	None;Not Available	None;Not Available	None;Not Applicable	None;Not Applicable	None;Not Available	None;Not Available	Alive;Not Available	2012;2014	FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	54	Pelvic (external iliac, internal iliac, obturator);Common iliac;Para-aortic	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	10	G3												Not Available	6	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A1MP	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N1	T1b2	8.7	Not Available	NO	YES	C5	1	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2011	2009
TCGA-ZJ-AAXI	67	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T2b	NX	M0	Stage IIB	G2	0	0			Unknown		67	Not Available	Not Applicable	TCGA-ZJ-AAXI	40A86987-E77F-4977-92B1-8217796E1938	Unknown	Not Available	Not Available	Not Applicable	Not Available	31	-24497	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXI	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	NX	T2b	Not Available	Not Available	NO	YES	ZJ	Unknown	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2010
TCGA-FU-A57G	49	FEMALE	160	1078	57	22.265625	Endocervical Type of Adenocarcinoma	Cervical	Alive	T1b2	N0	MX	Stage IB2	G2	0	1078			TUMOR FREE		49	Not Available	Not Applicable	TCGA-FU-A57G	968BD652-786C-4DDB-A937-DC480CB821FC	Former User	ABSENT	Not Available	Not Applicable	Not Available	31	-17905	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	40	40	Not Available																												1	Not Available	NOT HISPANIC OR LATINO			Not Available			Complete Response			Not Applicable	TCGA-FU-A57G-F65838	579A889E-B348-4E07-B574-54AB09E53033							30						Not Applicable	1078		Not Available	Not Available		Not Available		NO	9							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	160	Endocervical Type of Adenocarcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.0	8384/3	C53.0	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	26	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	A57G	1	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Unknown	WHITE																			Not Applicable	Not Applicable	Stage IB2	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b2	Not Available	Not Available	YES	NO	FU	1	3	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	57	2013	2011
TCGA-VS-A9V2	29	FEMALE	156	555	49	20.134779750164366	Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB1	G2	0	555			TUMOR FREE		29	Not Available	Not Applicable	TCGA-VS-A9V2	03804F9B-DF7C-462C-8984-8EB3A5ED4999	Never Used	Not Available	Not Available	Not Applicable	Not Available	5	-10637	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	237	-1	Not Available																												1	Not Available	Not Evaluated			Not Available			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-VS-A9V2-F67677;TCGA-VS-A9V2-F70886	45109410-95C1-430B-8FDA-BDAC9C9DB559;ADF66038-E257-40F9-9A32-91F618B48CF2							9;10						Not Applicable;Not Applicable	427;555		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;NO	11;3							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	NO;NO	Complete Remission/Response;Complete Remission/Response									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	NO;NO	YES;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	156	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Wertheim Meiggs	Other	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	26	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	9	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	2	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A9V2	Not Available	Not Available	Preoperative	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Regional site	TCGA-VS-A9V2-R64587	6CCF4683-024E-4970-8E95-0F658529E1BB	Not Available	5	142	104	Complete Response	9	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	VS	1	2	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Alive	49	2014	2013
TCGA-GH-A9DA	27	FEMALE	170	540	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T1b	N0	MX	Stage IB1	G3	0	540			TUMOR FREE		27	14	Not Applicable	TCGA-GH-A9DA	67195401-9099-4CA9-9790-F42BCB815289	Unknown	ABSENT	Not Available	Not Applicable	Not Available	7	-10160	Not Applicable	Not Available	Not Available	42	0	Not Available	274	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO		Pelvic Nodes Present	Not Available			Complete Response			routine follow-up visit	TCGA-GH-A9DA-F71246	47A760E4-E796-44B7-95BF-C5549CA49ECF							23						Not Applicable	540		540	Not Available		0		NO	3							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Other	TUMOR FREE	NO	Complete Remission/Response									NO						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2015	FEMALE	170	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	15	Not Available	Not Available	ABSENT	Not Evaluated	5	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	3	6.5	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A9DA	2	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	11.6	Not Available	YES	NO	GH	2	5	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2013
TCGA-EK-A2PM	81	FEMALE	157	18	51	20.690494543389185	Cervical Squamous Cell Carcinoma	Cervical	Alive				Stage IIB	G3	0	18			WITH TUMOR		81	Not Available	Not Applicable	TCGA-EK-A2PM	085FB6D8-6265-484E-9307-8292386714B7	Not Available	Not Available	Not Available	Not Applicable	Not Available	2	-29747	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	0	Not Available																												0	Not Available	Not Available			Not Available			Unknown			Not Applicable	TCGA-EK-A2PM-F58253	51ECDB55-6CE0-4614-8E9B-0593B8E7DAFE							3						Not Applicable	18		18	Not Available		0		YES	4							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Preoperative	Not Available	Unknown	Not Available									Unknown						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	12	G3												Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A2PM	Not Available	Not Available	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	WHITE																			Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1988	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	EK	Not Available	3	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	51	2011	2008
TCGA-VS-A94Y	47	FEMALE	154	144	44	18.552875695732837	Cervical Squamous Cell Carcinoma	Cervical	Dead	T2b	NX	MX	Stage IIB	GX	0	144			WITH TUMOR		47	44	Not Applicable	TCGA-VS-A94Y	0E7F79CD-D188-42EA-BF96-4BA9E9B8606B	Current User	Not Available	Not Available	Not Applicable	Not Available	27	-17465	144	Not Available	Not Available	Not Available	0	Not Available	Not Available	1	Not Available					TCGA-VS-A94Y-D62789	6D107EBB-1755-4A7C-9A3A-21A49777DDFB	Not Available	24	104	95	Cisplatin	Clinical Progressive Disease	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	1	Not Available	Not Evaluated			Not Available																																																																																										FEMALE	154	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	5	GX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	1	1	Not Available	Not Applicable	No	Cervical Cancer	Unknown	Not Available	A94Y	Not Available	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	NO	NO	Progressive Disease	WHITE	Regional site	TCGA-VS-A94Y-R62788	FB46420F-6375-437E-B620-1B0324E5445C	Not Available	24	137	89	Radiographic Progressive Disease	7	25	4500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	T2b	Not Available	Not Available	NO	YES	VS	2	1	Not Applicable	Adverse event/ complications	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	YES	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	3D conformal	4500	Not Available	Cervical	Dead	44	2014	2010
TCGA-ZJ-AAXD	35	FEMALE	Not Available	0	Not Available		Cervical Squamous Cell Carcinoma	Cervical	Alive	T3b	N0	M0	Stage IIIB	G2	0	0			Unknown		35	Not Available	Not Applicable	TCGA-ZJ-AAXD	AF33DF2E-9737-4F63-952C-858A70AA589C	Unknown	Not Available	Not Available	Not Applicable	Not Available	30	-12968	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	0	Not Available	Not Available																												Not Available	Not Available	Unknown			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Available	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	Not Available	Unknown	Not Available	AAXD	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Unknown	Unknown																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T3b	Not Available	Not Available	NO	YES	ZJ	Unknown	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Unknown	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	Not Available	2014	2010
TCGA-ZX-AA5X	64	FEMALE	157	119	56	22.7189744005842	Cervical Squamous Cell Carcinoma	Cervical	Alive	TX	NX	MX	Stage IIIB	G2	1				WITH TUMOR		64	Not Available	Not Applicable	TCGA-ZX-AA5X	4756ACC0-4E96-44D4-B359-04D64DC7EB84	Unknown	Not Available	Bilateral pelvic wall involvement on imaging	Not Applicable	Not Available	24	-23440	Not Applicable	-2	Not Available	52	0	Not Available	119	7	Not Available		Bladder Present;Unknown;Unknown;Unknown;Unknown;Unknown																										1	0	NOT HISPANIC OR LATINO		Unknown;Extra-Pelvic Metastatic Disease Absent;Unknown;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	Not Available			Unknown			Not Applicable	TCGA-ZX-AA5X-F69357	123886C1-D172-45B4-BD3A-6FF205BA4FF4							7						Not Applicable	119		7	Not Available		1		YES	1							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown		Not Available	Pre-Adjuvant Therapy	WITH TUMOR	Unknown	Unknown									Unknown						Not Applicable	Participant refusal	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2015	FEMALE	157	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	11	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	2	Not Available	Not Available	Not Applicable	No	Not Available	Other, specify	Positive for Hepatitis A	AA5X	0	0	Pre-Adjuvant Therapy	WITH TUMOR	0	NO	NO	Not Applicable	WHITE																			Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	NX	TX	15.8	Not Available	YES	NO	ZX	1	2	Not Applicable	Participant refusal	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	Unknown	Unknown	Not Available	Not Applicable	Not Available	Not Available	Participant refusal	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	56	2014	2013
TCGA-VS-A9UZ	61	FEMALE	149	2044	54	24.32322868339264	Mucinous Adenocarcinoma of Endocervical Type	Cervical	Alive	T1b	N0	MX	Stage IB1	G2	0	2044			TUMOR FREE		61	Not Available	Not Applicable	TCGA-VS-A9UZ	6817BB3E-1F8A-457C-9AB0-31CCDA8B6868	Never Used	Not Available	Not Available	Not Applicable	Not Available	20	-22344	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	1939	Not Available	Not Available																												Not Available	Not Available	Not Evaluated			Not Available			Complete Response			Not Applicable	TCGA-VS-A9UZ-F68142	2EC2F2ED-57AC-42BE-8AF9-8D2481CE5E8E							13						Not Applicable	2044		Not Available	Not Available		Not Available		NO	11							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response									YES						Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2014	FEMALE	149	Mucinous Adenocarcinoma of Endocervical Type	No	Not Available	Not Applicable	Not Available	Not Available	Wertheim Meiggs	Other	C53.9	8482/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	26	Not Available	Not Available	Not Available	Peri (6-12 months since last menstrual period)	8	G2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	4	Not Available	Not Available	Not Applicable	No	Not Available	Not Evaluated	Not Available	A9UZ	Not Available	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Complete Remission/Response	WHITE	Primary Tumor Field	TCGA-VS-A9UZ-R63875	CF8B5425-7534-452A-B764-655E123D1EBB	Not Available	20	256	241	Complete Response	8	4	3600	NO	Internal	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b	Not Available	Not Available	NO	YES	VS	1	4	Not Applicable	Not Available	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	3600	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Alive	54	2014	2009
TCGA-C5-A7UI	42	FEMALE	Not Available	2888	86		Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b1	N0	MX	Stage IB1	G3	0	2888			TUMOR FREE		42	Not Available	Not Applicable	TCGA-C5-A7UI	CE5765FB-5221-4CBF-AA76-BB863803DF57	Not Available	Not Available	Not Available	margins free of tumor	Other Location, specify	1	-15349	2888	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	Not Available	NOT HISPANIC OR LATINO			Not Available																																																																																										FEMALE	Not Available	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Non-keratinizing squamous cell carcinoma	Not Available	24	Not Available	Not Available	Not Available	Not Available	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	3	12	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A7UI	1	Not Available	Not Available	TUMOR FREE	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN																			Not Applicable	Not Applicable	Stage IB1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	MX	N0	T1b1	Not Available	Not Available	NO	YES	C5	2	4	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	86	2014	2004
TCGA-C5-A2LZ	65	FEMALE	163	3046	85	31.992171327486922	Cervical Squamous Cell Carcinoma	Cervical	Dead				Stage IIIB	G2	1	2893.0		Distant Metastasis	WITH TUMOR		65	15	Not Applicable	TCGA-C5-A2LZ	BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0	Unknown	Not Available	Not Available	Not Applicable	Not Available	10	-24059	3046	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available																												Not Available	0	NOT HISPANIC OR LATINO			Not Available			Progressive Disease			Not Applicable	TCGA-C5-A2LZ-F33609	1E30F6A6-F672-4B24-8113-9A237BA43709							10						3046	Not Available		Not Available	Not Available		Not Available		NO	7							Unknown	Unknown	Not Available	2893	Unknown	Not Applicable	Not Available	Distant Metastasis	Not Available	Unknown	Not Available	YES		Cervical Cancer	Not Available	WITH TUMOR	NO	Complete Remission/Response									YES						Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Dead	2012	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Not Evaluated	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	Not Available	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	7	G2	Unknown	Unknown	Not Available	2893	Unknown	Not Applicable	Not Available	Distant Metastasis	Not Available	Unknown	Not Available	YES	Not Available	Not Available	4	50	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A2LZ	1	0	Not Available	WITH TUMOR	0	NO	Not Available	Complete Remission/Response	WHITE	Primary Tumor Field;Primary Tumor Field	TCGA-C5-A2LZ-R33611;TCGA-C5-A2LZ-R33612	F2E7AFCB-4077-4208-8E9A-87AB06FF294F;0A88AE6F-B055-43BF-B6E8-24B1B1B6733A	Not Available;Not Available	10;10	62;58	14;28	Complete Response;Complete Response	7;7	Not Available;Not Available	4500;Not Available	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2012;2012	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	C5	2	5	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	YES	Not Available	Not Applicable	LDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	4500	Not Available	Cervical	Dead	85	2012	1998
TCGA-MY-A913	28	FEMALE	163	524	76	28.604764951635364	Cervical Squamous Cell Carcinoma	Cervical	Alive	Tis	N0	M1	Stage IIA	G3	0	524			TUMOR FREE		28	Not Available	Not Applicable	TCGA-MY-A913	C9F519B6-73F1-4737-83CB-F5EF208592CD	Unknown	Not Available	Not Available	Not Applicable	Not Available	23	-10379	Not Applicable	166	21	-7	0	Not Available	167	152	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Absent;Paraaortic Nodes Absent;Pelvic Nodes Absent;Supraclavicular Absent	TCGA-MY-A913-D59733	6CFF5264-76FD-43DC-87CB-9C01433D42E3	Not Available	20	79	30	Cisplatin	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	0	Not Available	HISPANIC OR LATINO		Bladder Absent;Unknown;Unknown;Unknown;Pelvic Nodes Present;Unknown	Not Available			Complete Response			Not Applicable	TCGA-MY-A913-F71177	2AF15E75-7DCC-4C3B-8308-CE67192BFBC5							20						Not Applicable	524		524	Not Available		1		NO	3							Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO		Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response									YES						Not Applicable	Not Available	YES	6	Cisplatin	40mg	Once weekly	Not Applicable	YES	YES	21	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Alive	2015	FEMALE	163	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not applicable	Not Applicable	Not Available	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	5	Not Available	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A913	1	1	Post-Adjuvant Therapy	TUMOR FREE	Not Available	NO	NO	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Primary Tumor Field;Primary Tumor Field	TCGA-MY-A913-R58806;TCGA-MY-A913-R58805	8D1B87D3-E4A5-4149-A40F-8B14101D8BA3;40D24AF3-A51A-412A-9D75-ABAC9509BAB0	Not Available;Not Available	23;23	108;84	98;30	Complete Response;Complete Response	4;4	3;25	21;50	NO;NO	Internal;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M1	N0	Tis	26.1	Not Available	YES	NO	MY	5	7	Not Applicable	Not Available	YES	5	Cisplatin	40mg	Once weekly	Not Applicable	YES	YES	50	Not Applicable	HDR	Not Available	Not Available	Not Applicable	Not Applicable	External beam radiation	50	Not Available	Cervical	Alive	76	2014	2013
TCGA-IR-A3LH	49	FEMALE	154	2394	74	31.202563670096136	Cervical Squamous Cell Carcinoma	Cervical	Alive	T2a1	N0	M0	Stage IIA1	G4	0	2394			TUMOR FREE		49	24	Not Applicable	TCGA-IR-A3LH	F24ED9C0-92BB-4003-86D2-42AB26617A05	Former User	ABSENT	Not Available	Not Applicable	Positive vaginal margin	13	-18118	Not Applicable	Not Available	Not Available	Not Available	0	Not Available	2394	Not Available	Not Available					TCGA-IR-A3LH-D38301	3D3105F8-BC2E-4485-B58F-96DDF1DB8EE8	Not Available	14	183	148	Cisplatin	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2012	Not Available	1	Not Available			NO			Complete Response;Complete Response			Not Applicable;Not Applicable	TCGA-IR-A3LH-F38298;TCGA-IR-A3LH-F68422	588B37E3-4421-48B1-8E69-8BD9BD851994;21E6801B-0528-4809-AD68-1490F52A6750							14;17						Not Applicable;Not Applicable	2394;2394		Not Available;Not Available	Not Available;Not Available		Not Available;Not Available		NO;YES	12;11							Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Not Available									YES;YES						Not Applicable;Not Applicable	Not Available;Not Available	YES;Not Available	6;Not Available	Cisplatin;Not Available	40mg/m2;Not Available	Once weekly;Not Available	Not Applicable;Not Applicable	YES;YES	YES;YES	2000;Not Available	Not Applicable;Not Applicable	HDR;Not Available	0;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Applicable;Not Applicable	External beam radiation;Not Available	4500;Not Available	Alive;Alive	2012;2014	FEMALE	154	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Not Available	Not Available	40	Not Available	Not Available	ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G4												Not Available	0	0	1	20	Not Available	Not Applicable	No	Not Available	Not Available	Not Available	A3LH	0	0	Not Available	TUMOR FREE	0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Primary Tumor Field;Primary Tumor Field	TCGA-IR-A3LH-R38299;TCGA-IR-A3LH-R38300	0CE9C2F8-E78E-497A-A8B1-BDDEC1A38D07;935C72D9-C883-4BEE-8ACC-06576DBD4495	Not Available;Not Available	14;14	182;220	148;192	Complete Response;Complete Response	12;12	25;5	4500;2000	NO;NO	External;Internal	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Stage IIA1	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	2009	Not Applicable	Not Applicable	Not Applicable	M0	N0	T2a1	Not Available	2000	NO	YES	IR	4	2	Not Applicable	Not Available	Not Available						Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Not Applicable	Not Applicable	Not Available	Not Available	Complete response	Cervical	Alive	74	2012	2005
TCGA-JX-A3PZ	25	FEMALE	175	642	58	18.93877551020408	Cervical Squamous Cell Carcinoma	Cervical	Dead	T1b	N0	M0	Stage IB	G2	1	617.0	Other, specify	Distant Metastasis	WITH TUMOR		25	Not Available	Not Applicable	TCGA-JX-A3PZ	3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04	Never Used	ABSENT	Not Available	Not Applicable	Unknown	17	-9303	642	-1	Not Available	Not Available	0	Not Available	Not Available	538	Not Available		Bladder Absent;Extra-Pelvic Metastatic Disease Absent;Parametrium Present;Paraaortic Nodes Absent;Pelvic Nodes Absent;Unknown																										0	0	Unknown			Not Available																																																																																										FEMALE	175	Cervical Squamous Cell Carcinoma	No	Not Available	Not Applicable	Not Available	Not Available	Not Applicable	Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Not Applicable	Biopsy (cervical / CT-guided / Other)	Keratinizing squamous cell carcinoma	Not Available	22	Not Available	Not Available	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	4	G2	Not Available;YES;Not Available;Not Available	YES;Not Available;YES;YES	Not Available;Not Available;Not Available;Not Available	617;491;617;617	Other, specify;Other, specify;Other, specify;Other, specify	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Cytology;Not Available;Not Available	Distant Metastasis;Locoregional Recurrence;Distant Metastasis;Distant Metastasis	Brain;Pelvis;L shoulder;L chest wall	NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available	YES	0	0	0	Not Available	Not Available	Not Applicable	No	Cervical Cancer	Not Available	Not Available	A3PZ	0	0	Pre-Adjuvant Therapy	WITH TUMOR	0	NO	YES	Complete Remission/Response	WHITE																			Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	1995	Not Applicable	Not Applicable	Not Applicable	M0	N0	T1b	Not Available	Not Available	NO	YES	JX	1	0	Not Applicable	Not done per treating physicians discretion	NO	Not Available	Not Available	Not Available	Not Available	Not Applicable	NO	NO	Not Available	Not Applicable	Not Available	Not Available	Not done per treating physician discretion	Not Applicable	Not Applicable	Not Available	Not Available	Not Available	Cervical	Dead	58	2014	1995
